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Abstract
A6-desaturase is located in a pivotal position in the metabolism of essential fatty
acids and a low activity may lead to coronary heart disease (CHD). Experimental
evidence suggests that A6-desaturase is low in humans and data from cross-cultural
and case-control studies using fatty acid compositional analyses propose that its
activity is reduced by risk markers for CHD. In this thesis the role of some factors
implicated in CHD such as diabetes, hypercholesterolaemia and stress are considered
and their effect on A6-desaturase activity and tissue fatty acid composition is assessed
in the rat.
The assay for the A6-desaturation of linoleic acid was re-examined and optimised.
Microsomal protein and albumin concentrations were found to be critical because of
their substrate binding effects. It was also found necessary to measure the amount of
non-esterified linoleic acid in microsomal preparations as it competes with the
radioactive substrate.
The role of dietary cholesterol on both linoleic acid A6-desaturation and tissue
fatty acid composition was assessed. Cholesterol enrichment increased A6-desaturase
activity and this was reflected in the increased product-precursor ratio of y-linolenic to
linoleic acid in microsomal phospholipids. However, the total amount of long chain
polyunsaturated fatty acids derived from linoleic acid, including arachidonic acid, was
reduced in cholesterol fed rats, suggesting an impaired A5-desaturase. The increased
activity of liver microsomal A6-desaturase was not associated with any significant
changes to adipose tissue n-6 fatty acid composition.
Further studies were conducted to elucidate possible reasons for the disparity
between the present and published studies on the effect of cholesterol. Cholesterol
feeding was carried out in grouped and isolated rats and microsomal A6-desaturase
reassessed. Although stress caused by isolation reduced A6-desaturase activity, dietary
cholesterol increased its activity again. This was observed under both saturating and
non-saturating substrate conditions with a good correlation observed between the two.
Levels of non-esterified fatty acids in the microsomal preparations were not different
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between the four groups, indicating that this was not the explanation for the lower
activity of A6-desaturase reported by others.
The effect of dietary cholesterol on the in vivo metabolism of linoleic acid was
subsequently pursued to investigate whether this differed from that demonstrated in
vitro. The overall metabolism of linoleic acid, assessed on the basis of the decline in
the specific activity of linoleic acid with time, was decreased by cholesterol feeding,
whilst A6-desaturase activity of isolated liver microsomes increased in one experiment
and no change was found in the remaining experiments.
Further studies examined linoleic acid metabolism in the spontaneous diabetic
BB/E rat. Using the optimised A6-desaturase assay system, the activity of A6-
desaturase was decreased by 25 % in diabetic rats treated with insulin compared with
controls. Withdrawal of insulin for 54 h reduced microsomal A6-desaturase activity
slightly further. Microsomes from BB/E diabetic rats in whom insulin was withdrawn
contained high levels of non-esterified linoleic acid, which made it necessary to correct
for the specific activity of [l-I4C]linoleic acid in the estimation of A6-desaturase
activity. A6-desaturase activity as indicated by microsomal phospholipid fatty acid
composition, varied depending on which ratio was used. Adipose tissue fatty acid
composition was not altered in a manner consistent with a depressed A6-desaturase
activity in diabetic rats.
These results show that there is no consistent effect on A6-desaturase by risk
factors for CHD such as raised cholesterol, diabetes and 'stress' and that tissue fatty
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Lipids constitute a major component ofWestern diets (Fehilly, 1984). They make
food more palatable but also provide a good source of energy and nutrients such as the
fat soluble vitamins and essential fatty acids. Yet about 100 years ago dietary fats were
perceived as insignificant (Lawes and Gilbert, 1877) and more recently it was believed
that the beneficial effects of fat could be ascribed to the lipid soluble vitamins or to the
caloric effects of fat itself (McAmis et al., 1929). Rigorous dietary fat exclusion
experiments by Burr and Burr eventually provided evidence for the essentiality of fat
(Burr and Burr, 1929; Burr and Burr, 1930). They described how an acute deficiency
state, characterised by impaired fertility, low growth rates and dermatitis, could be
produced in Long-Evans rats maintained on a fat-free diet and concluded that linoleic
acid was an essential fatty acid (EFA).
Many years later, EFA deficiency in humans was described (Collins et al., 1971;
Wene et al., 1975) in patients receiving long-term naso-gastric and intravenous feeds.
A similar skin condition to that manifest in rats has been shown in infants receiving
formula feeds deficient in EFA (Holman et al., 1964). Other reported defects arising
from human EFA deficiency include increased transepidermal water loss, modified
pulmonary and digestive function and altered liver morphology (Yamanaka et al.,
1982).
Full blown EFA deficiencies rarely exist but the role of a moderate deficiency in
disease processes has been speculated upon. Sinclair (1956) suggested that changes in
food manufacturing processes, especially those concerned with refining food oils to
improve shelf-life (first introduced by Sabatier and Senderens in 1897), could make
diets moderately EFA deficient. He posed the question, do diets 'high in saturated or
unnatural fats' and 'low in EFA' exist? And speculated that some of the chronic
1
diseases characteristic ofWestern 'civilised' society, such as atherosclerosis and cancer,
resulted from this dietary manipulation. Many studies have since been devised to assess
this hypothesis but prior to examining the strengths and weaknesses of such studies it
is necessary to go briefly through properties ofEFA and characteristics of the enzymes
responsible for EFA metabolism.
1.2 Structure, occurrence and nomenclature of EFA
Two series ofEFA exist. They are termed n-6 and n-3 and can be differentiated by
the location of the first double bond from the methyl end of the molecule. They contain
two or more cis double bonds in a straight chain of between 18 and 22 carbon atoms in
length. Linoleic and a-linolenic acids are the parent fatty acids of the n-6 and n-3
series, respectively. Other important members can be derived from these acids in
humans by an alternating sequence of oxidative desaturation and elongation.
The essentiality of the so called parent EFA is due to the inherent inability of
mammals, including humans, to desaturate oleic (cis, 9-octadecenoic) acid between the
centrally located double bond and the methyl terminus. Only terrestrial plants (Gurr et
al., 1969; Stymne and Appelqvist, 1978; Stymne et al., 1992), marine phytoplankton
and some protozoa and insects (Borgeson et al., 1990) have the cellular machinery for
this specific task. Within such organisms A12-desaturase inserts a cis double bond
(between carbon atoms 12 and 13) into oleic acid to form linoleic (cis, cis, 9, 12-









Figure 1.1 Essential fatty acid synthetic scheme in plants (hold numbers indicate site
ofcis double bond insertion numberingfrom the carboxylic end)
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In higher plants, a further site-specific modification by A15-desaturase yields a-
linolenic (cis, cis, cis, 9, 12, 15-octadecatrienoic) acid (Fig 1.1). Therefore in plants
the parent n-6 and n-3 fatty acids are interconvertible (n-6 formed from n-3) but as
humans and mammals do not possess A15-desaturase these EFA are entirely separate.
Membrane and storage lipids in both animals and plants form the predominant
intake of EFA in humans. Animal fats, such as butter, contain a preponderance of
saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) with only minor
amounts of n-6 and n-3 polyunsaturated fatty acids (PUFA) (2.2 and 1.0 %,
respectively (Table 1.1)). Natural seed oils such as olive oil contain approximately 80
% oleic and 7 % linoleic acids whereas sunflower and corn oils contain a high level of
linoleic acid (52 and 75 % by weight, respectively).
Table 1.1 Proportions of prmciple fatty acids in selected animal, marine and
vegetable sources
Fatty acid a
Oil/fat source Palmitic Stearic Oleic Linoleic y-LA # a-LA EPA DHA
Animal
Butter 28 12 30 2 - 1 -
Beef tallow 27 7 48 2 - 1 -
Marine
Menhaden 21 3 11 1 - 3 13 8
Plant
Olive 10 2 78 7 - 1 -
Sunflower 7 3 14 75 - <1 -
Evening primrose 5 2 10 74 9 <1 -
Corn 13 3 31 52 - 1 -
Linseed 6 3 17 14 - 60 -
Values expressed as % (w/w) total fatty acids. a Data compiled from Gunstone et al. (1986) and
Abraham et al. (1990). # y-LA=y-linolenic acid , a-LA=a-linolenic acid. EPA=eicosapentaenoic acid.
DHA=docosahexaenoic.
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A simple abbreviated notation is often used to express the structures of fatty acids
and acyl groups (Table 1.2). Linoleic and a-linolenic acids are written 18:2 n-6 and
18:3 n-3, respectively. The first number in the notation refers to the number of carbon
atoms in a straight chain and the digit following the colon refers to the number of
methylene interupted cis double bonds. Small n represents the total number of carbon
atoms in the chain and n-6 (n minus 6) refers to the number of carbon atoms from the
methyl end of the molecule to the first double bond. This notation will be used
frequently throughout this thesis.
Table 1.2 Common fatty acids and their nomenclature






Palmitoleic cis, 9-hexadecenoic 16:1 n-7
Oleic cis, 9-octadecenoic 18:1 n-9
Vaccenic cis, 11 -octadecenoic 18:1 n-11
Gadoleic cis, 11-eicosaenoic 20:1 n-9
PUFA (n-6)
Linoleic cis, cis, 9, 12-octadecadienoic 18:2 n-6
y-Linolenic all cis, 6, 9, 12-octadecatrienoic 18:3 n-6
Dihomo-y-linolenic all cis, 8, 11, 14-eicosatrienoic 20:3 n-6
Arachidonic all cis, 5, 8, 11, 14-eicosatetraenoic 20:4 n-6
Adrenic all cis, 7, 10, 13, 16-docosatetraenoic 22:4 n-6
Docosapentaenoic all cis, 4, 7, 10, 13, 16-docosapentaenoic 22:5 n-6
PUFA (n-3)
a-Linolenic all cis, 9, 12, 15-octadecatrienoic 18:3 n-3
Stearidonic all cis, 6, 9, 12, 15-octadecatetraenoic 18:4 n-3
Eicosatetraenoic all cis, 8, 11, 14, 17-eicosatetraenoic 20:4 n-3
Eicosapentaenoic all cis, 5, 8, 11, 14, 17-eicosapentaenoic 20:5 n-3
Clupanodonic all cis, 7, 10, 13, 16, 19-docosapentaenoic 22:5 n-3
Docosahexaenoic all cis, 4, 7, 10, 13, 16, 19-docosahexaenoic 22:6 n-3
PUFA (n-9)
Mead all cis, 11. 14, 17-eicosatrienoic 20:3 n-9
Numbers within systematic nomenclature e.g. cis, cis, 9,12-octadecadienoic refer to the location of the
double bonds in the carbon chain counting from the carboxylic end of the molecule.
In addition to the small number of n-6 and n-3 fatty acids present in nature, several
non-essential fatty acids exist. Most are termed either saturated or monounsaturated
(Table 1.2) and can be derived either from the diet or de novo synthesis. Desaturation
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of SFA by A9-desaturase yields the respective monoene. This elimination of two cis Id-
atoms from SFA such as 18:0 reduces the melting point and is believed to facilitate
biochemical processing of entities such as lipoproteins (Jeffcoat, 1979).
1.3 Outline of EFA metabolism
EFA have an indispensable function as integral components of membrane
phospholipids involved in the regulation of cellular functions (Stubbs and Smith, 1984;
Brenner, 1984; Spector and Yorek, 1985). They also have an important role in the
production of prostanoids in various physiological and pathological processes. Linoleic
acid is an important structural component of skin (Melton et al., 1987; Hansen and
Jensen, 1985) and also a regulator of cholesterol transport (Horrobin and Manku,
1983). Yet in order to perform its full physiological and structural roles it must be
converted to more unsaturated, longer chain n-6 fatty acids. This is achieved by an
alternating sequence of desaturation and elongation steps with the same pathway being
used for both 18:2 n-6 and 18:3 n-3 (Fig. 1.2). Oleic acid can also be converted in the
same way to 20:3 n-9 but this fatty acid, which accumulates in EFA deficiency, cannot
entirely replace n-3 or n-6 long chain fatty acids.
5
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Figure 1.2Mammalian fatty acid conversions. Allfatty acids are in acyl-CoA form.
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As for many metabolic inter-conversions that involve fatty acids, appropriate
activation by esterification with coenzyme A is necessary for further metabolism
(Groot et al., 1976). The endoplasmic reticulum, site for desaturation and elongation,
contains long chain fatty acyl-CoA synthetases [EC 6.2.1.3] that utilise ATP, CoA and
Mg2+ to form acyl-CoA derivatives (Kornberg and Pricer, 1953; Groot et al., 1976;
Normann et al., 1981). This two-step process, with an intermediary compound fatty
acyl-AMP, also takes place in mitochondria (De Jong and Hiilsmann, 1970; Aas, 1971)
and peroxisomes (Waku, 1992). The activity of acyl-CoA synthetase in liver
microsomes is high (50-100 nmol/min/mg protein; Aas, 1971; Normann et al., 1981)
and not considered rate limiting in the metabolism of EFA. Further characteristics of
this enzyme have been reviewed in some detail (Groot et al., 1976) and will not be
discussed here.
Once activated, linoleoyl-CoA undergoes stereo-specific abstraction of two El-
atoms to form a cis double bond. The process is carried out by A6-desaturase, so
termed because it abstracts H-atoms from carbons 6 and 7 (numbering from the
carboxyl end of the fatty acid). The resultant product contains three methylene (-CH2-)
interrupted cis double bonds and is termed y-linolenyl-CoA. Further metabolism by the
microsomal elongase adds two carbon atoms provided by malonyl-CoA (in contrast to
malonyl-ACP used by fatty acid synthetase) and forms dihomo-y-linolenyl-CoA.
Oxidative desaturation of dihomo-y-linolenyl-CoA by A5-desaturase (stereo specific
H-atom abstraction from carbons 5 and 6) yields arachidonyl-CoA (Fig. 1.2).
Up until very recently it was assumed that A4-desaturation ensued the elongation
of 20:4-CoA to adrenyl-CoA. This is now known not to be the case. The revised
pathway is now considered to consist of three separate steps (Voss et al., 1991,
Sprecher, 1992). First, adrenyl-CoA undergoes elongation to 24:4 n-6 CoA; second,
oxidative A6-desaturation of 24:4 n-6 CoA forms 24:5 n-6 CoA; and finally, partial
peroxisomal [3-oxidation of 24:5 n-6 CoA yields 22:5 n-6 CoA. The equivalent
pathway also proceeds for n-3 fatty acids (Voss et al., 1991). Therefore in the standard
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mammalian system, A6-desaturase is placed in a unique and pivotal location as six fatty
acids (one n-7, one n-9, two n-6 and two n-3 acids) can all compete at the level of this
desaturase.
Rates of both desaturation and elongation have been measured extensively in liver
microsomes. The desaturation step is relatively slow and this is particularly true of A6-
desaturase (25-600 pmol/min/mg). Fatty acid elongation is approximately five times
more rapid than desaturation in rat liver microsomes (Bernert and Sprecher, 1975). As
a consequence, levels of fatty acids in microsomal lipids often show a pattern that
reflects rapid elongation and slow desaturation.
Dietary, hormonal and pharmacological modulators, as well some related disease
states, have received considerable attention in connection with alterations in the
metabolism of EFA. The position of A6-desaturase in EFA metabolism means that it
plays a pivotal role in the formation of long chain PUFA. Prior to discussing some of
these modulators in detail it is essential to outline the enzymology of A6-desaturase.
1.4 Enzymology of A6-desaturation
In mammalian and avian systems, the oxidative desaturation of fatty acyl-CoA is
accomplished by a terminal desaturase moiety coupled to a mini-electron transport
chain associated with the endoplasmic reticulum. Much of the preliminary information
on such systems has been established with stearoyl-CoA desaturase (Bernhard et al.,
1959; Marsh and James, 1962). This complex contains a flavoprotein, NADH-
cytochrome b5 reductase (Holloway and Wakil, 1970) and a haem-protein, cytochrome
b5 (Oshino et al., 1966; Oshino et al., 1971; Holloway and Katz, 1972; Shimakata et
al., 1972) as components of the mini-electron transport chain. Data supporting the
involvement of these two electron transport proteins in linoleoyl-CoA desaturation has
also been demonstrated (Lee et al., 1977; Okayasu et al., 1977; Okayasu et al., 1981).
Both desaturase complexes have a requirement for molecular oxygen and NADH (or
NADPH) and are sensitive to cyanide but not carbon monoxide (Okayasu et al., 1981).
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In the linoleoyl-CoA desaturase complex, the terminal moiety is A6-desaturase while
for stearoyl-CoA desaturase the terminal component is A9-desaturase.
In 1974 Strittmatter and co-workers confirmed the presence of the three
components in stearoyl-CoA desaturase by purifying the complete desaturase system
from rat liver (Strittmatter et al., 1974). Prasad and Joshi (1979) reproduced these
findings in chicken liver. Linoleoyl-CoA desaturase has also been purified (Okayasu et
al., 1981). The schematic layout of this complex is shown in Fig. 1.3.
Figure 1.3 Hypothetical structure of the linoleoyl-CoA desaturation system within the
lipid bilayer
1.4.1 NADH-cytochrome t>5 reductase
NADH-cytochrome b5 reductase [EC 1.6.2.2] was originally isolated from
microsomes using cobra venom (Strittmatter and Velick, 1957) but subsequent
isolations have employed lysosomes (Takesue and Omura, 1970) and detergents (Spatz
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and Strittmatter, 1973). This flavoprotein has a molecular weight 44,000 (Spatz and
Strittmatter, 1973) and contains distinct hydrophilic (MW 33,000) and hydrophobic
domains (MW 11,000). The hydrophilic domain, which is projected into the
surrounding cytosol, contains the active site FAD. The hydrophobic domain anchors
the protein by strong non-covalent interactions with the lipid bilayer.
1.4.2 Cytochrome b5
Cytochrome b^ exists in large amounts in liver cell endoplasmic reticulum and has
been isolated using either proteolytic enzymes (Omura et al., 1967) or detergents (Ito
and Sato, 1968). It contains 133 amino acids and has a molecular weight of 16,700. It
is amphipathic (Tajimura et al., 1978) and projects the hydrophilic domain containing
97 amino acid residues into the cytosol. The hydrophobic chain of 44 amino acids
anchors the bulk of the protein to the membrane (Sullivan et al., 1973; Enomoto and
Sato, 1973).
1.4.3 Terminal A6-desaturase
The terminal moiety of linoleoyl-CoA desaturase was first isolated by Okayasu and
co-workers in 1980 (Okayasu et al., 1981). It was partially characterised at this time
and found to contain one atom of non-haem iron per molecule of enzyme. Further
analysis revealed that the enzyme was comprised of a single polypeptide chain with a
molecular weight of approximately 66,000. Reconstitution of the terminal A6-
desaturase with NADFI-cytochrome b5 reductase, cytochrome b5 and lipid (or
detergent) demonstrated the ability to desaturate 18:2-CoA to 18:3-CoA in the
presence ofNADH and molecular oxygen (Okayasu et al., 1981). The desaturase was
inactive toward 18:0-CoA but substrates such as a-linolenyl-CoA and oleoyl-CoA
were unfortunately not examined.
The linoleoyl-CoA desaturase terminal moiety shows some similarities with A9-
desaturase (Table 1.3). This latter protein is probably the most studied and well
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understood desaturase in both biochemical and molecular terms. It is smaller than A6-
desaturase but contains a slightly higher proportion of non-polar amino acid residues.
Table 1.3 Comparison ofmammalian A6- and A9-desaturase characteristics
Measurement A6-desaturase a A9-desaturase b
Molecular weight 66,000 53,000
Total amino acid residues 598 458
Non-polar residues (%) 49 62
Inhibition by iron chelators Yes Yes
Inhibition by pCMBS Yes Yes
Inhibition by cyanide Yes Yes
Gene isolation No Yes
Gene expression No Yes
a Data compiled from Okayasu et al. (1981). b Data compiled from Strittmatter et al. (1974), Thiede et
al. (1986) and Strittmatter et al. (1988). /jCMBS, p-chloromercuribenzene sulphonate. Pugh and
Kates (1979) have partially purified A5-desaturase. However, no studies have been reported on the
purification of the complex or the terminal desaturase to homogeneity.
Both reconstituted desaturases are inhibited by iron chelators, cyanide and p-
chloromercuribenzene sulphonate. However, studies with the A9-desaturase have gone
further establishing the rate limiting step in desaturation as hydrogen abstraction
(Enoch et al., 1976). Moreover, much of the molecular biology of A9-desaturase has
been elucidated (Thiede and Strittmatter, 1985; Thiede et al., 1986; Strittmatter et al.,
1988; Mihara, 1990). In contrast, since Okayasu et al. (1981) purified A6-desaturase
from rat liver, little progress has been made with either biochemical or molecular
biological characterisation of this desaturase in mammalian systems. One of the reasons
for this will become evident below (Section 1.4.5).
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1.4.4 Cytosolic factors
Accessory factors required for the full activity of A6-desaturase were first reported
by Brenner (1974) and later by Catala et al. (1975). They showed that the extraction of
microsomes, using low ionic strength solutions with subsequent centrifugation, yielded
a soluble component that activated the desaturation of 18:2 n-6 in 'washed'
microsomes. This lightly bound moiety has no desaturation activity itself (Catala et al.,
1975) and has a lipoprotein-like nature with a protein-lipid ratio of 1.22 (Leikin and
Brenner, 1986). The activation of A6-desaturase is believed to result from the cytosolic
factor binding to the desaturation product, 18:3 n-6 (Leikin and Brenner, 1986). This
prevention of retro-inhibition has also been described for A5-desaturase (Leikin and
Brenner, 1989b). However, it appears that two separate subfractions of the cytosolic
fraction prevent A5- and A6-desaturase retroinhibition independently, by binding to
their respective desaturation products (Leikin and Brenner, 1989b).
1.4.5 Desaturation assays
At present a number of different methods are available for the measurement of the
oxidative desaturation of SFA and PUFA. In the most commonly used assessments,
applicable to all liver desaturases, the relevant radioactive fatty acid or fatty acyl-CoA
is employed. For example microsomal A6-desaturase, first measured by Nugteren
(1962), can be determined using either [l-14C]linoleoyl-CoA (Jeffcoat et al., 1976) or
[ 1 - 14C] 18:2 n-6 (Brenner, 1971) with the appropriate cofactors. The latter, more
commonly used substrate, requires activation to the CoA form by acyl-CoA synthetase
[EC 6.2.1.3] but this is not considered rate limiting (Brenner, 1971). After an
appropriate incubation time (5-20 min), the reaction mixture undergoes alkaline
hydrolysis and the resultant non-esterified fatty acids are extracted, methylated and
separated by thin-layer (TLC) (Morris, 1966; Christie, 1982; Gardiner and Duncan,
1991), gas-liquid (Brenner et al., 1965; De Schrijver and Privett, 1982) or high
pressure liquid chromatography (Narce et al., 1988a).
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The original method, employing argentation TLC and liquid scintillation counting,
provides the greatest sensitivity as relatively large amounts of lipid (~1 mg) can be
separated and counted. This is particularly important in the measurement of A6-
desaturase as the resultant product, 18:3 n-6, contains a low level of counts. Gas-liquid
(GLC) and high pressure liquid chromatography (HPLC) separate small amounts of
lipid and therefore product counts can be extremely small. Advantages of GLC and
HPLC include their ability to separate 18:3 n-6 and 20:3 n-6. However, this quality of
separation is not strictly necessary in the measurement of A6-desaturase.
Specifically labelled [9,10-3H]stearoyl-CoA and [9,10-3H]18:0 have been used to
assess the activity of A9-desaturase (Talamo and Bloch, 1969; Johnson and Gurr,
1971). In contrast to the time consuming methods involving [l-14C]labelled fatty acids
the method is relatively quick and simple. Measurement is dependent on 3H release
from positions 9 and 10 of 18:0 which is liberated into the aqueous phase as 3H20
Subsequent trichloroacetic acid precipitation of microsomal protein and associated
radioactive lipid in the incubation mixture allow 3H20 quantification which is
proportional to desaturation. The isotopic effect interferes with the measurement but
this is overcome by standardising the assay with [ 1 - 14C] 18:0 (Johnson and Gurr,
1971). The lack of commercial availability of [6,7-3H]linoleoyl-CoA or [6,7-3H]18:2
n-6 restricts the assay application to A9-desaturase.
The microsomal mini-electron transport chain, associated with the oxidative
desaturation of fatty acids, has been used as a further method to estimate desaturase
activity (Oshino et al., 1971). This spectrophotometry method uses the rate of
reoxidation ofNADH-reduced cytochrome b5 in the presence and absence of linoleoyl-
CoA as a measure of A6-desaturation (Fig. 1.4). Briefly, NAL)H is added to a dilute
microsomal suspension and the time of onset of cytochrome b5 reoxidation (assessed
simultaneously at 424 and 409 nm) is determined in the absence of linoleoyl-CoA (Fig.
1.4, Curve A). In another incubation, NADH and linoleoyl-CoA are added together to
the incubation mixture and the time for cytochrome b5 reoxidation is measured for a
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second time (Fig. 1.4, Curve B). The difference in the time due to linoleoyl-CoA
induced NADH oxidation (indicated by the difference in cytochrome b5 reoxidation), is
used to calculate the desaturase activity assuming that one mole of NADH is required
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Figure 1.4 Representation ofa cytochrome h5 reduction and reoxidation trace
The assay employing cytochrome b5 reoxidation requires specialised equipment
including a dual wavelength spectrophotometer. This type of equipment is expensive
and not generally available. As a consequence the assay is not frequently used except
when large numbers of samples have to be assayed quickly as in the case of desaturase
protein purification.
The metabolism of 18:2 n-6 has also been evaluated using stable isotopes (Emken
et a/., 1993). Advantages of this method include its applicability to human studies in
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vivo. However, only a limited number of studies have used stable isotopes owing to the
considerable expense of both the substrate, [1-13C]18:2 n-6, and the associated GLC-
mass spectrometry analysis equipment.
An indirect measurement of the level of desaturase activity is frequently derived
from tissue fatty acid compositional data. In animal studies, for example,
product/precursor ratios from liver microsomal phospholipids are generally considered
to reflect desaturase activities. This is due to the close proximity of these lipids to the
site of desaturation. Ratios typically used for A9-, A6-, and A5-desaturases are shown
in Table 1.4.
Table 1.4 Typical desaturase fatty acid ratios
Desaturase Fatty acid ratio
A9 18:1 n-9/18:0
A6 18:3 n-6/18:2 n-6
A6 18:4 n-3/18:3 n-3
A6 22:5 n-6/22:4 n-6
A6 22:6 n-3/22:5 n-3
A5 20:4 n-6/20:3 n-6
A6 and A5 20:4 n-6/18:2 n-6
Combined D & E of 18:2 n-6 (18:3 n-6+20:2 n-6+20:3 n-6+20:4 n-6+22:4 n-6+22:5 n-6)/18:2 n-6
D desaturation, E elongation.
In human studies the liver is essentially unavailable and as a result plasma and/or
adipose tissue fatty acids are frequently used. Yet, criticism can be directed at the use
of indices in general as tissue fatty acid composition is not solely dependent on the
availability of products derived from desaturation and elongation. Other factors that
determine the tissue fatty acid profile include acyl transferase activity, competition for
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acyl sites, phospholipase activity, extent of lipid peroxidative processes and
requirements for energy and prostaglandins.
Advances in the genetics of A6-desaturase in Synechocystis (Reddy et a/., 1993)
will, if homology exists with mammals, provide further means to improve studies in the
measurement of the capacity of mammalian tissues to metabolise EFA.
1.4.6 A6-desaturase in animals
Nutritional and hormonal studies have frequently focused upon the A6-desaturative
capacity of liver mainly because it exhibits the highest activity (Ackman and Cunnane,
1992). The animal model most often used is the rat generally because it is easy to study
and will consume a wide variety of diets. Other species, however, also possess to
differing extents, the capacity to desaturate 18:2 n-6. The mouse (Bourre et al., 1990),
pigeon (Borlakoglu et al., 1990), sheep (Shand et al., 1978), dog (Giron et al., 1989)
and pig (Clandinin et al., 1985) have all been demonstrated to desaturate 18:2 n-6
(Table 1.5).
Table 1.5 Hepatic A6-desaturase activity in atumals §











detectable using stable isotopes
-100
§ None of these studies attempted to compare species under controlled dietary conditions. # 18:2 n-6
employed as substrate, pmoles/min/mg microsomal protein, n.d. not detectable, a Bourre et al. (1990);
b Garg et al. (1988a), Christiansen et al. (1991); c Borlakoglu et al. (1990); d Rivers et al. (1976); e
Pawlosky and Salem. (1992); fGiron et at. (1989).
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Once it was believed that felinae could not desaturate either 18:2 n-6 or 20:3 n-6
(Rivers et al., 1976). This is not so as cats do possess A6-desaturase during EFA
deficiency (Pawlosky and Salem, 1992). It is therefore probable that the rat and cat
form two ends of a broad spectrum of desaturation efficiency (Table 1.5).
Some comparisons have been made between A6-desaturase activities and the
propensity for particular species to develop atherosclerosis. Different animals,
however, consume considerably different diets and therefore inter-species comparisons
are not valid. The values in Table 1.5 provide only a very rough guideline.
1.5 Dietary modification of A6-desaturase activity
Studies examining the effects of dietary modification on A6-desaturase activity
have generally focused on rat liver microsomes. In such studies different types of lipid,
protein, carbohydrate, metal ions and vitamins have been examined. The sections
below summarise the findings of some of these studies.
1.5.1 Dietary lipids and A6-desaturation
It has been long known that the absence of adequate dietary levels of 18:2 n-6
leads to an elevated A6-desaturase activity (Brenner, 1981). Subsequently, the activity
of A6-desaturase has been measured extensively in dietary manipulation studies using
purified fats and oils rich in specific types of lipid (i.e. SFA, MUFA, n-6 PUFA, n-3
PUFA etc.). Beef tallow provides an abundance of SFA and MUFA and the feeding of
such fat (in a well balanced diet) leads to an increased liver A6-desaturase activity
compared to a sunflower oil enriched diet (Garg et al., 1990). Similarly, diets high in
trans fatty acids (Shimp et al., 1982; Kirstein et al., 1983), linseed oil (Garg et al.,
1990; Christiansen et al., 1991) and fish oil (De Schrijver and Privett, 1982, Garg et
al., 1990, Christiansen et al., 1991) all decrease liver microsomal A6-desaturase
activity. Dietary oils rich in MUFA (e.g. olive oil) also decrease A6-desaturase activity
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when compared to rats fed sunflower oil (Mahfouz et al., 1984) as does the
incorporation of partially hydrogenated herring oil into rat diets (Svensson, 1983).
Many of the findings in vivo have been supported by in vitro studies using pure
fatty acid preparations. Thus, trans 18:1 (Mahfouz et al., 1980) inhibits the conversion
of 18:2 n-6 to 18:3 n-6. Oleic acid and 18:3 n-3 also compete with 18:2 n-6 for A6-
desaturation (Brenner and Peluffo, 1966). The order of affinity of these fatty acids for
A6-desaturase is 18:3 n-3 > 18:2 n-6 >18:1 n-9. SFA, however, do not affect A6-
desaturase activity in vitro (Brenner and Peluffo, 1966).
Dietary sterols, including cholesterol, also influence EFA metabolism. Some of the
first studies on dietary cholesterol enrichment showed an exacerbation of EFA
deficiency in rats (Holman and Peifer, 1960). Unfortunately no A6-desaturase
measurements were made in this investigation. Further studies have examined the
effect of dietary cholesterol within diets enriched with different in types of lipid or
protein. For example, cholesterol feeding has a large depressive effect on A6-
desaturase activity in diets rich in beef tallow but little effect in diets enriched with fish
oil (Garg et al., 1988a). Further work has concentrated on the viscotropic effects of
cholesterol and in particular its role in vivo and in vitro on membrane bound enzymes
(Brenner, 1984; Castuma and Brenner, 1986). Cholesterol enrichment of microsomal
membranes in vitro increases A6-desaturase activity (Garda and Brenner, 1985) while
the opposite occurs in vivo (Garg et al., 1988a).
1.5.2 Dietary proteins and A6-desaturation
Diets high in protein, in the form of casein, increase A6-desaturase activity (Peluffo
and Brenner, 1974). No additional stimulation, however, is shown above 35 % (w/w)
protein. In contrast, diets low in protein (<5 % w/w) evoke low activities of A6-
desaturase (De Tomas et al., 1980; Narce et al., 1988b). Further studies have
examined the effects of different types of protein on A6-desaturative capacity. Rats fed
casein supplemented diets possess a higher A6-desaturase activity than those fed a
18
soybean based diet (Choi et al., 1989; Lindholm and Eklund, 1991). In addition,
20:3 n-9 is raised in liver microsomal phospholipids of rats fed casein with an adequate
amount of dietary 18:2 n-6. The mechanism for these phenomena are not entirely
understood. However, it may relate to the arginine content of the dietary protein
(Koba et al., 1993) or possibly the effect different dietary proteins have on microsomal
cholesterol levels (Koba et al., 1993). Interestingly, the effects of casein are also
demonstrable in diets supplemented with cholesterol (Lindholm and Eklund, 1991).
1.5.3 Dietary metal ions and A6-desaturation
A small number of divalent cations have been studied in the context of modified
tissue fatty acid compositions and altered desaturase activities. Zinc has been
implicated in the regulation of EFA metabolism and interestingly humans with diseases
associated with zinc deficiency also display altered tissue fatty acid profiles.
Experimental studies by Cunnane (1982) have shown that tissue 18:2 n-6 content is
increased in EFA supplemented, zinc deficient rats which has led to the suggestion that
A6-desaturation capacity may be impaired. Results on tissue A6-desaturase activities,
however, show disparities. Wahle (1983) has demonstrated that zinc deficiency does
not alter hepatic microsomal A6-desaturase activity. Yet, Tsai et al. (1983) have
shown that A6-desaturase activity is depressed in zinc deficient rats fed ad libitum.
Other studies have shown that dietary zinc deficiency reduces testicular microsomal A
6-desaturase activity which is consistent with some of the fatty acid compositional
changes (Clejan et al., 1982). In agreement with these latter findings are the palliative
effects of 18:3 n-6 in zinc deficiency (Cunnane and Horrobin, 1980).
Magnesium deficiency produces hypercholesterolaemia and other lipid metabolism
defects in both humans and rats. Patients with latent tetany present increased levels of
18:2 n-6 and depressed levels of 20:3 n-6 and 20:4 n-6 in plasma phospholipids. These
observations are in accord with decreased A6-desaturase activities and altered tissue
fatty acid patterns in rats pair-fed magnesium deficient diets (Mahfouz and
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Kummerow, 1989). Low A6-desaturase activities are also a feature of porcine kidney
cells cultured in low magnesium concentrations (Mahfouz et al., 1989).
1.6 Hormonal modification and A6-desaturase activity
A wealth of information has been assembled over the years on hormonal action and
A6-desaturation. Insulin is the main anabolic hormone in this context with many other
hormones acting antagonistically.
1.6.1 Insulin
Rat liver microsomes from alloxan-induced diabetic rats are deficient in the
capacity to desaturate 18:2 n-6 (Mercuri et al., 1966; Brenner et al., 1968; Castuma et
al., 1972). Similar observations have been documented for A9-desaturase (Gellhorn
and Benjamin, 1964). Insulin therapy repairs the defects in both A9- and A6-desaturase
activities (Mercuri et al., 1966; Brenner et al., 1968) but this correction is partially
blocked by prior in vivo treatment with actinomycin D (Brenner et al., 1968). The
inhibitory effect of actinomycin D on RNA synthesis has led to the conclusion that
insulin restores desaturase activities through enzyme induction (Brenner et al., 1968).
Similar findings have been documented in fasted rats treated with actinomycin D prior
to refeeding (Inkpen et al., 1969).
Defective A9-, A6- and A5-desaturase activities have equally been demonstrated in
rats made diabetic using streptozotocin (Eck et al., 1979; Faas and Carter, 1980).
Insulin treatment (8 U/day for 2 days) corrects these desaturase activities (Faas and
Carter, 1980). In agreement with this is the normalisation of microsomal fatty acid
composition with the exception of 20:4 n-6 which remains reduced (Faas and Carter,
1980). Furthermore, the defect in A6-desaturation in streptozotocin-induced diabetes
has been identified not in the associated electron transport chain but in the terminal
desaturase (Eck et al., 1979).
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Diabetic studies using chemical agents, however, can be generally criticised. The
animals are hyperphagic, polydipsic, dehydrated and very ill. Such studies also do not
represent the situation in human diabetics (i.e. daily insulin injections with fluctuating
glycaemia and associated long term complications). The genetically prone diabetic rat
offers a better alternative for the study of diabetes on EFA metabolism. These animals
suffer from retinal capillary basement membrane thickening (Chakrabarti et al., 1993)
and polyneuropathy (Sima et al., 1992) despite regular insulin treatment. EFA
metabolism in the spontaneously diabetic rat has been explored but results, all from one
research group, have been inconsistent. No difference in A6-desaturase activity
between control and BB diabetic rats was demonstrated in one study (Chanussot et al.,
1989) despite some changes in n-6 fatty acid composition. Other studies have shown
the opposite (Mimouni and Poisson, 1990; Mimouni and Poisson, 1992).
1.6.2 Glucagon, adrenaline and associated hormones
Fasting decreases A6-desaturase activity and refeeding reactivates the system
(fnkpen et al., 1969; De Gomez Dumm et al., 1970). Administration of glucagon to
rats after fasting abolishes the increase elicited by refeeding (De Gomez Dumm et al.,
1975). Dibutyryl cAMP has the same effect (De Gomez Dumm et al., 1975).
Furthermore, co-administration of theophylline enhances the action of dibutyryl cAMP.
Conclusions from these studies hypothesised that glucagon produces its effect either
directly or indirectly by influencing cAMP.
Hormones such as catecholamines also operate through the activation of adenylate
cyclase. Subcutaneous administration of large amounts of adrenaline to rats (1 mg/kg
body weight) increase cAMP levels (maximal at 0.5 h) and decrease the microsomal A
6-desaturation of 18:2 n-6 and 18:3 n-3 (De Gomez Dumm et al., 1976). A6-
desaturation is maximally reduced 12 h after adrenaline injection (p<0.01) but recovers
to control values between 12 and 36 h later. Lower doses of adrenaline induce a small
but non-significant depressive effect (De Gomez Dumm et al., 1976). The action of
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adrenaline is proposed to be mediated through an increase in cAMP levels that enhance
the concentration of a glucose metabolite but little more is known. Unfortunately,
tissue fatty acid compositional data was not reported in either the fasting-refeeding
studies or the glucagon and adrenaline work.
1.6.3 Other factors affecting A6-desaturation
The activity of A6-desaturase is modulated by other components of the endocrine
system. Intraperitoneal hydrocortisone injection into rats (-50 mg/kg body weight),
reduces A6-desaturase activity in liver microsomes with a maximal response observed
24 h after administration (De Gomez Dumm et al., 1979). Synthetic corticosteroids,
triamcinolone (-12 mg/kg) and dexamethasone (-5 mg/kg) reduce A6-desaturase
activity in a similar manner but are more potent compared to hydrocortisone (De
Gomez Dumm et al., 1979). Dexamethasone is believed to exert its inhibitory effect on
A6-desaturation through the synthesis of a regulatory cytosolic factor (Marra et al.,
1986). However, washed microsomes prepared from dexamethasone-induced rats also
have reduced A6-desaturase activity indicating that desaturase protein synthesis is also
impaired (Marra et al., 1986).
The affects of thyroid hormones have also been examined in the context of A6-
desaturase activity (Faas and Carter, 1981; Ves-Losada and Peluffo, 1993). Rats given
daily intraperitoneal injections of L-triiodothyronine (10 mg/kg) for 5 consecutive days
reduced microsomal A6-desaturase activity (Ves-Losada and Peluffo, 1993). Yet,
changes in microsomal fatty acid composition did not parallel this impaired A6-
desaturase activity.
The effects of more physiological stimuli have also been examined. A high A6-
desaturase activity is present in the neonatal rat which generally declines with age
(Bourre et al., 1990; Bordoni et al., 1988; Biagi et al., 1991). However, Maniongui et
al. (1993), do not support this ageing effect and demonstrated no difference in A6-
desaturase activity between rats aged 1.5 and 24 months. In contrast with this are the
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results of Ullmann et al. (1991a) who reported an age-related increase in A6-
desaturase activity. It is possible that some diets prevent an age associated decline in A
6-desaturase activity (Biagi et al., 1991).
Diurnal and seasonal variations have also been documented. Diurnal changes are
believed to reflect feeding behaviour (De Gomez Dumm et al., 1984) and are clearly
important in the planning of experiments. The documented seasonal effects on A6-
desaturase activity may be dubious, however, as temperatures within the animal




1.7.1 A6-desaturase in humans
Obviously studies on A6-desaturase activity in human liver are scarce due to the
lack of readily available material. Activities for adults range between 7 and 125
pmol/min/mg microsomal protein (De Gomez Dumm and Brenner, 1975; Biagi et al.,
1990) and that of neonates is even lower (Poisson et al., 1993). The necessary use of
anaesthetics (De Gomez Dumm and Brenner, 1975) and the selection of patients
requiring liver biopsy, implies that results from these studies may not adequately
represent true activities of A6-desaturase in man in general. Indeed, A6-desaturase
activities measured in a neonate study (Poisson et al., 1993) used liver samples
obtained 1-3 h after death, which may have also affected enzyme activities.
As a result, studies on humans often rely on tissue fatty acid compositions. These
will be discussed in the context of coronary heart disease below.
Table 1.6 Liver microsomal A6-desaturase activities in humans
Study A6-desaturase activity #
Human (neonate) a 5-8
Human (cholecisteclomy patients) b 125
Human c 7-60
# pmol/min/mg microsomal protein, a Poisson et al. (1993), b Biagi et al. (1990). c De Gomez Dumm
and Brenner (1975).
1.7.2 Past and present trends of CHD
Coronary heart disease (CHD), ignored for much of the 19th century and before, is
now recognised as one of the main causes of death in men and women within
industrialised countries since the 1920's. In the UK, a peak in the mortality rate was
reached in the late 1960's but mortality rates have since declined in England and Wales
across all age ranges in recent years (Table 1.7). Nevertheless, the epidemic remains to
be one of the leading causes of death afflicting men in their peak years of economic
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activity. On an international scale, WHO figures demonstrate the condition's severity
with approximately 1 in 3 (or 2.4 million) people dying from the disease in the
developed world in 1987 (Lopez, 1990).
Table 1.7 CHD mortality ratesfor men aged 35-74 over the last decade in England
and Wales
Age band
Census year 35-44 45-54 55-64 65-74
1983 443 2330 6824 15851
1984 402 2176 6777 15557
1985 414 2150 6700 15611
1986 406 2093 6397 14893
1987 398 1938 6192 14501
1988 352 1816 5899 14011
1989 355 1658 5460 13307
1990 356 1537 5206 13180
1991 335 1468 4967 12806
1992 314 1369 4723 12417
Reduction 1983-92 (%) 29 41 31 22
Values expressed per million population. Source: Office of Population, Censuses and Surveys 1983-
1992
1.7.3 Risk markers and CHD
More than 240 risk markers have been associated with CHD (Hopkins and
Williams, 1981). Even though the disease is believed to be multifactorial in origin,
epidemiological studies cannot prove causal relations and some of these markers may
be spurious and/or trivial (McCormick and Skrabanek, 1988). Established risk markers
include elevated serum cholesterol (Kannel et a/., 1971, Kannel et al., 1986), increased
blood pressure (Kannel et al., 1981), smoking (Doll and Peto, 1976; Townsend and
Meade, 1979), age (Kannel, 1976), male gender (McGill and Stern, 1979) and diabetes
(Brownlee and Cahill, 1979, Stamler et al., 1993). More recently, low levels of dietary
EFA have been associated with the disease (Logan et al., 1978; Riemersma et al.,
1986).
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1.7.4 Dietary EFA and CHD
Hugh Sinclair stated in his Lancet article in 1956 that diets high in saturated or
unnatural fats were in fact low in EFA (Sinclair, 1956). Interest at that time was
generally focused upon SFA and their involvement in the pathogenesis of CHD
through raised serum cholesterol levels (Keys et al., 1957). Sinclair's postulate was
that diseases prevalent in Western civilised countries such as atherosclerosis, coronary
thrombosis and cancer were due to a moderate EFA deficiency (Sinclair, 1956). Since
this time many studies have been undertaken to assess whether such a dietary
deficiency exists.
Dietary fatty acid intakes are difficult to assess and as a consequence alternative
methods are often used. Adipose tissue triacylglycerols are a reliable indicator of long
term EFA intake (Dayton et al., 1966; Wood et al., 1984; Katan et al., 1991). Plasma
cholesterol ester and triacylglycerol fatty acid composition are also used as indicators
ofEFA intake (De Backer et al., 1989).
Pioneering studies by Kingsbury et al. (1962) demonstrated that adipose tissue
diene content (mainly 18:2 n-6) was lower in patients with atherosclerotic disease
compared with healthy controls. Furthermore, serum cholesterol esterified trienes were
raised in these patients. The analytical technique used in this era, prior to gas liquid
chromatography, did not permit a more in-depth assessment of triene composition but
it is apparent from further studies by this group that 20:3 n-9 was the main component
(Kingsbury et al., 1974). This was therefore indicative of a moderate EFA deficiency
and was possibly the first identification of raised 20:3 n-9 in patients with a low 18:2 n-
6 content. The study, however, can be criticised as patients were of mixed aetiology
(angina, aortic aneurysm, ischaemic pain and coronary thrombosis) and no adjustments
were made for confounding factors such as smoking and other risk factors.
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1.7.5 Population studies
The Edinburgh-Stockholm study was the first formal investigation establishing a
significant association between low adipose tissue 18:2 n-6 concentration and CHD
mortality rates (Logan et al., 1978). It was devised to identify factors that might
explain the high CHD mortality and morbidity in Edinburgh which is three times
greater than in Stockholm. The study, carried out in 1976, was conducted on randomly
selected healthy men aged 40. Edinburgh men had lower levels of cholesterol esterified
18:2 n-6 (p<0.001) although total cholesterol levels were not different. Adipose tissue
triacylglycerol 18:2 n-6, a biomarker for 18:2 n-6 intake, was also significantly lower in
Edinburgh men (7.3±1.5 vs. 11.8±2.1 %, p<0.001). Known classical risk factors such
as LDL and total cholesterol, smoking and obesity could not explain the difference in
CHD mortality between the two populations.
The above findings were confirmed by a cross-cultural study in apparently healthy
men (aged 40-49) from four European regions (Riemersma et al., 1986). Adipose
tissue 18:2 n-6 contents were as follows: North Karelia (Finland) 7.4 %, South West
Finland 8.1 %, Edinburgh (Scotland) 8.8 % and Sapri (Italy) 13.5 %. These results
correlated inversely with CHD mortality rates (Fig. 1.5). In addition, the desaturation
and elongation product 20:3 n-6 was also inversely associated with CHD mortality
rates (Fig. 1.5) suggesting that the metabolism of 18:2 n-6 through A6-desaturase may
be impaired in subjects with CHD. Furthermore, the difference in the proportion of
18:2 n-6 in adipose tissue between the four regions remained significant after
adjustment for classical CHD risk factors. It is important to note that similar
differences in CHD mortality rates and serum 18:2 n-6 content have also been
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Figure 1.5 Correlations of adipose tissue n-6 EFA content and CHD mortality from
four European regions (Datafrom Riemersma et al., 1986)
Other epidemiological studies support some of these findings. The Scottish Heart
Health Study, a cross-sectional survey of coronary risk factors in 4144 Scottish men
and women, evaluated associations between adipose tissue EFA and CHD mortality
(Tavendale et al., 1992). The mean adipose tissue 18:2 n-6 content, from each of the
twenty-two regions studied, was inversely correlated with the standard mortality ratio
(SMR) for CHD in both men and women (r=-0.60 and -0.62, respectively). In
contrast, levels of 20:3 n-6 showed no association with the SMR. Wahle et al. (1991)
also document comparably low 18:2 n-6 concentrations in another coronary prone
population (Aberdeen) but values for 20:3 n-6 were not reported.
1.7.6 Case-control studies
Early case-control studies on atherosclerotic and normal individuals measured
relative amounts of EFA esterified with plasma cholesterol (Lewis, 1958; Bjorntorp,
1960; Schrade et al., 1961; Bottcher and Woodford, 1961). In general these studies
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documented lower levels of 18:2 n-6 and 20:4 n-6 in the atherosclerotic individuals
compared with controls. However, criticism can be levelled at these studies. For
example, the controls used by Bottcher and Woodford (1961) were 30 years younger
than the cases, who were of mixed aetiology. Finally, the possibility that these subjects
might have changed their diets after the diagnosis was not always examined.
A cross-sectional study in the East of Scotland avoided this problem by detecting
men with previously unidentified or occult CHD (Wood et al., 1984). The study
entailed an assessment of adipose tissue and platelet fatty acid composition in a total
random sample of 448 men. Retrospective analysis showed that 28 had occult CHD
and therefore had not contacted their doctors regarding lifestyle and dietary changes.
Lower concentrations of adipose tissue 18:2 n-6 content were demonstrated in these
new cases compared with men with no CHD (n=343). In addition, low levels of
adipose tissue 20:3 n-6 were more significantly related with new CHD than 18:2 n-6
suggesting a possible impairment of EFA metabolism as the most important factor
(Oliver et al., 1989).
This study was followed by a prospective case-control investigation of angina and
acute myocardial infarction. There was an inverse relative risk of new angina pectoris
and acute myocardial infarction (AMI) according to the concentration of 18:2 n-6 in
adipose tissue (Wood et al., 1987). However, in contrast to the above retrospective
study no differences were observed for the concentration of either 20:3 n-6 or 20:4 n-6
in adipose tissue. There is no satisfactory explanation for this discrepancy between the
two studies ofWood et al.
1.7.7 Prospective studies
One of the main problems with case-control studies is that measurements are made
after the onset of the disease and it cannot be ascertained therefore whether the
differences are a cause leading to or promoting disease development or an effect of the
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disease itself. Prospective studies have the advantage over typical case control studies
because dietary analyses are made long before the disease is manifest.
An assessment of the predictive power of serum fatty acid composition in the
development of CHD formed the basis of a prospective study by Miettinen et al.
(1982). Briefly, 1222 men, initially free from CHD, were followed-up for 5 to 7 years.
During this time 33 sustained fatal AMI, non-fatal AMI or sudden death. The relative
amount of phospholipid esterified 18:2 n-6, a poor marker of dietary 18:2 n-6 intake,
was discovered to be an independent risk factor for CHD. The absence of an inverse
association between the percentage of cholesterol esterified 18:2 n-6 (which does
reflect dietary 18:2 n-6) and subsequent AMI, was not different between patients with
infarcts and the retrospectively selected controls.
A number of other prospective studies have been undertaken assessing the dietary
intakes of PUFA in association with CHD mortality (Gordon et al., 1981; McGee et
al., 1984; Kushi et al., 1985; Kromhout and Coulander, 1984). The findings from these
studies in different populations have also been inconsistent.
1.7.8 Intervention studies
CHD intervention studies can be classified as either primary or secondary trials.
Primary trials are established to prevent end points of CHD (such as angina, MI or
death) in people who are at risk but are nevertheless still free from discernible disease.
In contrast, secondary intervention trials are aimed at the prevention of the occurrence
of a second MI or similar cardiac related event.
Only a small number of primary intervention studies have solely examined the
effect of dietary change in connection with CHD. The randomised and double-blinded,
Los Angeles Veterans study (Dayton et al., 1969), demonstrated a decrease in
coronary events in men fed diets with a high P/S ratio. Yet, the effect was only
significant in those who had an initially high serum cholesterol. The study, however, is
associated with a number of uncertainties. For example, a high non-CHD mortality rate
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was recorded in those who received the experimental diet. In addition, adherence to
either the control or experimental diet was poor (Gurr, 1992).
The Finnish mental hospitals study also examined the effect of dietary change on
CHD mortality using a dietary protocol similar to the Veterans study (Turpeinen et al.,
1979). Patients were recruited from two mental hospitals and received either their
usual diet or a modified diet for a period of six years. Despite a large reduction in
serum cholesterol and a generally favourable risk profile, deaths from CHD remained
unchanged. Unfortunately, this may have been due to the changeable study population
as a result of new admissions and discharges.
Other CHD intervention trials have concentrated upon changing a broad range of
risk factors (Rose et al., 1980; Hjermann et al., 1981; Neaton and Wentworth, 1992).
Indeed, the study of Neaton and Wentworth (1992) is more commonly known as the
Multiple Risk Factor Intervention Trial. As their name suggests, however, they
examine a whole variety of risk factors and as such the contribution of one element,
namely dietary 18:2 n-6, is uncertain.
1.7.9 Other EFA studies in humans
The finding that low levels of adipose tissue 20:3 n-6 reflected regional gradients
of CHD mortality (Riemersma et al., 1986) prompted Abraham et al. (1990) to
examine whether an impaired A6-desaturase was important in an Edinburgh based
CHD prone population. Apparently healthy men with a low adipose tissue 20:3 n-6
content, that had previously taken part in an earlier study (Wood et al., 1987), were
selected. Adipose tissue and serum lipid fatty acid compositions were analysed before
and after a four month supplementation with evening primrose oil (EPO, containing
9% 18:3 n-6) or saffower oil (containing no 18:3 n-6) as control. EPO but not
safflower increased adipose tissue 20:3 n-6 content. Similar qualitative changes were
observed in both serum triaclyglycerols and cholesterol esters. The results suggested
that 18:2 n-6 is not readily converted to 20:3 n-6 and this may be due to a low activity
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of A6-desaturase in these highly selected men. A similar type of study is required in a
population with a low rate ofCHD mortality, such as that of Southern Italy.
In a small study of two patients with hyperlipidaemia and two controls, the
conversion of an orally administered dose of [ 1 -14C] 18:2 n-6 was investigated by
Nichaman et al. (1967). Blood samples were taken at two hour intervals after the dose
and plasma radioactivity determined. The conversion [1-14C] 18:2 n-6 to 20:3 n-6 and
20:4 n-6 in plasma phospholipids was limited and shown to be lower in
hyperlipidaemics than controls. Other studies investigating the effects of risk factors on
18:2 n-6 metabolism in humans are scarce.
1.8 Summary
Low levels of 18:2 n-6 in adipose tissue are associated with increased risk of CHD
mortality. Decreased quantities of the desaturation and elongation product 20:3 n-6
also reflect CHD mortality gradients and suggest a role for an impared 18:2 n-6
metabolism at the level of A6-desaturase. Evidence from animal studies have shown
that certain factors change the activity of A6-desaturase and some of these modulators
are also risk markers for CHD. What is unkown is how these factors alter the fatty acid
composition of tissues that are used to determine risk of CHD in individuals.
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Hypothesis
This thesis evaluates the effects of different modulators of A6-desaturase activity
and assesses how fatty acid composition is altered by these modulators in liver, plasma
and adipose tissue. It postulates that the activity of the A6-desaturase is reflected in the





Male, Sprague Dawley rats (-100 g, 4-5 weeks old), purchased from Bantin and
Kingman Company (Kingston-upon-Hull, Humberside, U.K.), were employed in the
majority of the dietary experiments (Chapters 4, 5 and 6). They were housed in groups
of four (unless otherwise stated) at a constant temperature (21±1°C), with water
available ad libitum and a cycle of 12 h dark, 12 h light (0800-2000 hours). Free
access to food (dependent on experiment type) was given unless stated to the contrary.
Diabetic studies (Chapter 7) were performed on male, Wistar Bio Breeding rats
(300-400 g, 20-23 weeks old) resident in the Biomedical Research Facility of the
Western General Hospital, Edinburgh. Rats were housed in groups of four at ambient
temperature (20±1°C) with a 12 h dark/light cycle (0800-2000 hours). They were
provided food (Rat & Mouse No.l (Modified), S.D.S., Witham, Essex, U.K.) and
water ad libitum. Daily subcutaneous injections of bovine insulin (Ultratard, Novo
Nordisk, Copenhagen, Denmark) were given to diabetic rats at 1000 hours. The dose
was adjusted for each animal individually according to daily measurements of body
weight and the degree of glycosuria (Chapter 7).
2.2 Experimental diet formulation
The diets for the cholesterol feeding studies (Chapters 4, 5 and 6) were semi¬
synthetic. The control diet was prepared from the basic dietary components of casein,
cornflour, glucose, beef tallow, safflower oil, non-nutritive cellulose, L-methionine,
salt mix (Appendix A) and vitamin mix (Appendix B). The constituents were combined
to give 38.4 % of total energy from fat, 38.0 % from carbohydrate and 23.6 % from
protein (Appendix C). Diets were prepared by combining the dry ingredients (including
salt and vitamin mixes) in a commercial food mixer (Robot Coupe) and blending
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thoroughly using the low speed setting for two minutes. The fat mix (comprising
molten beef tallow (liquefied in a Microwave oven (Toshiba, model ER-7820EW,
Tokyo, Japan)) and safflower oil with 106 mg supplemental (+)-a-tocopherol acetate;
Appendix C) was added slowly to the dry mix preparation at low mixing speed and
then blended at high speed for two minutes. The mineral and vitamin quantities given
in the diets were derived from Unilever Research, Vlaardingen, Holland.
To minimise potential peroxidative effects on dietary PUFA, diets were not
hydrated or pelleted, prepared weekly and stored at <4°C under argon in sealed
polythene containers. Fresh diets were supplied on the same days that animal cages
were changed (i.e. Monday, Wednesday and Friday of each week) with used diet being
discarded.
2.3 Tissue collection and preparation
2.3.1 Liver
Rats were sacrificed (normally between 0900 and 1000 hours) by stunning
followed by cervical dislocation (unless otherwise stated). Livers were quickly excised
and rinsed in ice cold homogenisation buffer (0.25 M sucrose, 1 mM dithiothreitol,
1 mM disodium EDTA, 0.1 M potassium dihydrogen orthophosphate, pH 7.2). The
liver from each rat was weighed individually and minced finely with scissors on an ice-
cold petri-dish. The tissue was then homogenised with five volumes of the above
buffer in a Dounce tissue grinder (Wheaton, Millville, New Jersey, U.S.A.) with ten up
and down strokes of loose and tight plungers respectively. The homogenate was
centrifuged for 10 min at 800 x g in a Beckman rotor (JA 14). The resultant pellet was
discarded and the supernatant was centrifuged for 20 min at 15,000 x g (Beckman
rotor Ti 45). The microsomal pellet was obtained by centrifugation of the 15,000 x g
supernatant at 105,000 x g for 60 min (Ti 45). The pinkish pellet that resulted was
gently reconstituted in a volume of homogenisation buffer in proportion to the starting
weight of the tissue (0.1 ml/g liver). The samples were stored at -20°C until analysis
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(within four weeks). All centrifugation steps were carried out using the Beckman J2.21
centrifuge and the Beckman L8-55 ultracentrifuge at 4°C (Beckman Instruments Inc.,
Palo Alto, U.S.A.) according to Garg et al. (1988a).
2.3.2 Blood, heart and adipose tissue
Just prior to liver excision, blood was taken by cardiac puncture, collected in
lithium heparin tubes (Sterilin Ltd., Teddington, Middlesex, U.K.), centrifuged (800 x
g) and plasma stored (-20°C) for biochemical analyses. The heart was then excised,
rinsed in ice-cold saline, weighed and frozen in liquid nitrogen. Adipose tissue from the
inguinal region of each rat was also removed, rinsed in ice cold 0.9 % (w/v) saline and
stored (-40°C).
2.4 Biochemical analyses
2.4.1 Plasma cholesterol and triacylglycerol
Plasma cholesterol and triacylglycerol were determined enzymatically (CHOD-
PAP, Cholesterol C system, Boehringer Mannheim, Germany and Merkotest 14360,
Merck, Germany). Both assessments were carried out using a Cobas Bio centrifugal
analyser (Roche Diagnostics, Welwyn Garden City, Hertfordshire, U.K.). Details are
presented in Appendix D. The intra- and inter- assay coefficients of variation for the
cholesterol analyses were 0.8 and 4.9 %, respectively. The corresponding coefficients
for the triacylglycerol analyses were 1.1 and 1.5 %, respectively.
2.4.2 Plasma insulin
Plasma insulin was determined using radioimmunoassay with rat insulin standards
(Novo Research Institute, Bagsvaerd, Denmark) and charcoal separation (Ashby and
Speake, 1975). This assay was performed courtesy of Dr R.M. Lindsay, Principal
Biochemist, Metabolic Unit, Western General Hospital, Edinburgh. The intra- and
inter- coefficients of variation for insulin analyses were 4.2 and 7.3 %, respectively.
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2.4.3 Plasma glucose
Plasma glucose analyses were performed at the Western General Hospital using a
Beckman Synchron AS4 automated analyser system (Beckman-RIIC, High Wycombe,
Buckinghamshire, U.K.) employing the glucose oxidase method (Swoboda and
Massey, 1965). The intra- and inter- coefficients of variation for this assay were 0.8
and 2.2 %, respectively.
2.4.4 Glycosylated haemoglobin
Red blood cells were washed three times in isotonic saline on the day of sample
collection and then frozen (-20°C). Glycosylated haemoglobin was analysed at the
Western General Hospital using boronic acid affinity chromatography (Pierce and
Warriner, Chester, Cheshire, U.K.). The intra- and inter- coefficients of variation were
1.9 and 3.4 %, respectively.
2.4.5 Microsomal protein
Analysis of microsomal protein concentration was carried out by the method of
Lowry et al. (1951) modified by Clifton et al. (1988) for estimation on the Cobas Bio
centrifugal analyser fitted with the DENS calculation programme (Roche Diagnostics,
Welwyn Garden City, Hertfordshire, U.K.). Bovine serum albumin (Fraction V)
dissolved in homogenisation buffer was the protein standard solution. The start
reagent was Folin and Ciocalteu's phenol reagent (diluted 1:3 (v/v) with double
distilled water) and the absorbance measured at 750 nm. The standards 0, 100, 200,
300, 400 and 500 pg/ml were run within each estimation and the sample protein
concentration calculated through the DENS plot mode. The inter- and intra-
coeflficients of variation were 2.9 and 5.7 %, respectively.
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2.4.6 Microsomal succinate dehydrogenase
Succinate dehydrogenase (SDH) activity was assessed by the ability ofmicrosomes
and total homogenate to reduce 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-
tetrazolium chloride (INT) in the presence of phenazine methosulphate (PMS)
(Porteous and Clark, 1965). The incubations (1.0 ml) contained (in pinoles) sodium
phosphate, 50.0; sodium succinate, 10.0; INT, 0.40; PMS, 0.33 and Triton X-100,
0.0001 %. Microsomes and total homogenate (2 mg protein) were assayed. Electron
acceptors were added after a 6 min pre-incubation (30°C). Absorbance increases were
followed at 540 nm on a SP 8-100 ultraviolet spectrophotometer (Pye Unicam). The
reference incubation contained 10 pinoles sodium malonate instead of sodium
succinate. An absorbance increase of 0.1 represented a reduction of 1.77 x 10~8 moles
INT (assuming a transfer of 2 electrons per INT molecule). SDH activity was
expressed as nmol/min/mg protein. Mitochondrial contamination of microsomes was
expressed as a percentage of the activity of SDH in microsomes of SDH in the total
homogenate.
2.4.7 Adenosine triphosphate and creatine phosphate
ATP and CP concentrations were determined using the enzymatic ultraviolet
method of Trautschold et al. (1985) adapted for use on a Cobas Bio centrifugal
analyser (Wardle, 1990). Details are provided in Appendix D.
2.4.8 A6-desaturase
Liver microsomal A6-desaturase activity was analysed in groups according to the
design of the individual experiments (n=16-24) with a blank measured alongside. For
larger experiments (Chapter 6), the analyses were paired (i.e. control and experimental
microsomes from the same study were measured in the same analytical run) with a
quality control and blank assessed alongside.
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Oxidative desaturation of 18:2 n-6 by liver microsomes was estimated by
measuring the amount of [ 1 - 14C] 18:3 n-6, [l-l4C]20:3 n-6 and [1-14C]20:4 n-6
produced from [1-14C]18:2 n-6 (Brown and Riemersma, 1995, submitted for
publication). The freshly prepared incubation medium contained in a total volume of
1.2 ml the following compounds (in pinoles): ATP, 4.0; Coenzyme A, 0.25; NADH,
1.25; nicotinamide 0.5; magnesium chloride 5.0; bovine serum albumin (essentially
fatty acid free) 0.01; glutathione 1.5; potassium phosphate 45.0 (pH 7.2) and 200
nmoles of [1-14C] 18:2 n-6 (CFA 104, Amersham International, Amersham,
Buckinghamshire, U.K.) dissolved in 4.2 pi ethanol. The substrate was diluted with
unlabelled 18:2 n-6 to produce a specific activity of 700 dpm/nmol.
Incubations were commenced by the addition of 500 pg of microsomal protein (in
200 pi homogenisation buffer) to 1.0 ml of pre-warmed (37°C) incubation medium in a
Quick-fit tube (18 mm x 125 mm). The desaturation preparation was quickly vortexed
(1-2 s) and placed back into the reciprocal shaking (120 cycles/min) water bath (37°C)
for 20 min. The reaction was terminated by the addition of 2.0 ml of 10 % (w/v) KOH
in 80 % (v/v) aqueous methanol containing 0.005 % (w/v) butylated hydroxytoluene
(BHT). Lipids were saponified (45 min, 82°C, under argon), cooled to room
temperature and acidified with 1.0 ml 7 M HC1, the non-esterified fatty acids were then
extracted into hexane (4.0 ml, 0.005 % (w/v) BHT). The hexane extract was
evaporated under argon (British Oxygen Company (B.O.C.) Ltd, Guildford, Surrey,
U.K.) in an aluminium block at 30-40°C (Wess, Technischer Werkstatten, Germany)
and methylated by heating in an oven (100°C, 60 min) with 1.0 ml 14 % (w/v) BF3-
methanol reagent under argon. The methylation mixture was then cooled to room
temperature, 4.0 ml distilled water was added and the fatty acid methyl esters
extracted with 2.0 ml hexane (0.005 % (w/v) BHT). Carrier methyl esters of 18:2 n-6,
18:3 n-6 and 20:4 n-6 were added to the hexane extract and evaporated to dryness
using a Btichi R rotary evaporator (Orme Scientific Ltd., Manchester, U.K.) at 30°C.
The extract was resuspended in chloroform (100 pi) and applied to silica gel 60 TLC
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plates impregnated with 10 % (w/v) silver nitrate (Section 2.5.8). Plates were
developed in chloroform-methanol-acetic acid-water (90:7.5:7.5:0.8, v/v/v/v, Gardiner
and Duncan, 1991) in solvent tanks lined with filter paper (20 by 20 cm, Whatman
International Ltd, Maidstone, Kent, U.K.) for separation of dienes (methyl linoleate,
R/=0.91) from trienes (methyl-y-linolenate and methyl dihomo-y-linolenate, R/=0.79)
and tetraenes (methyl arachidonate, R/=0.76). No attempt was made to separate
methyl-y-linolenate from methyl dihomo-y-linolenate. The bands were made visible
under ultraviolet light (365 nm) after light spraying with 2',7'-dichlorofluorescein (0.1
% (w/v) in 50 % (v/v) aqueous methanol) and scraped directly into scintillation vials
(25 mm x 58 mm, Sarstedt, Leicester, Leicestershire, U.K.). Methanol (0.5 ml) was
added to elute the fatty acids from the scraped silica bands and samples were counted
with 10 ml scintillation fluid (0.125 % (w/v) 2-(4-t-butyl phenyl)-5-(4-biphenylyl)-
1,3,4-oxadiazole (butyl-PBD) in toluene) using a liquid scintillation counter (Model
1209 Rackbeta, Wallac Oy, Finland) for 20 min with external standardisation.
The percentage desaturation was calculated as the ratio of the counts in the
desaturation products (triene plus tetraene fatty acid methyl esters) to the total counts
(sum of the counts in the substrate plus products). The number of pmol of products
formed were then calculated. Enzyme activity was expressed as pmol of products
formed from 18:2 n-6 per min per mg of microsomal protein. Average recovery of
radioactivity was 78±4 %. The intra- and inter-coefficients of variation were 3 .1 and
4.8 %, respectively.
2.4.9 A9-desaturase
Oxidative desaturation of 18:0 was estimated by measuring the amount of [1-14C]-
18:1 n-9 formed during the incubation of liver microsomes with [1-14C]18:0 (CFA 24,
Amersham International, Amersham, Buckinghamshire, U.K.). The cofactors in the
incubation were the same as those described for 18:2 n-6 desaturation except that half
the amount of albumin (essentially fatty acid free) was used as the amount of substrate
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utilised was 100 nmol per 1.2 ml. The same saponification, extraction and methylation
procedures were used as described in Section 2.4.8. Carrier methyl esters of 18:0 and
18:1 n-9 were used to facilitate the isolation of the saturated and monounsaturated
radioactive methyl esters. Plates were developed in hexane-diethyl ether (95:5, v/v;
Christie, 1982) and visualised under ultraviolet light after spraying lightly with 2',7'-
dichlorofluorescein. Bands were scraped from the plates into vials and counted with
scintillation fluid (as described in Section 2.4.8).
The percentage desaturation of 18:0 was calculated as the ratio of counts in the
monounsaturated band to the total counts (sum of counts of saturated plus
monounsaturated methyl esters). The number of pmol of 18:1 n-9 formed was then
calculated. The enzyme activity was expressed as pmol of 18:1 n-9 formed from 18:0
per min per mg of microsomal protein.
2.5 Chromatographical analyses
2.5.1 Gas liquid chromatography
All fatty acid methyl ester quantifications were carried out on a Pye Unicam series
204 chromatograph fitted with an auto-injector (Pye Unicam 4700) and linked to a
Perkin Elmer Nelson 900 series interface (Perkin Elmer Nelson Systems, Inc.,
Cupertino, U.S.A.) and a Perkin Elmer Nelson integration system (Model 2600, 5.1)
on an IBM Personal System 2 computer (Model 30, 286). A 1.5 m long glass column
(i d. 2 mm) packed under vacuum with a stationary phase of GP 10 % SP 2330 on
100/120 mesh chromosorb® WAW (Supelchem, Saffron Walden, Essex, U.K.) was
used in all separations. The parameters used for the separation of one pi injected
samples were as follows:- injector temperature 220°C; column temperature 180°C;
detector temperature 300°C; carrier gas (oxygen free nitrogen, B.O.C. Ltd, Guildford,
Surrey, U.K.) flow 50 ml/min.; hydrogen gas (B.O.C. Ltd, Guildford, Surrey, U.K.)
flow 50 ml/min.; air flow 550 ml/min. A single step oven temperature programme was
employed for the separation of the fatty acid methyl esters. It was composed of: 180°C
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for 3 min then 3°C/min up to 250°C and 5 min at 250°C. The chromatograms were
individually examined on the video screen for correct separation, retention times and
base line tracking of the fatty acid peaks. Samples were reanalysed where necessary on
a Perkin Elmer Nelson integration system.
A typical trace of fatty acid methyl esters derived from a rat plasma phospholipid
sample is shown in Figure 2.1. The intra-coefificient of variation for individual fatty
acids was dependent upon the size of the peak involved. In the analysis of adipose
tissue triacylglycerols for example, the coefficient of variation for larger peaks (e.g.


























Retention Fatty acid Retention Fatty acid Retention Fatty acid
time (min) J methyl ester time (min) methyl ester time (min) methyl ester
2.43 14:0 9.00 18:3 n-6 # 12.75 20:4 n-6
3.98 16:0 9.17 18:3 n-3 14.38 20:5 n-3
4.60 16:1 9.93 20:1 16.35 22:4 n-6
6.27 18:0 11.31 20:6 n-6 16.95 22:5 n-6
6.95 18:1 11.48 20:3 n-9 18.02 22:5 n-3
8.05 18:2 n-6 12.03 20:3 n-6 18.65 22:6 n-3
J Peak at 0.43 min is injection solvent, peak at 2.17 min is BHT. peak at 5.03 min is 17:0 (internal
standard). # Unresolved peak contained unspecified amounts of 20:0.
Figure 2.1 Pi typical GLC trace ofplasma total phospholipidfatty acid methyl esters
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2.5.2 Fatty acid composition - liver microsomes
Liver microsomal lipids were analysed in groups according to the design of
individual experiments (n= 16-24) with a blank assessed alongside. However, for larger
experiments (Chapter 6) paired analyses were performed so that the control
microsomes were run with the experimental samples in each batch.
Liver microsomes (8-10 mg) were thawed on ice, diluted to 1.0 ml with
homogenisation buffer and extracted essentially to the method of Folch et al. (1957).
This procedure employed shaking the sample cumulatively with 3.0 ml methanol, 3.0
ml chloroform (including heptadecanoic acid, cholesteryl heptadecanoate, L-a-
phosphatidylcholine diheptadecanoyl and triheptadecanoin internal standards), a
further 3.0 ml chloroform and 2.5 ml 0.88 % KC1 solution in a Quick-fit tube (23 mm
x 150 mm). The extraction mixture was then left overnight (4°C). Following
centrifugation (800 x g, 10 min), the upper aqueous phase was aspirated and
discarded, the lower chloroform layer (5.0 ml) was transferred to a clean Quick-fit
tube (18 mm x 125 mm) and evaporated to dryness using a Btichi R rotary evaporator
at 30°C. The extract was redissolved in 200 pi chloroform and applied as a 5 cm band
to silica gel 60 TLC plates (Merck No. 5721, 20 by 20 cm, 0.25 mm, pre-run in
chloroform-methanol (4:1, v/v) and re-activated for 30 min at 110°C). Plates were
developed in hexane-diethyl ether-formic acid (80:20:2, v/v/v) for 50 min, dried,
sprayed lightly with PPO-POPOP (l,2-bis[2-(5-phenyloxazolyl)] benzene, 0.01 %
(w/v) and 2,5-diphenyloxazole, 0.006 % (w/v)) in chloroform and the relevant lipids
(most commonly phospholipids but also triaclyglycerols etc.) identified under
ultraviolet light at 365 nm. The position of the bands using this separation had been
identified previously using known standards. The bands of interest were scraped from
the plate onto grease-proof paper and placed into separate Quick-fit tubes (18 mm x
125 mm).
Transmethylation (base catalysed) was carried out using toluene and sodium
methoxide as described by Christie (1982). The methyl esters produced from this
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trans-esterification were redissolved in 25 pi chloroform (containing 0.01 % (w/v)
BHT) and analysed on a packed column GLC (see Section 2.5.1).
2.5.3 Fatty acid composition - liver microsomal fractionated phospholipids
For fractionated phospholipid fatty acid analysis, microsomes were extracted for
total lipids as described in Section 2.5.2. The internal standards used in this analysis
were L-a-phosphatidylcholine diheptadecanoyl and L-a-phosphatidylethanolamine
diheptadecanoyl. After extraction, the lipid extract was evaporated to dryness (Biichi
R rotary evaporator at 30°C) and redissolved in 1.0 ml chloroform-methanol (2:1,
v/v). Phospholipids were separated into PC, PE and PI by TLC (Fine and Sprecher,
1982). An aliquot (500 pi) was spotted as a 10 cm streak on Whatman LK5 plates (20
by 20 cm, 0.25 mm, preadsorbant strip) which had been pre-developed in chloroform-
methanol (1:1, v/v), impregnated with 1.2 % boric acid in ethanol-water (1:1, v/v) and
activated (100°C, 60 min). Plates were developed in chloroform-methanol-water-
ammonium hydroxide (120:75:6:2, v/v/v/v) in filter paper lined tanks for 60 min.
Plates were then air dried and sprayed lightly with dichlorofluorescein (0.1 %, w/v) to
allow individual bands to be identified under ultraviolet light (365 nm). The bands of
interest were scraped individually from the plate and put directly into Quick-fit tubes
(18 mm x 125 mm). In the case of PI (which was not available in the diheptadecanoyl
form), 4.0 pg of L-a-phosphatidylcholine diheptadecanoyl was added as an internal
standard to the silica scrapings. Transmethylation, extraction and analysis of methyl
esters were carried out as described in Sections 2.5.2 and 2.5.1.
2.5.4 Fatty acid composition - plasma lipids
Plasma (0.50 ml) samples were thawed on ice and diluted with 0.50 ml saline.
Plasma lipids (phospholipids, cholesterol esters and triacylglycerols) were extracted,
separated, transmethylated and analysed as in Sections 2.5.2 and 2.5.1.
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2.5.5 Fatty acid composition - dietary lipids
An accurately weighed sample of diet equivalent to ~80 mg fat was extracted with
240 ml chloroform-methanol (2:1, v/v). A 15.0 ml aliquot was withdrawn and
transferred to a Quick-fit tube (23 mm x 150 mm) containing 1.0 ml triheptadecanoin
as internal standard. KC1 (4.0 ml, 0.88 % (w/v)) was added and the mixture shaken
and centrifiiged (800 x g, 10 min). A 5.0 ml aliquot was withdrawn, transferred to a
clean Quick-fit tube (18 mm x 125 mm) and evaporated to dryness using a Buchi R
rotary evaporator at 30°C. Transmethylation and analysis were carried out as
described in Sections 2.5.2 and 2.5.1.
2.5.6 Fatty acid composition - adipose tissue triacylglycerols
Adipose tissue triacylglycerol was extracted essentially according to Walldius and
Rubba (1976). Approximately 10 mg of adipose tissue (previously rinsed in saline
solution at sample collection) was homogenised in all-glass Potter-Elvjehem
homogenisers using 5.0 ml 2-propanol-heptane (4:1, v/v). Phospholipids and non-
esterified fatty acids were back-extracted using 3.0 ml KOH (0.05 %, w/v) with the
triacylglycerol fraction remaining in the upper organic phase. This upper phase was
washed with 8.0 ml 2-propanol-KOH (0.05 % (w/v); previously shaken with heptane
(4:1:3, v/v/v). The heptane layer was then transferred to a Quick-fit tube (18 mm x
125 mm) and evaporated to dryness using the Biichi R rotary evaporator. The adipose
triacylglycerol fraction was transmethylated (as in Section 2.5.2) and methyl esters
were extracted into hexane. The hexane was evaporated and the residue was
redissolved in 40 pi chloroform for GLC analysis.
2.5.7 Cholesterol - liver microsomes
Total rat liver microsomal cholesterol content was determined according to the
method of Miettenen et al. (1965). Microsomes (equivalent to 4-6 mg microsomal
protein) were thawed and pipetted into Quick-fit tubes (18 mm x 125 mm) containing
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500 |ig 5-(3-cholestane as internal standard (previously added in 1.0 ml 2-propanol and
evaporated to dryness using a Biichi R rotary evaporator, 30°C). After alkaline
hydrolysis in 10.0 ml 1 M KOH in 90 % ethanol (82°C, 60 min) the samples were
cooled, filtered (Whatman No.l, Whatman International Ltd, Maidstone, Kent, U.K.)
and a 5.0 ml aliquot withdrawn for extraction. Double distilled water (2.5 ml) was
added and the cholesterol extracted, with shaking, into hexane (2 x 3.0 ml, then 1 x
5.0 ml hexane). The combined extract (reduced to 5.0 ml, Biichi R rotary evaporator,
30°C) was washed with double distilled water (2 x 5.0 ml) and dried with anhydrous
sodium sulphate. The final hexane extract was evaporated to dryness (Btichi R rotary
evaporator, 30°C). Neutral sterols were derivatised to their trimethyl silyl (TMS)
ethers with 8 drops Tri-Sil® reagent (Pierce and Warriner Ltd., Chester, Cheshire,
U.K.) and incubated at room temperature (30 min). The mixture was evaporated to
dryness (Buchi R rotary evaporator, 30°C), resuspended in 1.0 ml n-decane, shaken
for 5 min, centrifuged (800 x g, 10 min) and transferred to vials for analysis. All sterol-
TMS ether analyses were carried out by GLC (Chrompack Model CP 9000 GC,
Middelburg, Holland). Separations were conducted on a capillary column (25 m x
0.32 mm i.d.) with BPX as stationary phase (SIG. Pty Ltd, Milton Keynes,
Buckinghamshire, U.K.) and nitrogen (B.O.C. Ltd. Guildford, U.K.) as carrier gas
(split ratio 60). Initial oven temperature was 260°C increasing to 330°C, rising 5°C per
min. Peak integration was performed on a Spectra-Physics SP 4600 integrator
(Chrompack, Middelburg, Holland). The intra- and inter- assay coefficients of
variation were 4.6 and 9.0 % respectively, when performed on liver microsomes. An
example of a typical chromatogram is presented in Fig. 2.2.
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Figure 2.2 Typical GLC trace of rat liver microsomal cholesterol with 5/3-cholestane
as internal standard
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2.5.8 AgN03 thin layer chromatography plate preparation
Precoated silica gel 60 TLC plates (20 by 20 cm, 0.25 mm, No. 5721, Merck Ltd,
Leicestershire, U.K.) were immersed in 10 % (w/v) silver nitrate in 80 % (v/v)
aqueous ethanol for 10 s in a dipping chamber (Whatman International Ltd,
Maidstone, Kent, U.K.) in low light. The plates were dried briefly in air and
immediately activated (110°C, 60 min). After activation the plates were either used
forthwith or stored for up to 24 h in the dark. The typical silver content of the silica
gel was 7.3 % (determined by weighing plates pre and post silver nitrate
impregnation).
2.6 Preparation of [11,12-^H] stearic acid
2.6.1 Synthesis
The in vivo metabolism of [11,12-3H] 18:0 is dealt with in this thesis (Chapter 6).
This substrate, used to assess A9-desaturase activity in vivo, is not available
commercially and therefore had to be synthesised within the Unit from vaccenic acid
methyl ester (11-octadecenoic acid methyl ester).
Catalytic reductions of vaccenic acid methyl ester were performed using tritiated
sodium borohydride (NaB3H4, TRA 45, 98 % purity, 338 mCi/mmol, Amersham
International, Amersham, U.K.) and a finely divided platinum catalyst on carbon,
essentially according to Brown and Brown (1962) and Brown et al. (1963). The
product fatty acid methyl esters (FAME) were hydrolysed with 30 ml 1 M KOH-
ethanol (82°C, 45 min) acidified with 20 ml 6 M HC1 and extracted into hexane. The
extracted non-esterified fatty acids were then remethylated using BF3-methanol
(100°C, 60 min) and the resultant FAME were extracted into hexane and separated by
silver ion acid-washed-Florisil™ column chromatography (Section 2.6.2). The product
was analysed by GLC for purity (Section 2.5.1) then hydrolysed with KOH (1 M),
acidified HC1 (6 M) and extracted into hexane.
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Preliminary fatty acid hydrogenations, using non-radioactive NaBH4 and oleic acid
methyl ester, were conducted in a similar manner as intended for the radioactive
synthesis. This was due to the high cost of vaccenic acid methyl ester (£73.40/g) and
to obtain relevant experience in the technique. In addition it was necessary to optimise
the conditions for the reduction of the monoene.
NaBH4 (3 mg) was put into the reaction vessel previously oven dried and argon
flushed. Dry ethanol containing 50 mg carbon and a magnetic stirrer were added and
the vessel sealed. Other reagents were added via a 100 pi syringe (Hamilton Co.,
Reno, Nevada, U.S.A.) through a rubber seal; platinic chloride (^PtClg, 10 mg/1500
pi (in dry ethanol), oleic acid methyl ester (880 mg), and 340 pi 6 M HC1. The
reaction was allowed to proceed at room temperature for 25 min with vigorous stirring
and then NaBH4 (94.5 mg in 2900 pi dry ethanol) was added gradually so that the
pressure within the vessel remained constant (assessed with a water filled manometer).
Samples for GLC analysis were obtained (via the rubber sealed port) at time zero, 1
min post HC1 addition, and then at 15, 30, 60, 120, 180, 300 and 360 min from the
start of the hydrogenation and revealed a 90±2 % reduction of oleic acid methyl ester
after 2 hours.
The procedure used for the fatty acid tritium-hydrogenation, employing a large
excess of non-radioactive (cold) NaBH4 chaser, was recommended by Dr R.L. Baxter
(Dept. of Chemistry, University of Edinburgh). It was claimed that this cold tracer
chase technique would increase tritium incorporation into the monoene. The
incorporation of tritium into cis vaccenic acid methyl ester was 2.8 %. This gave
insufficient material for the biological experiments. The extent of incorporation could
be predicted when the amount by which the tritiated sodium borohydride had been
diluted by the cold material was taken into consideration. Assessment of losses
revealed that most of the tritium (-97 %) was present in the acidified aqueous phase.
The large excess of cold NaBH4 chaser was believed to have decreased the efficiency
of the 3H incorporation.
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Owing to the large diluting effects of the cold NaBH4, the synthesis was scaled
down. Small scale two hour hydrogenations were carried out in thick glass walled
vessels (1 ml, MFX, Camlab, Cambridge, Cambridgeshire, U.K.). As in the larger scale
hydrogenations, ~3 mg NaB3H4 were decanted into the oven dried vessel followed by
cis vaccenic methyl ester (33.5 pi), carbon (1.5 mg in 150 pi dry ethanol) and platinic
chloride (0.3 mg in 45 pi dry ethanol). The vessel was then tightly closed. HC1 (0.6 M)
was added slowly to the system via a 23 g Microlance® needle and 1 ml Plastipak®
syringe (Becton Dickinson, Dublin, Ireland) to create the tritium atmosphere. The
synthesis mixture was sonicated for 2 h (to ensure adequate mixing) and the reaction
mixture worked up. Results of the smaller scale hydrogenations again showed low
tritium incorporation with only 5.5 and 3.7 % from two syntheses, but this was
adequate for the biological experiments.
2.6.2 Purification
The reduction mixture, containing both saturated and monounsaturated fatty acid
methyl esters, was purified using AgN03-impregnated Florisil™ (acid washed) column
chromatography (Willner, 1961). Acid washed Florisil™ was prepared as described by
Carroll (1961) and AgN03 impregnation by the method of Anderson and Hollenbach
(1965).
For the large scale separations (i.e. -0.9 g fatty acid methyl esters) a 70 cm column
(i.d. 0.8 cm) was employed. The smaller scale purifications used a 5 cm column. Both
columns were protected from light using aluminium foil. The AgN03-impregnated
Florisil™ was poured into the columns as a slurry in hexane-diethyl ether (199:1, v/v).
Elution of 92 % of the stearate methyl ester was achieved with 180 ml and 30 ml
hexane-diethyl ether (199:1, v/v) from the 70 cm and 5 cm columns respectively with
retention of the methyl ester of 18:1 n-9.
2.7 Analyses of [1-14C] linoleic and |11,12-3H| stearic acids and
metabolites in vivo
2.7.1 Plasma
Plasma aliquots (40 pi) were counted in duplicate with 10 ml Optiphase 'safe'
scintillant (F.S.A. Laboratory Supplies, Loughborough, Leicestershire, U.K.) for 14C
and 3H labels on a Model 1209 Rackbeta scintillation counter. The Three Over Two
dual counting method (Pharmacia Wallac Ltd., Uppsala, Sweden) with external
standardisation was used. This facility employs three fixed counting windows and
mathematically adjusts sample counts for the extent of quenching. This method
provided good counting conditions for both 14C and 3H and after correction the
degree of 14C spill into the 3H channel was low (0.2±0.02 %).
Individual classes of plasma lipids were extracted and separated as described in
2.5.4. and 2.5.2 respectively. They were then scraped from the TLC plates and
counted with scintillant (0.125 % butyl-PBD in toluene) using the dual counting
facility with external standardisation.
2.7.2 Liver microsomal phospholipid fatty acids
Phospholipids were isolated and transmethylated from liver microsomes as
described in Section 2.5.2. The FAME extract was divided into three aliquots. Twenty
percent of the extract was analysed by GLC (as described in Section 2.5.1). The
remaining extract (80 %) was divided into two equal parts and separated by
argentation chromatography. One aliquot was separated using the TLC method for the
A6-desaturase assay. Bands of silica containing saturates and monoenes (together),
dienes, trienes, tetraenes and pentaenes were scraped from the plates into separate
vials and counted with scintillant (0.125 % butyl-PBD in toluene) using the dual label
facility. FAME from the remaining aliquot were isolated using the TLC separation
technique for A9-desaturase. Bands of silica containing saturated and monoene fatty
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acids were separately scraped from the TLC plates and counted with scintillant. All
separations were carried out within the same day following extraction.
Typical R/ values for the A6 separation were as follows:-






Typical R/ values for the A9 separation were as follows:-
Saturates 0.46
Monoenes 0.20
2.7.3 Adipose tissue triacylglycerol fatty acids
The triacylglycerol fraction from freeze-dried adipose tissue was extracted and
transmethylated as in Sections 2.5.6 and 2.5.2, respectively. The FAME extract was
then divided into three aliquots. Twenty percent of the extract was analysed by GLC
(Section 2.5.1) and the remaining extract (80 %) was divided into two equal parts and
separated by argentation chromatography as described in Section 2.7.2.
2.8 Statistical analyses
Statistical analyses were conducted using MINITAB version (CLE.COM Ltd.,
Birmingham, U.K.). Biochemical measurements were normally distributed and the
statistical protocol was one- or two- way analysis of variance (ANOVA), followed by
unpaired Student's t-test. For unbalanced data (with missing values or unequal group
sizes) that were unable to be analysed by two way ANOVA, the MINITAB general
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linear model (GLM) was used. All results are presented as mean ± one standard
deviation. Statistical significance was accepted when p<0.05 was achieved.
2.9 Materials
All chemical supplies were of at least analytical grade. Other than the reagents
specified below or detailed in the text, all were purchased from Sigma Chemical Co.,
Ltd., Poole, Dorset, U.K.
Aldrich Chemical Co., Ltd., Gillingham, Dorset, U.K.
Sodium methoxide
BDH (Chemicals) Ltd., Poole, Dorset, U.K.
Carbon (decolorising purified, Norit GSX), copper sulphate (CuS04.5H20), diethyl
ether, disodium EDTA, ethanol (dry), formic acid, hydrochloric acid (concentrated),
magnesium chloride (MgCl2.6H20), methanol (sodium dried), potassium chloride,
potassium hydroxide, potassium phosphate (KH2PC>4), silver nitrate, sodium
carbonate, sodium chloride, sodium-potassium tartrate, sucrose, toluene (Aristar®)
Rathburn Chemicals Ltd., Walkerburn, U.K.
Acetic acid, chloroform, diethyl ether, heptane, hexane, methanol, 2-propanol, toluene
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Chapter 3
Methodological aspects in the determination of
the activity oflinoleic acid A6-desaturase
3.1 Introduction
Most of our current knowledge on the A6-desaturation of 18:2 n-6 is based on
studies using a radio-labelled in vitro activity assay in liver microsomal preparations
(De Gomez Dumm et at, 1979; Garg et al1988a; Ulmann et at., 1991a). Within this
system, the study of lipid metabolism is a complex process in which the lipid under
investigation must be dispersed in such a form that it is metabolised effectively. For A
6-desaturase in liver microsomes a supply of Mg2+, ATP and CoASH is required for
the activation of [1-14C] 18:2 n-6 (usually albumin bound) by acyl-CoA synthetase to
produce [l-14C]linoleoyl-CoA (Brenner and Catala, 1971). Activated 18:2 n-6 is
subsequently oxidatively desaturated by the A6-desaturase enzyme system in the
presence of 02 and NADH to produce [l-14C]y-linolenyl-CoA, which is then isolated
and quantified.
Our initial results yielded low enzyme activities at the higher microsomal protein
concentrations (2-5 mg) which are commonly used in some of the assay systems
currently in the literature (Garg et al., 1988a). This merited further investigation. This
work reports the results of a study of factors influencing the 18:2 n-6 A6-desaturase
assay, in particular the role of NaF and the importance of substrate to microsomal
protein ratio.
3.2 Methods
Chow fed rats (200-300 g) were sacrificed and liver microsomes prepared as
described in Section 2.3.1. Microsomal pellets were resuspended in homogenisation
buffer, frozen at -20°C and analysed within four weeks. Microsomal protein
concentration was analysed as outlined in Section 2.4.5. The standard incubation
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mixture for A6-desaturase estimation consisted of the co-factors detailed in Section
2.4.8.
Before embarking on our studies on the A6-desaturase assay, a thorough appraisal
of factors that affect the blank value was made in the system. Linoleic acid is
susceptible to oxidation. Products originating from this process have a reduced
mobility during argentation chromatography and may therefore coincide with the
18:3 n-6 band, resulting in a high blank. We therefore examined whether flushing tubes
with argon and the addition of BHT (0.005 % or 0.05 % (w/v)) as an anti-oxidant to
all solvents during the extraction, derivitisation, and chromatographic procedures
could reduce the blank. The results demonstrated that blanks (i.e. no microsome
addition) could be maintained at the lowest and most reproducible level (0.30±0.03 %
of total counts) when samples were argon flushed and all solvents contained 0.005 %
(w/v) BHT.
The influence of microsomal protein (0.25-5.0 mg) on A6-desaturase activity using
a fixed amount of [1-14C]18:2 n-6 (200 nmol) as substrate was investigated with a 20
min incubation and the cofactors as described in Section 2.4.8.
The effect of NaF (to inhibit ATPase) was investigated with 0.25-1.5 mg
microsomal protein. Incubations were carried out in the presence or absence of 45 mM
NaF, with 200 nmol [1-14C]18:2 n-6 and a 20 min incubation. ATP concentrations
were measured in duplicate samples as described in Section 2.4.7.
The use of an ATP re-generating system was assessed (without NaF) with the
standard incubation medium supplemented with creatine phosphate (20 mM) and
creatine kinase (80 U/incubation (Reddy, 1989)). ATP and creatine phosphate
measurements were made as described in Section 2.4.7.
The effect of substrate concentration was investigated over a range of 40-200 nmol
of [1-14C] 18:2 n-6 with the standard amount of 0.5 mg microsomal protein. The effect
of maintaining a constant ratio of substrate to microsomal protein was also
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investigated utilising the standard incubation conditions with a microsomal protein
range of 0.25-1.8 mg and [1-14C] 18:2 n-6 range of 100-800 nmol.
In order to examine whether the lower activities were due to a relatively non¬
specific binding effect on the substrate we also studied the effect of bovine serum
albumin. Albumin at two levels (0.5 mg and 1.5 mg, Fraction V, essentially fatty acid
free) with a fixed amount of [1-14C] 18:2 n-6 (200 nmol) was added to microsomal
protein (0.5 mg) under the standard incubation conditions. The effect of controlling
the 18:2 n-6 to albumin ratio was also studied by increasing the total 18:2 n-6
concentration to 400 and 800 nmol in the incubations that contained 0.5 and 1.5 mg
albumin, respectively.
Finally we decided to examine the influence of anaesthesia (sodium pentobarbital,
60 mg/kg, Sagatal®, Rhone Merieux Ltd., Dublin, Ireland) in a small number of rats
(three per group). The effect of freezing (for one hour, one week, two weeks and four




The amount of [ 1 -14C] 18:2 n-6 converted over a broad range of microsomal
protein concentrations was maximal at ca. 0.75 mg microsomal protein, with linearity
to this level (Fig. 3.1). Thereafter a steady decline was observed in 18:2 n-6
conversion with the lowest activity at 5 mg microsomal protein.
Microsomal protein (mg)
Figure 3.1 Effect of microsomal protein concentration on A6-desatnrase activity
(pmol/min) using a fixed amount of [1-14C]18:2 n-6 (200 nmol). Each point
represents the mean of duplicate analyses. Pattern is typical of three separate
experiments. Values ofactivity are lower than those presented in Figures 3.2, 3.3 and
3.4 and relate to the variability in activity of liver microsomal A6-desaturase from
different batches of rats.
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NaF tended to increase the activity of A6-desaturase using <0.5 mg microsomal
protein by about 10 %; however, this result was not significant (p>0.05, Table 3.1).
The effect of NaF at higher microsomal protein concentrations (i.e. >0.5 mg) was
more marked with a significantly lower (not higher) A6-desaturase activity. Higher
ATP concentrations were maintained during the 20 min incubations with NaF. Some
90 % of the added ATP remained at the end of the 20 min incubation with NaF when a
small amount of microsomal protein was used (0.33 mg). Less ATP was found in two
other experiments when 0.62 mg and 1.1 mg microsomes were used: 75 % and 65 %,
respectively. In the absence of NaF the respective figures in these experiments were
78 %, 59 %, and 38 % of ATP remaining.
Table 3.1 Effect of inhibition of endogenous ATPases by NaF and re-generation of
ATP on liver microsomal A6-desatnrase activity
Incubation conditions n Activity p value
Control 100 %
+ 45 mM NaF 3 110±11% n.s.
+ 45 mM NaF # 4 82±7 % 0.005
+ ATP re-generation system 3 94±7 % n.s.
Results expressed as percentage of relevant control (Mean±SD). # Addition of high microsomal
protein (>0.5 mg). n.s. Not significant.
The use of an ATP re-generating system maintained ATP concentrations at a
constant 4 mM throughout the incubation period (measured at 5, 10, 15 and 20 min)
and was coupled with a concomitant decline in creatine phosphate levels (data not
shown). The maintenance of ATP concentration had no effect on A6-desaturase
activity (Table 3.1).
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Under standard incubation conditions (i.e. 0.5 mg microsomal protein in a medium
devoid of both NaF and the ATP re-generating system), the activity of A6-desaturase
activity was constant up to 20 min incubation (Fig. 3.2).
Figure 3.2 Conversion of [1-14C]18:2 n-6 (nmol/mg) by liver microsomal A6-
desaturase in relation to time of incubation using a fixed amount of [1-14C]18:2 n-6
(200 nmol). Each point represents the mean of triplicate analyses. Residts expressed
asMean±SD. Pattern is typical of three separate experiments.
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The effect of substrate concentration on A6-desaturase activity, analysed over a
40-200 nmol range, demonstrated an S-shaped relationship (Fig. 3.3). Maximal A6-
desaturase activity with 0.5 mg microsomal protein was obtained between 150 and 200
nmol 18:2 n-6. Activities for A6-desaturase assessed using 2 mg microsomal protein




Figure 3.3 Effect of substrate concentration on A6-desaturase activity. The
conversion of [1-14C]18:2 n-6 by liver microsomes (0.5 and 2.0 mg protein) was
examined in relation to the amount of substrate added (40-200 nmol per test). No
attempt was made to control the substrate to protein ratio in this experiment. Each
point represents the mean of triplicate analyses. Results expressed as Mean±SD.
Pattern is typical of two separate experiments for the analysis with 0.5 mg
microsomalprotein.
61
Albumin addition (0.5 mg) caused a significant (17 %) decrease in A6-desaturase
activity (p<0.02). Furthermore, 1.5 mg albumin reduced the activity by 60 %
(p<0.002, Table 3.2). When 0.5 mg albumin was added simultaneously with 200 nmol
extra 18:2 n-6 (final 400 nmol, to maintain a similar substrate-albumin ratio) no change
in A6-desaturase activity was observed. However, 1.5 mg albumin addition showed a
20 % decrease in A6-desaturase activity despite additional 600 nmol 18:2 n-6 (final
800 nmol).
Table 3.2 Effect of the addition of bovine
desaturase activity
serum albumin on liver microsomal A6-
Incubation conditions n Activity p value
Control 100 %
+ Albumin (0.5 mg) 3 83±3 % 0.015
+ Albumin (1.5 mg) 3 40±2 % 0.002
+ Albumin (0.5 mg) plus 18:2 n-6 § 2 103 % -
+ Albumin (1.5 mg) plus 18:2 n-6 { 2 80% -
Results expressed as percentage of control (Mean±SD). § Control incubation with additional albumin
(0.5 mg) and extra 18:2 n-6 (+ 200 nmol. thus final 400 nmol) to provide approximate fatty
acid/albumin molar ratio of 23:1. { Control incubation with additional albumin (1.5 mg) and extra
18:2 n-6 (+ 600 nmol. thus final 800 nmol) to provide approximate fatty acid/albumin ratio of 24:1. -
Not statistically feasible.
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When the ratio of [1-14C] 18:2 n-6 to microsomal protein concentration was kept













Figure 3.4 Conversion of [1-I4C]18:2 n-6 by A6-desatnrase in liver microsomes in
relation to the amount of microsomal protein and substrate. Note linear conversion
with the fixed substrate-protein ratio, but not when the substrate was maintained at
200 nmol with increasing microsomal protein. Results expressed as nmol converted
per 20 min incubation (Mean±SD). Pattern is typical of two separate experiments.
In contrast, when the substrate concentration was kept constant the expected
decline in A6-desaturase activity was evident at the higher microsomal protein
concentrations.
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Neither anaesthesia nor storage affected liver microsomal A6-desaturase activity
using the standard assay conditions (Table 3.3).
Table 3.3 The effect of anaesthesia and storage on microsomal A6-desaturase
activity
Preparation/incubation Activity p value
Control microsomes (stunned rats, n=3) 100 %
Microsomes from anaesthetised rats (n=3 rats) § 99.6±16.4 % n.s.
Control microsomes (fresh, n=4 livers) 100 %
Frozen one hour (n=4 livers) f 103.7±13.5 % n.s.
Frozen one week 103.2±17.6 % n.s.
Frozen two weeks 113.5±11.2 % n.s.
Frozen four weeks 105.6±15.6 % n.s.
§ Rats were anaesthetised with Sagatal® (60 mg/kg body weight, intraperitoneally); f All frozen
microsomal preparations were stored at -20°C and thawed on ice. All results are expressed as
percentage of control. Standard A6-desaturase incubation conditions were used. n.s. Nou significant.
3.4 Discussion
Although the activity of A6-desaturase is highest in mammalian liver compared to
other organs, the actual rate of conversion for 18:2 n-6 is low. Thus, large amounts of
microsomes (up to 5 mg protein) are normally used to maximise substrate conversion.
This study shows that using high microsomal protein concentrations to measure A6-
desaturase in vitro leads to a serious underestimation of its activity. This effect can be
attributed to the non-specific binding of [1-14C]18:2 n-6 to microsomal protein since
bovine serum albumin, which effectively binds non-esterified fatty acids (Spector et al.,
1969), also resulted in reduced A6-desaturase activity. This effect, however, does not
manifest itself if the 18:2 n-6 to protein ratio is kept constant. On the other hand, A6-
desaturase activity was not influenced by the presence of endogenous ATPases,
competing for ATP and thereby preventing the activation of the non-esterified acid by
microsomal acyl-CoA synthetase. Thus, addition ofNaF which inhibits ATPase did not
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result in a significant increase in A6-desaturase activity. The observed reduction in A6-
desaturase activity is perhaps due to the formation of insoluble MgF2 and hence a
reduction in free Mg2+ concentration.
The results therefore demonstrate that fatty acid-protein interactions in this system
create a prominent and important effect. Interestingly, Bar-Tana et al. (1971) have
shown a 70 % inhibition of palmitoyl-CoA synthetase by albumin addition.
Inconsistent with this, are the findings of Cook (1978) who demonstrated that albumin
additions had no effect in a brain microsomal A6-desaturase system. A closer
examination of both systems reveals the inhibitory effect of albumin on palmitoyl-CoA
synthetase could be abolished by the addition of the surface active compound Triton
X-100, while the brain microsomal A6-desaturase assay used 25 pM Triton WR 1332.
As the future work was to include an assessment of A6-desaturase in dietary
cholesterol enriched microsomal membranes we did not wish to include a detergent.
Alternatively, lipid-protein interactions may be overcome by controlling the
substrate-protein ratio as performed in this study. It is possible that some of the fatty
acids occupy non-specific binding sites on the microsomal protein. However, an
assessment of fatty acid binding properties of microsomal protein was not carried out
in a formal manner. But the conclusion seems justified in view of similar results with
additional albumin.
The method described here uses argentation-TLC combined with scintillation
counting to achieve the best sensitivity. The use of gas chromatography with
radiochemical detection is frequently used for A6-desaturase evaluation owing to the
greater specificity. Nevertheless, the present results pertain to incubation conditions
and therefore are still appropriate for A6-desaturase methods using gas-liquid
chromatography.
Sodium pentobarbital anaesthesia had no significant effect on the activity of A6-
desaturase compared with the quicker form of killing (stunning with cervical
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dislocation). Therefore, results from studies using either means of sacrifice are
comparable.
Several authors have determined liver microsomal A6-desaturase activity after
freezing (Eck et al., 1979; Faas and Carter, 1980; Shimp et al., 1982; De Shrijver and
Privett, 1983; Biagi et al., 1991; Ruiz-Gutierrez and Muriana, 1992). Yet, there is
little information on the effect of prolonged freezing. Faas and Carter (1980) have
documented that A6-desaturase activity is stable for up to two weeks when frozen in a
concentrated form (15 mg microsomal protein/ml buffer). This study showed no
significant storage effects on A6-desaturase activity for up to four weeks at -20°C
(microsomal protein concentration ~40 mg/ml). This information is useful since it
means that the sacrifice, liver microsome preparation and A6-desaturase activity
analysis do not have to be performed within the same day.
In conclusion, A6-desaturase activity in rat liver microsomes can be measured
without the addition of NaF or an ATP re-generating system. The effects of substrate
interaction with protein can be marked at high microsomal protein levels and must be
realised. Under the conditions described protein binding to the fatty acid substrate is
not a serious problem. The revised method using 0.5 mg microsomal protein, 200 nmol




Linoleic acid metabolism in the rat
The role ofdietary cholesterol
4.1 Introduction
Epidemiological studies, examining risk markers involved in the pathogenesis of
CHD in man, have frequently implicated serum cholesterol as having an important and
strong association (Keys et at., 1981; Kannel and Gordon, 1982; Martin et at., 1986;
Law and Wald, 1994). Yet, such studies are constrained by the small number of tissues
available for in-depth study and so limited information exists on tissues that perform
large scale EFA metabolism (e.g. liver). Plasma and adipose tissue analysis have
offered some information in human studies (Wood et al., 1984; Riemersma et al.,
1986) but do not answer more fundamental questions on the interaction between
dietary constituents and lipid metabolism.
Although cholesterol in many situations has been regarded as an enfant terrible by
the nutritional media, it is an essential molecule performing a wide range of key
biological functions that include its constituent role as a membrane fluidity regulator.
The structure of cholesterol is amphipathic in nature and it is well suited to mesh
within lipid bilayers (Yeagle, 1985; Brenner, 1990). Increased cholesterol
concentrations in cell membranes, by way of interacting with phospholipid esterified
fatty acids, will decrease membrane 'fluidity' (Yeagle, 1985; Brenner, 1990) and alter
enzyme activities (Garda and Brenner, 1985; Castuma and Brenner, 1986). Membrane
bound enzymes, such as glucose-6-phosphatase, are inhibited in cholesterol enriched
intact microsomes but not after microsomal disruption using detergents (Garda and
Brenner, 1985). Yet, NADH-ferricyanide reductase activity, a measure of NADH-
cytochrome b5 reductase, is unaffected by membrane cholesterol enrichment (Garda
and Brenner, 1985). The multi-component enzyme adenylate cyclase, which relies
upon 'collision coupling' between its subunits, is activated by reducing membrane
cholesterol levels (Salesse et al., 1982; Needham et al., 1985). Multi-component
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microsomal enzyme systems such as the desaturases are believed to be regulated by the
fluidity of their surrounding membrane (Brenner, 1990). These enzymes themselves
also influence membrane fatty acid composition.
The aim of this investigation is to assess A6-desaturase activity in liver
microsomes, using our newly optimised method that does not use detergents, from
cholesterol supplemented rats and to compare this with changes in the index for A6-
desaturase as derived from fatty acid composition of microsomal phospholipids and
adipose tissue triacylglycerols.
4.2 Methods
Male Sprague Dawley rats (n=16, -100 g) were randomised into two groups and
fed either the basal semi-synthetic diet (Section 2.2) or the same diet enriched with
2 % (w/w) cholesterol. Control and experimental diets were provided ad libitum for 27
days. Animals were housed as described (Section 2.1), examined regularly and
weighed weekly to ensure they were in good health for the duration of the experiment.
Rats of both groups were sacrificed under standardised conditions (Section 2.3 .1) and
in the fed state to control for diurnal variations and to maximise A6-desaturase activity.
Tissues were collected over two separate days to facilitate rapid sample processing
(four control and four experimental rats per day). Microsomes were prepared (Section
2.3.1) and assessed for protein content and mitochondrial contamination (Sections
2.4.5 and 2.4.6, respectively). A6-desaturase activity was measured under conditions
described in Section 2.4.8. Microsomal phospholipid fatty acid composition and
microsomal cholesterol content were analysed as in Sections 2.5.2 and 2.5.7,




4.3.1 General animal characteristics
The animals remained healthy throughout the duration of the study. Growth rates
of the two groups of rats were in close agreement (Fig. 4.1).
0 10 20 30
Diet duration (d)
Figure 4.1 Total body weights during the experiment of rats fed a control or
cholesterol enriched diet. Values expressed as Mean-SD.
No significant effect of cholesterol supplementation on body weight, liver weight
and heart weight was evident at the end of the study (all p>0.05, Table 4.1). Of
interest, however, was a significantly elevated liver weight to body weight ratio in the
cholesterol supplemented group (p=0.0015, Table 4.1). A similar relationship was not
apparent for heart weight.
Data for the remainder of the study consists of seven animals in the control group
and eight animals in the cholesterol supplemented group as one liver homogenate was
lost through a broken tissue grinder.
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Values expressed as Mean±SD. ** p<0.01 vs. control.
4.3.2 Microsomal phospholipid and cholesterol content
As expected cholesterol feeding increased the total cholesterol content of liver
microsomes by 56 % (p=0.0005, Table 4.2). Cholesterol supplementation had no
effect on the phospholipid content of liver microsomes expressed per mg protein.
Nevertheless the resultant effect was to increase the cholesterol to phospholipid ratio
by 58 % in the cholesterol fed animals (p=0.0003).
Table 4.2 Microsomal cholesterol andphospholipid contents and A6-desaturase and
succinate dehydrogenase activities of ratsfed a control or cholesterol enriched diet
Measurement Control Choi.
n=7 n=8
Cholesterol % 49±7 77±15***
Phospholipid c, 425±42 405±30
Cholesterol/phospholipid ratio 0.12±0.01 0.19±0.04***
A6-desaturase activity C 409±91 517±73*
Succinate dehydrogenase activity ¥ 1.7±0.9 I.7±0.4
Values expressed as Mean±SD. * p<0.05, *** p<0.001 vs. control, e nmol/mg protein, v|/ mol/mol, C
pmol/min/mg, ¥ nmol/min/mg protein.
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4.3.3 Microsomal A6-desaturase activity
The 27 day cholesterol supplementation regimen elevated liver microsomal A6-
desaturase activity by 26 % compared with control fed animals (p=0.025, Table 4.2).
No significant correlation existed between A6-desaturase activity and cholesterol/
phospholipid ratio or microsomal total cholesterol content. Microsomal succinate
dehydrogenase activity was similar between the two groups when expressed per mg
microsomal protein. Represented as a percentage of total homogenate activity, the
mitochondrial contamination was 0.05±0.02 % for the control microsomes compared
with 0.17±0.09 % for microsomes from cholesterol fed rats (p<0.05).
4.3.4 Microsomal phospholipid fatty acid composition
Cholesterol feeding induced widespread significant modifications to microsomal
fatty acid composition (Table 4.3). Overall, the cholesterol supplement increased the
percentage of MUFA by 50 % (mainly 18:1, but also small significant increases
occurred for 16:1 and 20:1) with a concomitant decline in SFA.
No change in the total percentage of n-6 fatty acids was detected but a distinct
shift in the distribution therein was apparent. Microsomal phospholipids from rats fed
cholesterol were enriched with 18:2, 18:3 (0.14±0.04 vs. 0.08±0.02 %) and 20:3
compared with control. These increases were accompanied by significantly decreased
amounts ofboth 20:4 and 22:4, though 22:5 was not different.
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Table 4.3 Liver microsomal total phospholipidfatty acid composition of rats fed a
control or cholesterol enriched diet
























Z SFA 46.3±0.4 42. l±0.9***
I MUFA 9.9±0.4 15.0±1.0***
E n-6 38.4±0.2 38.1±0.6
2 n-3 5.0±0.1 4.1±0.2***
DBI 171±2 166±5*
Values expressed as % (w/w) of total fatty acids (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 vs.
control. Isomeric forms of 18:1 not elucidated. # Unresolved peak contained unspecified amounts of
20:0. DBI double bond index.
The alterations in n-6 fatty acid composition were accompanied by reductions in
the relative amounts of both 22:5 n-3 and 22:6 n-3 culminating in a significantly
reduced double bond index (DBI). The lower DBI was associated with a 75 %
increase in 20:3 n-9 in cholesterol fed rats.
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4.3.5 Adipose tissue triacylglycerol fatty acid composition
The dietary cholesterol induced modifications to adipose tissue triacylglycerol fatty
acid composition were considerably more limited when compared to those found in
microsomal membrane phospholipids (Table 4.4).
Table 4.4 Adipose tissue triacylglycerol fatty acid composition of rats fed a control
or cholesterol enriched diet


















E SFA 34.3±1.5 34.4±0.8
Z MUFA 52.1±0.8 52.8±1.2
E n-6 12.2±1.0 11.4±0.4
E n-3 0.4±0.1 0.4±0.1
Unknown 1.0±0.2 1.0±0.1
DBI 78±2 77±2
Values expressed as % (w/w) of total fatty acids (Mean±SD). * p<0.05 vs. control. # Unresolved peak
contained unspecified amounts of 18:3 n-6. n.d. Not detectable.
The only fatty acid to alter, as a result of the cholesterol feeding, was 18:1 (mainly
18:1 n-9) which was significantly increased (p=0.023). This modification was in the
same direction as that detected for 18:1 in the microsomal phospholipid fraction.
Conversely, the relative amount of adipose tissue 18:2 n-6 showed an opposite trend
(p=0.08); increased in microsomal phospholipids but reduced in adipose tissue. These
modest changes in adipose tissue fatty acid composition led to a significant elevation in
the 18:1/18:2 n-6 ratio from 3.8±0.4 to 4.1±0.2 (p=0.04).
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As only modest changes to adipose tissue fatty acid composition were observed,
ratios pertinent to the metabolism of 18:2 n-6 were not modified by cholesterol
supplementation.
The relative amount of 18:2 n-6 in adipose tissue has been regarded as a valid,
long term indicator of dietary intake in men (Dayton et al., 1966; Wood et al., 1984).
Since diet is considerably more controlled in animal studies, it is of interest to compare
diet and tissue fatty acid compositions. A comparison between dietary fatty acids and
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Figure 4.2 Comparison between fatty acid composition of the diet and adipose tissue
of rats fed a control or cholesterol enriched diet. Results expressed as % (w/w) of
totalfatty acids.
Generally, the relative amounts of fatty acids in both adipose tissue and diet were
similar with 18:1 and 16:0 forming the bulk content. An exception to this was 18:0
which was 50 % greater in the dietary fat compared to adipose tissue. Conversely,
there was a 25 % increase in adipose tissue 18:1 compared to diet. Both EFA (18:2
n-6 and 18:3 n-3) in the diet reflected in their relative amounts in adipose tissue.
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4.3.6 Microsomal phospholipid fatty acid ratios
It is a common approach to use a product-precursor ratio of fatty acids from a
particular lipid pool as an indicator of n-6 fatty acid metabolism by the various
desaturases. These indices are demonstrated for the phospholipid esterified fatty acids
in Table 4.5.
Table 4.5 Indices ofdesaturase activities derived from microsomalphospholipid fatty
acid composition, and triene/tetraene ratios of rats fed a control or cholesterol
enriched diet
Fatty acid ratio Control Choi.
n=7 n=8
n-6
18:3/18:2 (A6) 0.007±0.002 0.011±0.004*
20:4/20:3 (A5) 13.65±1.46 9.13±1.48***
22:5/22:4 (A6) 3.4±0.6 3.3±1.4
18:2 D&E 2.52±0.21 1.97±0.38**
n-9
18:1/18:0 (A9) 0.294±0.015 0.491±0.051***
20:3 n-9/20:4 n-6 0.017±0.002 0.031±0.007***
Values expressed as Mean±SD. * p<0.05, ** p<0.01, *** p<0.001 vs. control. 18:2 D (Desaturation)
& E (Elongation) refers to (18:3 n-6 + 20:2 n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6)/18:2
n-6.
The 18:3 n-6/18:2 n-6 A6-desaturase ratio was increased in the cholesterol fed
group by 56 %. Using a combination of all desaturation and elongation products
derived from 18:2 n-6, the apparent throughput from 18:2 n-6 was depressed by 22 %
mainly due to decreased formation of fatty acids originating from 20:3 n-6. Indeed, the
20:4 n-6/20:3 n-6 ratio for A5-desaturase was also lowered by 33 % but the 22:5
n-6/22:4 n-6 A6-desaturase ratio was not different. The ratio derived for A9-
desaturase (18:1/18:0) was augmented by cholesterol feeding. This was accompanied
by an increased triene/tetraene ratio (20:3 n-9/20:4 n-6) that was almost doubled by
the cholesterol supplement. Nevertheless, signs of an EFA deficiency were not
observed in the living animal (i.e. no scaly skin or hair loss were visible throughout the
experiment).
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The n-3 fatty acid composition of microsomal phospholipids differed markedly
compared to the n-6 series. a-Linolenic acid was not detectable and its A6-
desaturation product, 18:4 n-3, was similarly absent. Indeed, the only n-3 fatty acids
observed in the phospholipid fraction were those derived after A5-desaturation. This
made it impossible to use a product-precursor ratio as an indicator for either A6-
desaturase (18:4 n-3/18:3 n-3) or A5-desaturase (20:5 n-3/20:4 n-3) and highlights the
differential metabolism undergone by these two distinct series of EFA. The A6-
desaturase index estimated from 22:5 n-3 and 22:6 n-3 is possible though and the
derived figures were 8.4±1.3 and 8.6±1.9 for control and cholesterol fed rats,
respectively. This result did not achieve statistical significance which is in close
agreement with that found using the respective n-6 fatty acids for the same index.
4.4 Discussion
Many studies have found that rat liver microsomal A6-desaturase activity is
reduced as a result of cholesterol feeding (Leikin and Brenner, 1987; Garg et al.,
1988a; Muriana et al., 1992). The results of A6-desaturase measurements
demonstrated here contrast with this literature. However, the overall metabolism of
18:2 n-6 to 20:4 n-6 depends on the activity of both A6- and A5-desaturases as well as
the relevant elongases. It is suggested from the lower fatty acid desaturation and
elongation index that cholesterol feeding may have reduced the overall activity of this
pathway.
The disparity between our results and those published may be due to a variety of
reasons. Firstly, the method described in Chapter 3 was developed so that the
maximum activity of A6-desaturase could be measured without the use of detergents,
as cholesterol enrichment alters membrane fluidity (Yeagle, 1985; Brenner, 1990). The
approach commonly used for A6-desaturase measurement uses very large amounts of
microsomal protein with relatively small amounts of substrate (Garg et al., 1988a;
Chanussot et al., 1989) that could be seen as sub-optimal. Notable are the results of
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Leikin and Brenner (1987) who demonstrated that A6-desaturase activity measured
with 60 p.M [1-14C]18:2 n-6 was slightly but non-significantly increased in cholesterol
fed rats. The measurement with 15 p.M [ 1 -14C] 18:2 n-6, however, showed a
significantly decreased activity in cholesterol supplemented rats. Thus indicating that
substrate concentration is an important determinant of the result obtained.
Unfortunately, these workers did not examine substrate concentrations greater than
60 \xM.
The role of cholesterol in an in vitro system (using microsomes enriched in vitro
with cholesterol rich liposomes) has also been shown to increase A6-desaturase by
Garda and Brenner (1985). This is opposite to the commonly accepted effect of
cholesterol on A6-desaturase activity but consistent with the data described in the
present study. The effect on A9-desaturase activity in the same study in vitro was
consistent with that shown for the A9-desaturase index in the present study using
dietary cholesterol. It has been argued that within the situation of cholesterol
membrane enrichment in vivo, other modifications take place such as those associated
with phospholipid head group composition (Brenner, 1990). No significant changes
were observed for the total amount of phospholipid present in microsomal membranes.
The effect of dietary cholesterol on phospholipid sub-classes was not examined within
the context of this study and requires further elucidation.
Isolation stress could have affected the results of Garg et al. (1988a). This group
used essentially a similar feeding protocol to that described here, except the animals
were isolated for the assessment of dietary intakes. Raised catecholamines, Cortisol
and blood pressure are all attributes of the socially deprived, stressed animal
(Crawford and Law, 1958; Sanford et al., 1986; Huang et al., 1990). The mechanism
whereby these hormones might affect A6-desaturase is not fully understood. However,
an infusion of a very large dose of the stress hormone adrenaline (1 mg/kg body
weight) has been shown to decrease A6-desaturase activity within two hours (De
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Gomez Dumm et al., 1976). Nevertheless, neither Garg et al. (1988a) nor this study
examined stress levels in these animals.
The semi-synthetic diets given to these animals in the present study were
completely devoid of fatty acids of the n-6 series other than 18:2 n-6. Thus, changes in
desaturation and elongation products of 18:2 n-6 present in a particular lipid pool
could relate to metabolic alterations in vivo. Large changes in the SFA and MUFA
composition of microsomal phospholipids could have altered the n-6 and n-3 series
purely because they are mathematically related when expressed as percentages.
However, the SFA and MUFA components can be calculated out so that their effects
are removed (Table 4.6). The cholesterol effect upon individual n-6 and n-3 fatty acids
remains the same when this calculation is done. In addition, the fact that some of the
n-6 fatty acids increase their percentage contribution while others decrease, indicates
that changes in SFA and MUFA do not affect n-6 and n-3 fatty acids in a mathematical
way. This suggests that the effect is of genuine metabolic origin.
Table 4.6 Comparison of p values obtained from the statistical analyses of
microsomal phospholipid n-6 and n-3 fatty acid contents allowing for SFA and
MUFA contributions
Fatty acid species P value from normal
calculation














On this basis one would conclude that cholesterol feeding causes large differences
to occur in 18:2 n-6 metabolism. Most affected of the n-6 series was 20:3 n-6 which
was increased by 33 % as a result of the cholesterol feeding. This, in combination with
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elevated 18:3 n-6 could be indicative of increased A6-desaturase activity that is
highlighted by the increased A6-desaturase (18:3 n-6/18:2 n-6) ratio. A packed column
GLC was used to determine the fatty acid compositions and unfortunately 18:3 n-6
coincides with the fatty acid 20:0. The precise contribution of this saturated acid to the
n-6 metabolite was later quantified by capilliary GLC to be 23.2±8.9 % (n=7). This
facility was not available for all samples but on the small number that were analysed
there was no systematic effect of cholesterol on the percent contribution of 20:0. This
is note worthy as the overall trend is for the dietary cholesterol to lower the long chain
SFA (16:0 and 18:0) in phospholipids. However, the factors that control phospholipid
and fatty acid composition are far from being understood. It is therefore unwise to
interpret indices of desaturation without actual measurements of the metabolic activity
of a pathway. However, our results suggest that the index may adequately depict
changes in 18:2 n-6 metabolism induced by large amounts of dietary cholesterol under
highly controlled dietary conditions in the rat. Whether similar effects could have been
observed with smaller amounts of cholesterol remains to be seen. It is also not clear
whether these results can be extrapolated to man. Angelico et al. (1983) demonstrated
that dietary intervention in hyper-cholesterolaemic patients increased the plasma 18:2
n-6/18:l n-9 ratio and was associated with a 10 % decrease in plasma cholesterol.
Unfortunately information on other n-6 fatty acids was not reported.
Fatty acids derived from 18:0 provide useful additional information. Decreased
amounts of 18:0 and elevated amounts of 18:1 n-9 in microsomal phospholipids may
indicate an elevated A9-desaturase activity. Further desaturation and elongation of
18:1 n-9 yields 20:3 n-9 (Mead acid) which is used as an indicator of EFA deficiency
(Fulco and Mead, 1959). Mead acid, absent from the diet, is elevated in the cholesterol
fed rats and may relate to increased 18:0 metabolism at the level of A9-, A6- and A5-
desaturases. This may therefore support the finding of increased A6-desaturase
activity. However, the metabolism of 18:1 n-9 by A6-desaturase was not examined
formally.
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Activity of A6-desaturase depends both on the amount of desaturase protein within
the membrane as well as its surrounding membrane fluidity. The protocol used in this
study was aimed at measuring maximal activity and thus the total amount of active
desaturase protein. Garda and Brenner (1985) have shown dramatic changes in A6-
desaturase activity as a result of enrichment of cholesterol into microsomal membranes
in vitro. Thus demonstrating that activity of a distinct amount of desaturase protein
can be altered by direct changes in membrane fluidity. However, changes at the level
of transcription and translation of the desaturase protein could also occur under the
influence of changes in insulin and related hormones.
A metabolic response to the cholesterol feeding may be to increase the actual
amount of A6-desaturase protein in order to prevent the potential lack of throughput
of 18:2 n-6. The level of A5-desaturase, however, does not seem to respond in a
similar way by reference to the fatty acid ratios and may therefore be a time related
event (i.e. the transcription and translation of this desaturase may not be triggered until
a certain level of the precursor, 20:3 n-6, has accumulated). Nevertheless, actual
measurements of A5-desaturase were not carried out.
It is important to remember that this study only investigated two tissues. As the
liver is the major metabolic site for the formation and distribution of EFA desaturation
and elongation products it is usually studied at the expense of other tissues. The
scenario of depressed levels of long chain n-6 fatty acids may have occurred through
depletion by excess output to extra-hepatic tissues via the plasma compartment. This
may be the result of excessive influx into the liver of cholesterol that needs to be
esterified. This area was not within the remit of the present investigation but it is
apparent that it requires investigation.
Elevated liver to body weight ratio was one of the preliminary findings of this
study. This has been shown by some but not all workers using similar cholesterol
feeding protocols. Differences may depend upon the amount of cholesterol given as
well as the amount and composition of the fat supplied. A dose response effect of
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supplemental cholesterol has been documented (Tsai et al., 1975), though some
dietary experiments feeding a highly polyunsaturated fat along with 1 % cholesterol
have found no such increase in liver weight (Muriana et al., 1992). Garg et al. (1988a)
fed diets of similar cholesterol and fatty acid composition to those described here for a
duration of 28 days to male Sprague Dawley rats but contrary to the present findings
no such effect on liver to body weight ratio was manifest. The control diet in the
present study contained 0.02 % w/w cholesterol compared to the one of Garg et al.
(1988a) that contained 0.12 %. It is feasible that the larger difference between control
and cholesterol enriched diets in this study, increased the effectiveness of cholesterol at
elevating the liver weight ratio. Indeed, studies with only low amounts of cholesterol
(0.25 % w/w, Tsai et al., 1975) have found increases in liver weight.
Thus in summary, dietary cholesterol in large amounts increased the maximum
activity of A6-desaturase in vitro, but tissue fatty acid compositions suggest that the
major effect was a reduction in the overall metabolism of 18:2 n-6 to 20:4 n-6 at the
level of the A5-desaturase. If these results could be confirmed by direct measurements,
then A6-desaturase activity should no longer be considered to be the major rate
limiting step of 18:2 n-6 metabolism.
The effect of isolation stress, which may have additional modulatory effects within
this model needs further examination. Measurement of phospholipid composition and
of A6-desaturase activity at sub-optimal conditions may also shed more light on the




Linoleic acid metabolism in the rat
Effect ofdietary cholesterol and isolation stress
5.1 Introduction
Dietary supplementation with cholesterol induced an increase not a decrease in
liver microsomal A6-desaturase activity (Chapter 4). This observation was contrary to
the results of other cholesterol feeding studies in the literature (Leikin and Brenner,
1987; Garg et al., 1988a; Muriana et at, 1992) but was in agreement with an index of
A6-desaturase activity (i.e. 18:3 n-6/18:2 n-6 ratio in microsomal phospholipids) in
these animals (Chapter 4).
A number of reasons might explain this contradictory finding. In some cholesterol
supplementation studies, A6-desaturase activity is estimated using a large amount of
microsomal protein with a small amount of substrate (Garg et at., 1988a), a situation
that could be sub-optimal. Furthermore, it is possible that non-esterified 18:2 n-6 in
microsomal preparations may have diluted the specific activity of [1-14C]18:2 n-6 in
the assay in vitro. Levels of non-esterified fatty acids are rarely reported but large
amounts could conceivably affect the A6-desaturase estimation leading to an erroneous
result. Finally, animal housing conditions were regarded as an important factor in
determining the activity of A6-desaturase in rat liver microsomes.
Therefore, some of the potential causes for the apparent controversy regarding the
effect of dietary cholesterol supplementation are examined in this chapter. Microsomal
phospholipid composition is also investigated to give more information on the changes
that occur in the microsomal membrane as a result of cholesterol supplementation.
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5.2 Methods
Male Sprague Dawley rats (n=24, -115 g) were randomised into four groups. Half
were fed the semi-synthetic diet (Section 2.2) while the other half were fed the same
diet enriched with 2 % (w/w) cholesterol. These groups were sub-divided into two
further groups of animals that were either group-housed (n=3 per cage) or housed
individually (with no visual or social contact). Control and experimental diets were
provided ad libitum for 27 days. Animals were examined regularly and weighed daily
to ensure they were in good health for the duration of the experiment.
Rats were sacrificed under standard conditions (Section 2.3.1) and in the fed state
to control for diurnal variations and to maximise A6-desaturase activity. Tissues were
collected over two separate days to facilitate rapid sample processing. Microsomes
were prepared as described in Section 2.3.1 and A6-desaturase activity was measured
under the optimal conditions described in Section 2.4.8. In addition, A6-desaturase
activity was measured under sub-optimal conditions with 5.0 mg microsomal protein
and 200 nmol 18:2 n-6 (essentially as described by Garg et al., 1988a).
Microsomal total and fractionated phospholipids were analysed as described in
Sections 2.5.2 and 2.5.3, respectively. Microsomal total cholesterol, plasma lipids and
plasma lipid fatty acid composition were determined as documented in Sections 2.5.7,
2.4.1 and 2.5.4 respectively. Adipose tissue triacylglycerol fatty acid composition was
analysed as described in Section 2.5.6.
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5.3 Results
5.3.1 General animal characteristics
Most of the animals remained healthy. The effect of isolation was evident as two
animals (one from each of the two isolation groups) developed alopecia with some
weight loss. The animal in the cholesterol fed group recovered quickly (after brief skin
treatment with Dermisol cream, Smith Kline Beecham, Tadworth, Surrey, U.K.) but
unfortunately the animal in the control (isolation) group had to be humanely destroyed.
The results presented are therefore from a total of 23 rats. The growth rates of the
four groups were in close agreement (Fig. 5.1) with no statistically significant
differences manifest.
Diet duration (d)
Figure 5.1 Mean body weights during the experiment of rats fed a control or
cholesterol enriched diet, with or without social isolation (No significant differences
were observed)
None of the four regimens had a significant effect on body weight, heart weight or
heart to body weight ratio (Table 5.1). Yet, both liver weight and the ratio of liver to
body weight were significantly elevated by cholesterol supplementation. Social
84
isolation in combination with cholesterol supplementation caused a significant increase
in liver weight (p<0.05). Isolation itself had no significant effect on these variables.
Table 5.1 Body weights, liver weight and heart weight of rats fed a control or













Initial 114±6 116±7 117±3 117±4 n.s.
Final 290±15 296±27 278±10 303±17 n.s.
Difference 176±13 180±22 161±7 186±12 n.s.
Liver 12.0±0.8 14.4±2.0 11.7±0.7 15.6±1.2 C*** c/i*
Heart 1.08±0.10 1.11±0.12 1.07±0.07 1.11±0.06 n.s.
Relative weight (%)
Liver/body 4.1±0.2 4.8±0.3 4.2±0.2 5.2±0.3 c***
Heart/body 0.37±0.02 0.38±0.01 0.39±0.02 0.37±0.01 n.s.
Values expressed as Mean±SD. ANOVA two-way analysis of variance. C cholesterol effect, C/I
cholesterol and isolation interaction. * p<0.05, *** p<0.001.
5.3.2 Microsomal total phospholipid and cholesterol contents
Cholesterol feeding increased the total cholesterol content of liver microsomes in
the two cholesterol supplemented groups as predicted (Table 5.2). Neither cholesterol
feeding nor isolation had any effect on the total phospholipid content. The resultant
cholesterol to phospholipid molar ratio was significantly increased by cholesterol
supplementation. Isolation had no effect on these variables (Table 5.2).
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Table 5.2 Microsomal cholesterol, phospholipid and non-esterified fatty acid
contents and A6-desaturase activities of rats fed a control or cholesterol enriched
diet, with or without social isolation
Measurement Control Choi. Isol. Choi. & Isol. ANOVA
n=6 n=6 n=5 n=6 significance
Cholesterol % 61±8 83±9 59±14 83±8 (2***
Phospholipid £, 408±33 424±33 400±16 401±40 n.s.
Cholesterol/phospholipid 0.15±0.03 0.20±0.03 0.15±0.04 0.21±0.02 c**
A6-desaturase activity C 411±27 447±56 353±38 411±28 C**j**
A6-desaturase activity # 12±3 16±4 10±3 14±4
Non-esterified 18:2 n-6 c 2.8±0.4 2.6±0.2 2.8±0.5 2.9±0.4 n.s.
Non-esterified 20:4 n-6 \ 2.6±0.3 2.4±0.3 2.7±0.6 2.5±0.3 n.s.
Non-esterified 18:1 7.1±1.3 8.8±1.5 6.7±1.5 9.1±1.6 Q**
Values expressed as Mean±SD. ANOVA two-way analysis of variance. C cholesterol effect, I isolation
effect. ** p<0.01, *** p<0.001. c nmol/mg protein, \\i mol/mol, C A6-desaturase activity estimated
with 0.5 mg microsomal protein (activity expressed as pmol/min/mg). # A6-desaturase activity
estimated with 5.0 mg microsomal protein (activity expressed as pmol/min/mg).
5.3.3 Microsomal A6-desaturase activity
As expected, A6-desaturase activity assessed using our standard amount of 0.5 mg
microsomal protein was significantly elevated by cholesterol supplementation (Table
5.2). This effect was apparent both with and without isolation. Furthermore, the
cholesterol effect on A6-desaturase activity was still evident when assayed with 5.0 mg
microsomal protein even though the activities were approximately 30-fold less than
those exhibited with the optimised A6-desaturase assay system (Table 5.2). Isolation
was effective at decreasing A6-desaturase activity when assessed with 0.5 mg
microsomal protein either in the presence or absence of supplementary cholesterol.
This effect, however, did not reach statistical significance when A6-desaturase activity
was estimated with 5.0 mg microsomal protein, although a similar pattern was
manifest. No cholesterol-isolation interactive effect was apparent with either of the
two amounts ofmicrosomal protein assessed.
Combining all individual results, there was a significant correlation for A6-
desaturase activity estimated at the two concentrations of microsomal protein
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Figure 5.2 Comparison of A6-desatnrase activity estimated with 0.5 and 5.0 mg of
microsomalprotein of rats fed a control or cholesterol enriched diet, with or without
social isolation. # Measured with 0.5 mgprotein, * measured with 5.0 mg microsomal
protein.
Measurements of the non-esterified fatty acids, 18:2 n-6, 20:4 n-6 and 18:1 are
shown in Table 5.2. The mean amount of non-esterified 18:2 n-6 in the microsomal
fraction was approximately 3 nmol/mg microsomal protein and did not differ
significantly between the four study groups. A similar result was evident for levels of
non-esterified 20:4 n-6. In contrast, levels of non-esterified 18:1, a competitive
inhibitor of 18:2 n-6 A6-desaturation, were significantly increased in microsomes
obtained from the two cholesterol supplemented groups. Isolation had no effect on
non-esterified fatty acid concentrations.
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5.3.4 Microsomal total phospholipid fatty acid composition
As documented in the previous study (Chapter 4), widespread modifications to
total phospholipid fatty acid composition resulted from cholesterol supplementation
(Table 5.3). The results presented here are expressed as percentages to facilitate
comparison with the earlier results. Microsomal phospholipid pool sizes did not differ
in this study and so the use of percentages is valid.
Table 5.3 Liver microsomal total phospholipid fatty acid composition of rats fed a
control or cholesterol enriched diet, with or without social isolation
Fatty acid species Control Choi. Isol. Choi. & Isol. ANOVA
n=6 n=6 n=5 n=6 significance
SFA
14:0 0.1±0.0 0.1±0.0 O.liO.O O.liO.O c**
16:0 14.2±0.9 13.1±0.7 13.6±0.3 13.1±0.5 c*
18:0 30.0±1.0 28.4±0.9 30.8±0.5 27.4±1.1 C** C/I*
MUFA
16:1 0.5±0.1 0.8±0.1 0.5±0.1 1.0±0.2 C** C/I*
18:1 7.5±0.6 11.4±0.9 7.6±0.3 12.Oil.1 Q***
20:1 0.1±0.0 0.3±0.0 O.liO.O 0.3±0.1 £***
PUFA (n-6)
18:2 10.2±0.7 11.8±0.9 10.0±0.5 12.3±0.6 £***
20:2 0.1±0.0 0.2±0.0 O.liO.O 0.2±0.0
18:3 # 0.2±0.2 O.liO.O O.liO.O O.liO.O n.s.
20:3 1.7±0.1 2.3±0.1 1.6±0.2 2.5±0.2
20:4 26.6±0.8 24.1±1.1 26.7±0.6 23.6±1.1
22:4 0.4±0.1 0.3±0.0 0.4±0.0 0.3±0.0 £***
22:5 1.6±0.6 0.9±0.3 1.6±0.3 0.9±0.2
PUFA (n-3)
20:5 O.liO.O 0.2±0.0 O.liO.l 0.2±0.0 c***
22:5 0.6±0.1 0.5±0.1 0.5±0.1 0.5±0.0 n.s.
22:6 5.7±0.5 4.6±0.2 5.7±0.3 4.7±0.3
PUFA (n-9)
20:3 0.5±0.1 0.8±0.1 0.5±0.2 0.9±0.2 C***
£ SFA 44.3±0.5 41.6±0.9 44.4±0.3 40.7±0.9
EMUFA 8.2±0.6 12.5±1.0 8.3±0.4 13.3±1.3 £***
£ n-6 40.7±0.7 39.6±0.6 40.4±0.2 39.7±0.5 C**
£ n-3 6.4±0.4 5.3±0.1 6.3±0.2 5.3±0.2 C***
DBI 190±5 180±3 189±2 180±3 C***
Values expressed as % (w/w) of total fatty acids (Mean±SD). ANOVA two-way analysis of variance,
C cholesterol effect, C/I cholesterol and isolation interactive effect. * p<0.05, ** p<0.01, ***
p<0.001. # Unresolved peak contained unspecified amounts of 20:0.
There was a significant increase in the MUFA fraction at the expense of total levels
of SFA. Total amounts of n-6 and n-3 fatty acids were also significantly reduced by
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cholesterol supplementation. N-6 and n-3 fatty acid class compositional changes were
generally similar to those demonstrated in Chapter 4. An exception to this was 18:3
n-6 which was not altered. This was due to a high level of 18:3 n-6 in one of the
control samples analysed by packed column GLC. Subsequent analysis by capillary
column GLC confirmed that the peak was 94 % (w/w) 18:3 n-6. The result was
therefore included in the statistical analysis.
5.3.5 Microsomal phospholipid composition
Phosphatidylcholine (PC) constituted the principal microsomal phospholipid sub¬
class amounting to over 60 % of the total phospholipid present in each of the four
experimental groups (Table 5.4). Cholesterol supplementation but not isolation
increased the PC component when expressed in absolute amounts (nmol/mg
microsomal protein). When presented as a percentage of total phospholipids, however,
isolation caused a statistically significant reduction in the PC contribution.
Table 5.4 Proportions of PC, PE and PI in liver microsomal phospholipids of rats
fed a control or cholesterol enriched diet, with or without social isolation
Phospholipid type Control Choi. Isol. Choi. & Isol. ANOVA
n=6 n=6 n=5 n=6 significance
PC J; 266±25 305±30 255±15 274±30 C*
pcc 65.1±3.5 71.7±1.6 63.8±1.8 68.2±1.9 Q*** J*
PE | 68±17 63±8 60±11 54±8 n.s.
PEC 16.5±2.7 14.9±1.9 14.9±2.4 13.6±1.8 n.s.
PIC 18±3 17±3 17±2 18±2 n.s.
PIC 4.3±0.3 4.1±0.7 4.2±0.4 4.5±0.2 n.s.
PC/PE (mol/mol) 4.0±0.7 4.9±0.7 4.4±0.8 5.1±0.8 C*
Values expressed as Mean±SD. ANOVA two-way analysis of variance. C cholesterol effect, I isolation
effect, * p<0.05, *** p<0.001. C nmol/mg microsomal protein, l mol %.
No changes in either phosphatidyl ethanolamine (PE) or phosphatidyl inositol (PI)
were apparent when expressed as either absolute amounts or as percentages. The
PC/PE ratio, which is frequently used in cholesterol feeding studies as an indicator of
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phospholipid metabolism, was also significantly increased by cholesterol
supplementation while isolation had no effect on this parameter.
5.3.6 Microsomal phospholipid sub-class fatty acid composition
Analysis of n-6 fatty acid composition of three sub-classes of microsomal
phospholipids revealed, as predicted, that many of the alterations were again
cholesterol induced (Table 5.5).
Table 5.5 Liver microsomal phospholipid sub-class n-6 fatty acid composition from
ratsfed a control or cholesterol enriched diet, with or without social isolation
Phospholipid fraction Control Choi. Isol. Choi. & Isol. ANOVA
and fatty acid species n=6 n=6 n=5 n=6 significance
PC
18:2 12.6±1.4 14.6±1.2 12.7±0.7 15.2±1.0 C***
20:2 0.2±0.0 0.2±0.0 0.2±0.0 0.2±0.0 £*** J*
18:3 # O.liO.O 0.2±0.0 O.liO.O 0.2±0.0 £***
20:3 1.9±0.2 2.6±0.2 1.9±0.2 2.7±0.2 £***
20:4 22.9±1.9 21.2±1.5 22.5±0.8 19.4±1.4 £**
22:4 0.3±0.0 0.2±0.0 0.2±0.0 0.2±0.0 C** C/I*
22:5 1.4±0.5 0.8±0.3 1.4±0.3 0.8±0.2 £**
E n-6 39.4±1.1 39.7±0.7 39.0±0.2 38.8±0.6 I*
DBI 173±9 171±5 171±3 164±5 n.s.
PE
18:2 6.2±0.7 7.8±0.5 6.4±0.8 8.0±0.3 c***
20:2 0.0±0.0 O.liO.O O.OiO.O O.liO.O c***
18:3 # 0.2±0.1 0.2±0.1 0.2±0.1 0.2±0.1 n.s.
20:3 0.9±0.1 1.3±0.1 0.8±0.2 1.3±0.1 C***
20:4 28.4±0.7 28.6±0.6 28.1±0.9 27.2±0.5 j**
22:4 1.2±0.4 0.9±0.2 1.1±0.2 1.3±0.4 n.s.
22:5 2.6±1.0 1.6±0.5 2.6±0.6 1.5±0.3 C**
E n-6 39.5±0.5 40.5±0.8 39.2±0.4 39.6±0.6 C* I*
DBI 220±6 220±3 217±4 212±2 j**
PI
18:2 2.3±0.5 2.5±0.3 1.8±0.2 2.0±0.4 j**
18:3 # 0.2±0.2 0.1±0.1 0.2±0.1 0.1±0.1 n.s.
20:3 1.3±0.1 2.5±0.4 1.4±0.2 2.6±0.4 c***
20:4 38.9±2.0 36.2±0.6 39.6±0.9 36.0±1.6 C***
22:4 0.5±0.1 0.5±0.0 0.4±0.1 0.6±0.1 C**
22:5 0.4±0.1 0.6±0.2 0.4±0.1 0.6±0.2 £**
E n-6 43.6±1.6 42.5±0.7 43.7±0.6 41.8±1.1 £**
DBI 186±6 188±2 186±3 185±4 n.s.
Values expressed as % (w/w) of total fatty acids (Mean±SD). ANOVA two-way analysis of variance,
C cholesterol effect, I isolation effect, C/I cholesterol and isolation interactive effect. * p<0.05, **
p<0.01, *** p<0.001. PI fraction contained no detectable 20:2 n-6. # Unresolved peak contained
unspecified amounts of 20:0.
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For PC, the pattern of increased 18:2, 18:3 and 20:3 with decreased levels of 20:4,
22:4 and 22:5 was similar to that observed in total phospholipids. Cholesterol also
increased 20:2 in normally housed rats (0.15±0.03 and 0.19±0.03 for control and
cholesterol supplemented, respectively) and in isolated rats (0.16±0.02 and 0.24±0.03
control diet and cholesterol supplemented, respectively). Isolation by itself also
increased 20:2 (p=0.02). The total amount of n-6 fatty acids present was also
significantly lowered by isolation while cholesterol supplementation had no effect on
this measurement. Despite all these fatty acid alterations the DBI remained unchanged.
Microsomal PE n-6 fatty acid composition was significantly modified both by
cholesterol and isolation. Cholesterol increased levels of 18:2, 20:2 and 20:3 while
only 22:5 was lowered. A notable exception to these cholesterol-induced modifications
was 20:4 that remained unchanged by the cholesterol supplementation but was
significantly lowered by isolation. Of interest, 18:3 and 22:4 were not modified by
either cholesterol supplementation or isolation.
Microsomal PI n-6 fatty acid composition was similarly affected by the cholesterol
supplementation. Cholesterol-induced increases were discernible for 20:3, 22:4 and
22:5 while 18:3 remained unchanged. Cholesterol induced decreases occurred for both
20:4 and total n-6 fatty acid content. No cholesterol supplementation effect was
apparent on the small amount of 18:2 present but isolation had a marked and
significant lowering effect on this fatty acid. The DBI remained unchanged.
5.3.7 Plasma lipid fatty acid compositions
As the total amount of each plasma lipid fraction differed between the four groups,
presumably owing to different lipoprotein patterns, the results are expressed as total
nmol of n-6 fatty acids present in each of the three fractions (Table 5.6).
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Table 5.6 Plasma phospholipid, cholesterol ester and triacylglycerol n-6 fatty acid
composition of rats fed a control or cholesterol enriched diet, with or without social
isolation
Plasma lipid and Control Choi. Isol. Choi. & Isol. ANOVA
fatty acid species n=6 n=6 n=5 n=6 significance
Phospholipid J 1.35±0.29 1.62±0.29 1.38±0.14 1.84±0.30 c**
PUFA (n-6)
18:2 731±159 895±149 741±71 1026±178
20:3 48±12 69±12 46±8 89±13 C/I*
20:4 544±118 570±112 546±61 645±118 n.s.
22:4 9.5±2.3 6.1±3.2 7.7±0.9 7.7±0.9 n.s.
22:5 30±13 20±7 30±8 21±4 C*
S n-6 1362±276 1560±262 1371±135 1788±302 C*
Cholesterol ester { 1.68±0.30 2.19±0.83 1.80±0.23 2.72±0.40 c**
PUFA (n-6)
18:2 408±81 374±116 430±57 478±78 n.s.
18:3 7.4±1.5 9.8±4.0 8.8±1.7 9.0±2.0 n.s.
20:3 12±3 12±4 15±4 17±4 I*
20:4 853±170 568±231 906±112 701±186
22:4 2.3±2.0 2.8±1.9 2.4±1.6 3.5±1.8 n.s.
22:5 3.4±1.9 2.1±2.5 3.9±1.7 1.5±1.1 C*
Z n-6 1286±237 969±345 1366±163 1210±262 C*
Triacylglycerol J 0.96±0.48 2.04±1.48 1.34±0.57 1.76±0.79 n.s.
PUFA (n-6)
18:2 317±160 589±417 446±201 510±213 n.s.
20:3 2.4±1.4 9.6±8.9 3.2±2.1 6.2±2.1 C*
20:4 30±13 43±35 40±19 30±14 n.s.
22:4 6.8±2.7 12±10 7.8±3.2 8.8±3.0 n.s.
22:5 11±6 17±16 15±10 12±4 n.s.
Z n-6 367±177 670±486 513±232 567±233 n.s.
All fatty acids expressed as pmol/1 (Mean±SD). J Expressed as mmol/1. ANOVA two-way analysis of
variance, C cholesterol effect, I isolation effect, C/I cholesterol and isolation interactive effect. *
p<0.05, ** p<0.01.
There was a significant increase in plasma total phospholipid content in cholesterol
fed animals. Within this fraction, the amount of esterified 18:2 was elevated by
cholesterol supplementation but no significant effect was evident for either 20:4 or
22:4. Lower amounts of 22:5 were present in cholesterol supplemented rats despite a
cholesterol-induced increase in the total amount of n-6 fatty acids. Interestingly,
cholesterol in combination with isolation increased the level of 20:3 n-6 (Table 5.6).
Cholesterol supplementation had no effect on the total amount of 18:2, 18:3 and
22:4, however, both 20:4 and 22:5 were significantly decreased despite increased
cholesterol ester levels induced by cholesterol feeding. Isolation by itself increased
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levels of 20:3 n-6 in both socially deprived groups but the total amount n-6 fatty acids
present in the cholesterol esters was decreased significantly by the cholesterol
supplement.
Triacylglycerol fatty acid modifications were limited and large variances observed
for this data may have been responsible. However, omission of one sample with a
particularly high triacylglycerol content (>4 rnM) had no effect on the pattern of
significant results. Nevertheless, 20:3 n-6 was elevated by cholesterol supplementation
within this fraction.
5.3.8 Adipose tissue triacylglycerol fatty acid composition
Small changes occurred in the fatty acid composition of adipose tissue
triacylglycerols as a result of the cholesterol supplementation. No such modifications
occurred as a result of social isolation (Table 5.7).
Table 5.7 Adipose tissue triacylglycerol fatty acid composition of rats fed a control
or cholesterol enriched diet, with or without social isolation
Fatty acid species Control Choi. Isol. Choi. & Isol. ANOVA
n=6 n=6 n=5 n=6 significance
SFA
14:0 2.3±0.3 2.1±0.1 2.2±0.1 2.1±0.1 C*
16:0 22.9±0.7 21.3±0.7 23.3±1.2 21.6±0.5
18:0 8.9±1.1 8.8±0.9 8.3±1.6 8.4±0.7 n.s.
MUFA
16:1 6.0±1.0 5.6±0.5 6.5±1.4 5.8±0.3 n.s.
18:1 45.6±0.6 47.9±1.0 45.8±0.6 48.2±0.7 c***
20:1 1.2±0.0 1.3±0.1 1.2±0.1 1.3±0.1 c**
PUFA (n-6)
18:2 11.0±0.5 10.8±0.3 10.7±0.9 10.5±0.3 n.s.
20:3 O.liO.O O.OiO.O O.liO.O O.liO.O n.s.
20:4 O.liO.O O.liO.O 0.1±0.1 O.liO.O n.s.
PUFA (n-3)
18:3 0.3±0.0 0.3±0.0 0.3±0.1 0.3±0.1 n.s.
Z SFA 34.8±1.1 32.8±1.3 34.4±0.5 32.6±0.8 £***
Z MUFA 52.7±1.3 54.8±1.2 53.5±1.2 55.3±0.9
Z n-6 11.3±0.6 11.0±0.3 10.9±0.8 10.7±0.3 n.s.
Z n-3 0.4±0.1 0.3±0.0 0.3±0.1 0.4±0.1 n.s.
DBI 77±1 78±1 77±1 79±1 0**
Values expressed as % (w/w) of total fatty acids (Mean±SD). ANOVA two-way analysis of variance,
C cholesterol effect, * p<0.05, ** p<0.01, *** pO.OOl.
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Both 14:0 and 16:0 were significantly lowered by the cholesterol supplement while
both 18:1 and 20:1 were elevated culminating in distinct reductions and elevations in
the SFA and MUFA components, respectively. The level of 20:3 n-6 was decreased
slightly by the cholesterol regimen but this did not achieve statistical significance
(p=0.072).
5.3.9 Microsomal phospholipid fatty acid ratios
Indices for the desaturases are shown in Table 5.8. Contrary to the previous
cholesterol feeding experiment no significant effect of the feeding protocol was
demonstrated for the 18:3 n-6/18:2 n-6 A6-desaturase index. In addition, isolation had
no significant effect on this ratio.
Table 5.8 Indices of desatnrase activity derived from microsomal phospholipid fatty
acid composition and triene/tetraene ratios of rats fed a control or cholesterol
enriched diet, with or without social isolation











18:3/18:2 (A6) 0.021±0.018 0.010i0.002 0.009i0.000 0.009i0.001 n.s.
20:4/20:3 (A5) 16.0±1.6 10.5±1.0 16.7±2.2 9.5i0.9 C***
22:5/22:4 (A6) 4. lil.2 3.4±0.8 4.3±1.1 3.2±0.5 C*
18:2 D&E 3.01i0.32 2.37i0.28 3.05i0.19 2.25i0.19 c***
n-9
18:1/18:0 (A9) 0.258i0.025 0.402i0.045 0.248i0.014 0.438i0.058 c***
20:3 n-9/20:4 n-6 0.018i0.003 0.032i0.005 0.018i0.006 0.036i0.008
Values expressed as Mean±SD. * p<0.05, *** p<0.001 vs. control. Indices for A6- and A5-desaturases
were calculated using the n-6 fatty acid series. 18:2 D (Desaturation) & E (Elongation) refers to (18:3
n-6 + 20:2 n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6)/18:2 n-6.
The effect of cholesterol feeding on the total metabolites derived from the
desaturation and elongation of 18:2 n-6 was highly evident and related mainly to the
depressive effect of cholesterol on the 20:4 n-6/20:3 n-6 A5-desaturase index. A small
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but significantly decreased 22:5 n-6/22:4 n-6 A6-desaturase index was also evident.
Once again cholesterol feeding increased the triene/tetraene ratio, while isolation had
no effect on any of these variables.
5.4 Discussion
This study demonstrated once again that A6-desaturase activity was elevated by
dietary cholesterol supplementation. Furthermore, the effect of cholesterol enrichment
was still evident, though much less strongly, when A6-desaturase activity was assayed
in sub-optimal conditions with 5.0 mg microsomal protein and 200 nmol substrate.
These activities, however, were markedly lower (30-fold) and associated with a larger
group variance.
It had been speculated that the isolation protocol used by Garg et al. (1988a), to
assess individual dietary intakes, could have had an additional modulatory effect on the
activity of A6-desaturase. Indeed, it was clear that isolation reduced A6-desaturase
activity in rats fed either control or cholesterol supplemented diets when assayed under
optimal conditions. Yet, with 5.0 mg microsomal protein the effect of isolation was no
longer apparent and must relate to the larger error associated with this measurement. It
was evident, however, that there was no interaction between the effects of cholesterol
feeding and social isolation stress.
The depressive effect of stress hormones on rat liver microsomal A6-desaturase
activity has been documented in vivo with the administration of pharmacological doses
of adrenaline and hydrocortisone (De Gomez Dumm et al., 1976; De Gomez Dumm et
al., 1979). Isolation of rats increases urinary catecholamine excretion (Crawford and
Law, 1958), raises blood pressure (Huang et al., 1990; Jimenez and Fuentes, 1993)
and may elevate corticosterone levels (Apple et al., 1993). The latter hormone reduces
protein synthesis and may have affected the synthesis of A6-desaturase by this route
(Marra et al., 1986). Alternatively, raised circulating adrenaline levels may have
decreased the activity of the enzyme mediated through cAMP (De Gomez Dumm et
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al., 1976; Mills et al., 1994). Interestingly, a recent investigation, unpublished at the
time of our study, examining A6-desaturase activity in normotensive (Wistar Kyoto)
and spontaneously hypertensive rats supports our observations of a psychosocial^
induced decrease in the activity of A6-desaturase (Mills et al., 1994). The present
study, however, goes further and demonstrates that microsomal total phospholipid
fatty acid composition does not mirror the isolation induced reduction in A6-
desaturase activity. Nevertheless, the level of 18:2 n-6 in the microsomal PI fraction
and the amount of 20:4 n-6 in the PE fraction were reduced by isolation.
Within the assay system, dilution of the radioactive substrate by endogenous non-
esterified fatty acids could affect the apparent activity of A6-desaturase. The results
demonstrated that the level of non-esterified 18:2 n-6 was similar in all groups. Results
are normally corrected for this lowering of [ 1 -14C] 18:2 n-6 specific activity but there
was no systematic bias introduced as a result. Nevertheless, the true activity of A6-
desaturase may be some 1-2 % higher.
Microsomal non-esterified 18:1 levels were higher in cholesterol fed rats compared
with control. Large amounts of 18:1 n-9 can act competitively with 18:2 n-6 for A6-
desaturation. A 50 % reduction in A6-desaturase activity has been documented using a
2.5:1 molar ratio of 18:1 n-9 to 18:2 n-6 (Mahfouz et al., 1980). Lower reductions in
activity (~10 %) have been demonstrated with equimolar concentrations of inhibitor
and substrate (Brenner and Peluffo, 1966). The inhibitor-substrate ratio in this study
was approximately 1:20 and therefore the inhibitory effect would be negligible.
Interestingly, A6-desaturase activity in microsomes from cholesterol fed rats was
increased despite this 30 % elevation in non-esterified 18:1.
Similar problems associated with non-esterified fatty acids were also considered for
18:3 n-6 and 20:4 n-6. The end products of A6- and A5-desaturation play important
roles as a feed back inhibitors of desaturation (Leikin and Brenner, 1986; Leikin and
Brenner, 1989b). Levels of non-esterified 18:3 n-6 were below the level of detection
and amounts of 20:4 n-6 were not significantly different between all groups. Thus the
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effect of cholesterol supplementation on A6-desaturation cannot be necessarily
explained in this way.
This experiment demonstrated that a large number of microsomal membrane
modifications occurred as a result of dietary cholesterol supplementation. Microsomal
total cholesterol, cholesterol/phospholipid ratio, PC content and PC/PE ratio were all
increased in cholesterol fed animals. In contrast, alterations to total phospholipid fatty
acid composition culminated in a decreased DBI. Within membranes cholesterol is
orientated parallel with phospholipid acyl chains which increases membrane ordering
and rigidity as demonstrated using steady state fluorescence anisotropy (Brenner,
1990; Muriana et al., 1992) and pyrene excimer formation (Brenner, 1990). One of the
observed responses to increased membrane cholesterol was an augmentation in
membrane PC. This is in agreement with the findings ofLeikin and Brenner (1987) and
Muriana et al. (1992) although Garg et al. (1988a) showed no effect of dietary
cholesterol enrichment on phospholipid composition. An increase in PC is associated
with an elevated activity of CTP:phosphocholine cytidylyltransferase (Hirata and
Axelrod, 1980; Lim et al., 1983) and is thought to provide a more thermodynamically
favourable membrane state. Indeed, intermolecular head group interaction is greater
for bilayers containing PE compared to those containing PC due to a greater
electrostatic attraction (Yeagle, 1985) and as a consequence incorporation of
cholesterol into membranes containing PE is thermodynamically less favourable than
those containing PC. Interestingly, increased levels of PE in mouse fibroblasts have a
greater membrane viscosity compared to controls (Esko et al., 1977) and dietary PE
supplementation in rats decreases A6-desaturase activity and is associated with an
elevated membrane PE content (Imaizumi et al., 1989). Infact, the increase in PC may
be viewed as a homeostatic mechanism to counteract the cholesterol-induced bulk
rigidity of membranes.
Changes in PC/PE ratio induced by membrane sterol incorporation have been
studied in the context of altered desaturase activities. Cholesterol incorporation in
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vitro increases the activity of A5-, A6- and A9-desaturases by a viscotropic effect
where there is no change in the PC/PE ratio (Garda and Brenner, 1985; Brenner,
1990). Cholesterol enrichment in vivo generally causes an increase in PC/PE ratio
which is associated with a decrease in A5- and A6-desaturases and an increase in A9-
desaturase (Leikin and Brenner, 1987). In effect, the increase in the PC/PE ratio
attempts to fluidize the membrane as a compensatory mechanism (Brenner, 1990).
Yet, when rats are fed 5% (w/w) phytosterol (3 % (3-sitosterol and 2 % campesterol)
no change in PC/PE ratio occurs and the activity of all the desaturases is increased
(Leikin and Brenner, 1989a). It is evident therefore that the increase in the PC content
may prevent the viscotropic regulation.
The role of cholesterol has also been examined by investigating dietary cholesterol
removal (Leikin and Brenner, 1988). Their study showed that even after one day
microsomal membrane modifications begin to occur. Of interest, no significant changes
were observed for the molar PC/PE or cholesterol/phospholipid ratios or A5- and A6-
desaturase activities. Nevertheless, the n-6 fatty acid composition of microsomal total
phospholipids was modified indicating that EFA metabolism had been up-regulated. It
is therefore pertinent that other factors must be considered in the regulation of
phospholipid fatty acid composition which do not necessarily relate to the activity of
the desaturases.
Although cholesterol fed animals had a greater A6-desaturase activity this was not
reflected in the microsomal phospholipid index of 18:2 n-6 desaturation and
elongation. It was considered that this may partially be due to a greater export of long
chain n-6 fatty acids, especially 20:4 n-6, into the plasma compartment. Plasma
cholesterol ester content was increased in both groups fed cholesterol but this was not
paralleled by an increased proportion of n-6 fatty acids esterified to cholesterol.
Indeed, the level of 20:4 n-6 esterified to cholesterol was reduced in cholesterol fed
rats but no differences were observed in the amount of 20:4 n-6 in phospholipids
Microsomal phospholipid composition cannot therefore be explained by an increased
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export of 18:2 n-6 desaturation and elongation products to the plasma pool.
Alternatively, it is possible that cholesterol ester accretion in the liver took place to
remove large pools of free cholesterol. In this case a large influx of peroxidisable
material may have overwhelmed the tissue antioxidant protection mechanisms (Tsai,
1975). This in turn may have increased the oxidation of fatty acids such as 20:4 n-6
and therefore explain the lower levels. However, this aspect of the work was not
examined formally.
In summary, isolation stress was not the explanation for the decrease in
microsomal A6-desaturase activity in Garg's earlier cholesterol supplementation study
and the increase in our study. Indeed, isolation did not interact with the effect of
cholesterol supplementation on n-6 fatty acid composition or microsomal cholesterol
content in this study.
This work therefore still raises important questions to be answered. It is apparent
that the assay system in vitro may not reflect the situation in vivo. Factors such as an
overwhelming amount of substrate and cofactors with the absence of cellular
controlling factors, including cytosolic fatty acid binding proteins, may explain these
discrepancies. It is this aspect of 18:2 n-6 metabolism in vivo, conducted by
Zevenbergen and Houtsmuller (1989), that has brought a new impetus to the study of
EFA metabolism. This kind of work has not been examined in the light of cholesterol
feeding and will be the subject for examination in Chapter 6.
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Chapter 6
Linoleic acid metabolism in the cholesterolfed rat in vivo
6.1 Introduction
Dietary cholesterol enrichment increased rat liver microsomal A6-desaturase
activity in Chapter 4. This finding was reproduced in Chapter 5 at both high and low
amounts of microsomal protein (5.0 and 0.5 mg, respectively). Although this result
was in agreement with the A6-desaturase fatty acid ratio (18:3 n-6/18:2 n-6) in
Chapter 4, the result was contrary to other workers using a similar protocol of
cholesterol enrichment in vivo (Garg el al., 1988a). This led onto the belief that the
findings could be due to an in vitro effect. It was considered that the results obtained
could have been due to a very unphysiological situation in which overwhelming
amounts of substrate and cofactors can be used solely for desaturation purposes. A
situation that is not representative of that in vivo where the amount of substrate is low
and many other metabolic fates for the substrate are available, such as fatty acid (3-
oxidation and esterification into complex membrane lipids.
This study was therefore undertaken to assess the effects of dietary cholesterol on
18:2 n-6 metabolism in vivo, in particular, in liver microsomes. The assessment of
microsomal A6-desaturase activity in vitro, as employed in the previous cholesterol
feeding experiments, was used as a comparison. In addition, to examine whether any
particular effect was specific for A6-desaturase, the role of dietary cholesterol
supplementation on 18:0 metabolism by A9-desaturase was also assessed in vivo and in
vitro. This additional part of the study was carried out simultaneously within the same
control and cholesterol fed rats.
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6.2 Methods
Four groups of male, Sprague Dawley rats (n=18 per group, ~80 g) were
purchased in order to phase this large feeding and oral dosing experiment. All rats
were group-housed (n=3) and fed their appropriate diets ad libitum. The study design
is shown in Figure 6.1.
Figure 6.1 Design ofexperiment £,
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DAY 30 56
% Duration of feeding either 30 or 56 d, # sham oral dosing, * dosing with [ 1-14C] 18:2 n-6 and
[11,12-3H]18:0, S blood samples, sacrifice and tissue excision (either 8, 24 or 48 h after the
radioactive oral dose, n=6 at each time point). Design details not to scale.
To limit systematic variations in the procedures used in this large study, control
and experimental rats were fed, sacrificed and analysed at the same time. Thus, each
group of eighteen rats was randomly divided into two groups of nine and one half fed
the control diet and the other half the same diet enriched with 2 % (w/w) cholesterol
(see Section 2.2). They were fed for either 30 or 56 d. During the last week of the
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feeding protocol rats were given sham oral dosing on four consecutive days to
familiarise them with the procedure. No actual dose of oil was given at these times,
although the oral dosing tube was lubricated with olive oil to facilitate the process.
The day before oral dosing with [ 1 -14C] 18:2 n-6 and [11,12-3H]18:0, groups were
fasted for 21 h to empty the animals' stomachs (to facilitate uptake of fatty acids). The
next day rats were transferred to an area designated for radioactivity (within the animal
house) and dosed transoesophageally at 1230 hours with 30 pCi [11,12-3H] 18:0
(prepared as described in Section 2.6) and 20 pCi [1-14C]18:2 n-6 (CFA 104,
Amersham International, Amersham, U.K.). The radioactive fatty acids were dissolved
in 0.2 ml olive oil (Lipid Teknik, Stockholm, Sweden) and administered to rats using
an infant feeding tube (8G, 100 mm, Portex Ltd., Hythe, Kent, U.K.) attached to a
1.0 ml calibrated syringe (Becton Dickinson, Dublin, Ireland). The coefficient of
variation of oil administration was determined by weighing the dose delivered into a
test-tube was 3.1 % (n=10). All rats were then provided with their respective diets and
water ad libitum.
Eight h after oral dosing with radioactivity, the first group (three rats from each of
the two dietary regimens) were anaesthetised (60 mg/kg body weight, Sagatal®,
Rhone Merieux Ltd., Harlow, Essex, U.K.). Blood was withdrawn from the heart
using a heparinised 10 ml syringe (Becton Dickinson, Dublin, Ireland) and plasma
prepared and stored as described in Section 2.3.2. Rats were sacrificed by heart
excision (under anaesthesia) and both liver and adipose tissue were removed and
processed as described in Sections 2.3.1 and 2.3.2, respectively. Exactly the same
procedures were employed for animals at 24 and 48 h after the radioactive oral dose.
Freshly prepared plasma aliquots (40 pi) were counted (20 min) in duplicate with
10 ml scintillant as described in Section 2.7.1. Plasma lipid classes (phospholipid,
cholesterol ester, triacylglycerol and non-esterified fatty acid) were extracted and
assessed for 3H and 14C (see Section 2.7.1). Plasma lipids (triacylglycerol and total
cholesterol) were measured as described (Section 2.4.1). Plasma lipid fatty acid
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composition was measured as outlined in Section 2.5.4. Microsomes were prepared
(see Section 2.3.1) and A6-desaturase activity was measured under the optimal
conditions described in Section 2.4.8. Owing to the nature of the study, all microsomal
preparations contained different amounts of [14C]triene and [14C]tetraene fatty acids
that might interfere with accurate A6-desaturase activity measurement in vitro.
Therefore, for each sample, microsomes (0.5 mg protein) were added to incubation
medium pre-treated with KOH-methanol and taken through the A6-desaturase
estimation. The blank value derived from this (i.e. counts in the triene and tetraene
bands adjusted for recovery) was subtracted from the actual A6-desaturase
measurement for each sample. The mean blank value of the 72 duplicate A6-desaturase
analyses carried out in this study was equivalent to a A6-desaturase activity of 106+16
pmol/min/mg microsomal protein (range 74-144).
Microsomal phospholipids were extracted, transmethylated and analysed for fatty
acid composition and radioactivity as described in Sections 2.5.2 and 2.7.2.
Microsomal total cholesterol was assessed as in Section 2.5.7. Adipose triacylglycerol
fatty acid composition and radioactivity were analysed as described (Sections 2.5.6 and
2.7.3).
6.3 Results
The main purpose of this experiment was to elucidate the effect of cholesterol
supplementation on [1-14C] 18:2 n-6 and [11,12-3H] 18:0 metabolism in vivo. The
effect of extending the cholesterol feeding protocol to 56 d was included as no studies
have examined the effect of this level of dietary cholesterol enrichment beyond 28 d.
The effects of dietary cholesterol supplementation for 56 d were generally similar to
the effects observed with the 30 d supplementation. Therefore to simplify result
description, particularly regarding the fatty acid data, only information from rats fed
control and cholesterol enriched diets for 56 d is described. Data for rats fed the
respective diets for 30 d are presented in appendix E.
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6.3.1 General background results
The data described in this section generally support the findings of the previous
two cholesterol feeding studies. An abbreviated form of these non-radioactive results is
presented to highlight some of the important changes that occurred.
6.3.1.1 Animal characteristics
All animals remained healthy for the duration of the experiment. Growth rates were
comparable between control and cholesterol supplemented groups with no significant
differences evident (data not shown). Fasting for 21 h reduced rat body weight by
approximately 8 %. Body weights steadily increased on refeeding following oral
administration with radioactive fatty acids (Table 6.1).
Table 6.1 Body and liver weights of ratsfed a control or cholesterol enriched diet for
56 days at 8, 24 and 48 h after administration of radioactive fatty acids
Measurement Time (h) Control Choi. Significance
Weight (g)
Body 8 311±28 332±46 n.s.
24 324±31 321±43 n.s.
48 333±13 338±65 n.s.
Liver 8 10.0±0.7a 13.7±2.6 *
24 12.0±1.0b 15.1±2.8 *
48 11.4±0.8b 14.3±3.0 n.s.
Relative liver weight (%) 8 3.2±0.3a 4. l±0.3a ***
24 3.7±0.3b 4.7±0.3b ***
48 3.4±0.2a'b 4.2±0.2a ***
Values expressed as Mean±SD. * p<0.05, *** p<0.001 vs. control. Single a, b, c unlike symbols
indicate statistical significance (p<0.05) between two groups in the vertical plane for a particular
measurement by unpaired t-test after significant (p<0.05) one-way ANOVA.
Liver weights were increased by cholesterol feeding reaching statistical significance
in rats appraised at 8 and 24 h after the radioactive oral dose. Dietary cholesterol
enrichment also increased relative liver weight which was evident at all three time
points following the administration of radioactive lipids.
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The importance of using an intubation familiarisation protocol was borne out by
the observation that two animals bit through the feeding tube during the sham
protocol. This did not occur with the radioactive oral dose.
6.3.1.2 Microsomal cholesterol and phospholipid contents
As in the two preceding chapters, microsomal cholesterol content was increased by
cholesterol supplementation (Table 6.2). This reached statistical significance at all
three time points following the administration of the radioactive dose.
As expected, no significant effect of cholesterol supplementation was detected on
microsomal total phospholipid content (Table 6.2).
Table 6.2 Microsomal cholesterol and phospholipid contents and A6-desaturase
activity of ratsfed a control or cholesterol enriched dietfor 56 days at 8, 24 and 48 h
after administration ofradioactive fatty acids
Measurement Time (h) Control Choi. Significance
Cholesterol % 8 77±7a 107±8a ***
24 61±4b 79±6b ***
48 56±7b 78±8b ***
Phospholipid c. 8 449±41 492±37 n.s.
24 450±21 462±31 n.s.
48 456±25 471±25 n.s.
Cholesterol/phospholipid vg 8 0.17±0.02a 0.22±0.02a **
24 0.14±0.02b 0.17±0.02b **
48 0.12±0.02b 0.17±0.02b **
A6-desaturase activity C, 8 533±92a'b 666±201 n.s.
24 469±46a 546±50 *
48 584±82b 592±19 n.s.
Values expressed as Mean±SD. * p<0.05, ** p<0.01. *** p<0.001 vs. control. % nmol/mg protein, vg
mol/mol, C A6-desaturase activity estimated with 0.5 mg microsomal protein (activity expressed as
pmol/min/mg). Single a, b, c unlike symbols indicate statistical significance (p<0.05) between two
groups in the vertical plane for a particular measurement by unpaired t-test after significant (p<0.05)
one-way ANOVA.
The cholesterol-phospholipid ratio was increased by cholesterol supplementation
(Table 6.2). Interestingly, the ratio was highest in both control and cholesterol fed
groups 8 h after the administration of the radioactive dose. Thereafter, the ratio
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generally diminished by the 48 h time point to a level similar to that observed in the
previous cholesterol feeding experiments (Chapters 4 and 5). This possibly reflected to
some extent the effect of the 21 h fast and subsequent refeeding on liver microsomal
cholesterol content.
6.3.1.3 Microsomal A6-desaturase activity
A6-desaturase activity was generally higher in cholesterol supplemented rats (Table
6.2). Owing to some large variations in activities, however, this was only significantly
evident at the 24 h time point (p=0.022).
6.3.1.4 Microsomal phospholipid fatty acid composition
Many cholesterol-induced alterations to microsomal phospholipid fatty acid
composition were observed. The results presented are limited to fatty acids relevant to
A9- and A6-desaturation (Table 6.3). They are expressed as nmol rather than relative
amounts to eliminate the effects of differences of other fatty acids1.
Table 6.3 Microsomal total phospholipidfatty acid composition of rats fed a control
or cholesterol enriched dietfor 56 days §
Fatty acid species Control Choi. Significance
PUFA (n-6)
18:2 94±7 120±7 ***
18:3 # 1.9±0.2 1.6±0.4 n.s.
20:3 18±2 22±3 *
20:4 205±16 188±15 n.s.
22:4 2.4±0.3 1.7±0.2 **
22:5 8.4±2.0 4.7±1.3 **
S n-6 331±21 339±23 n.s.
SSFA 406±23 376±16 *
SMUFA 100±7 150±11 ***
Values expressed as nmol/mg microsomal protein (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 vs.
control. # Unresolved peak contained unspecified amounts of 20:0. § All measurements made 48 h
after administration of radioactive fatty acids.
' To simplify presentation, only the fatty acid profile of rats sacrificed at 48 h is presented as this generally reflected the situation
found at both 8 and 24 h time points. In addition, data on liver weights (Section 6.3.3.1) suggests that the rats are achieving re-
equilibrium 48 h after their 21 h fast.
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In line with the previous cholesterol feeding studies, 18:2 and 20:3 were
significantly elevated by cholesterol supplementation. Similarly, cholesterol feeding
generally reduced levels of 20:4, 22:4 and 22:5. Interestingly, 18:3 was elevated in
cholesterol fed rats 8 h after the administration of radioactive fatty acids (0.9±0.1 vs.
1.1±0.1 nmol/mg microsomal protein, Table E.4, Appendix E) but no statistical
difference was evident at the two subsequent time points analysed.
Cholesterol supplemented rats had higher levels ofMUFA compared with controls
(due to increased levels of 16:1, 18:1 and 20:1). This was accompanied by reduced
levels of SFA (Table 6.3).
6.3.1.5 Microsomal phospholipid fatty acid ratios
The 18:3 n-6/18:2 n-6 A6-desaturase index did not significantly differ between
cholesterol and control fed rats at the earliest time point after dosing with radioactivity
but at the two subsequent time points the index was decreased in cholesterol fed rats.
In contrast, the 22:5 n-6/22:4 n-6 A6-desaturase index was not influenced by
cholesterol feeding (Table 6.4).
The 20:4 n-6/20:3 n-6 A5-desaturase index was at its peak level, in both groups,
8 h after the administration of radioactive fatty acids. At this time, the index in
cholesterol fed rats was 50 % that of controls. This large difference between control
and cholesterol supplemented rats was reduced at both 24 and 48 h after oral dosing
with radioactivity, but the suppressive effect of cholesterol on this index remained
significant.
The 18:2 D&E index was at its highest level in both groups 8 h after the
administration of radioactive lipids. The index was lower in both groups at 24 h and
recovered slightly by 48 h. Cholesterol feeding caused a significant decrease in this
index at all three time points analysed.
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Table 6.4 Microsomal phospholipid fatty acid ratios of rats fed a control or
cholesterol enriched diet for 56 days at 8, 24 and 48 h after administration of
radioactive fatty acids































































Values expressed as Mean±SD. ** p<0.01, *** p<0.001 vs. control. Single a, b. c unlike symbols
indicate statistical significance (p<0.05) between two groups in the vertical plane for a particular
measurement by unpaired t-test after significant (p<0.05) one-way ANOVA. 18:2 D (Desaturation) &
E (Elongation) refers to (18:3 n-6 + 20:2 n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6)/18:2 n-6.
Cholesterol supplementation increased the A9-desaturation index (18:1/18:0 ratio)
at each of the three time points following the administration of the radioactive dose
(Table 6.4).
6.3.1.6 Plasma lipid content and composition
Cholesterol fed rats had slightly higher levels of plasma total cholesterol compared
to controls. This reached statistical significance 48 h after the administration of
radioactive lipid (Table 6.5). Cholesterol ester concentrations generally reflected the
results demonstrated for the total cholesterol levels.
No significant differences were apparent for triacylglycerol levels between
cholesterol and control fed rats. Plasma phospholipid concentrations were also not
significantly different between the two groups at each of the three time points after oral
dosing with radioactivity.
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Table 6.5 Plasma total cholesterol, cholesterol ester, phospholipid and
triacylglycerol concentrations and phospholipid and cholesterol ester fatty acid
compositions of ratsfed a control or cholesterol enriched dietfor 56 days §
Plasma lipid and fatty acid species Control Choi. Significance
Total cholesterol f 2.0±0.3 3.6±0.9 **
Triacylglycerol f 1.740.5 1.440.4 n.s.
Phospholipid } 1.5±0.2 1.54:0.2 n.s.
PUFA (n-6)
18:2 594493 6254104 n.s.
20:2 2.940.9 3.541.1 n.s.
18:3 # 5.1±1.3 5.041.0 n.s.
20:3 65±10 69410 n.s.
20:4 451±65 377428 *
22:4 7.3±0.9 5.040.6 ***
22:5 21±6 1143 *
E n-6 11464166 10964133 n.s.
I SFA 1346±204 11724161 n.s.
I MUFA 453±87 5854102 *
Cholesterol ester J 1.7±0.3 2.740.5 **
PUFA (n-6)
18:2 399±53 381454 n.s.
18:3 # 19±2 1544 n.s.
20:3 2246 2043 n.s.
20:4 753±144 448460 **
22:4 0.9±1.0 0.841.0 n.s.
22:5 2.6±1.4 1.240.8 n.s.
E n-6 11964199 8654106 **
E SFA 143420 368495 **
EMUFA 262437 14284452 **
Fatty acids expressed as gmol/1 (Mean±SD). } Expressed as mmol/1. * p<0.05, ** p<0.01 ***
p<0.001 vs. control, if Unresolved peak contained unspecified amounts of 20:0. § All measurements
made 48 h after administration of radioactive fatty acids.
As in the previous cholesterol feeding experiment, marked changes were
discernible in the fatty acid profile of the phospholipid fraction2. Cholesterol feeding
significantly increased the amount of MUFA in plasma phospholipids (levels of 16:1,
18:1 and 20:1 were elevated by 57, 26 and 40 %, respectively). However, total levels
of SFA in plasma phospholipids were unaffected by cholesterol supplementation
despite a small but significant decrease in 18:0. The contribution of n-6 fatty acids with
two or three double bonds in plasma phospholipids was not significantly altered by
1 To simplify presentation, only the fatty acid profile of rats sacrificed at 48 h is presented as this generally reflected the situation
found at both the 8 and 24 h time points.
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cholesterol supplementation. Nevertheless, levels of 20:4, 22:4 and 22:5 were
significantly reduced in cholesterol fed rats (Table 6.5).
Despite cholesterol ester levels being approximately 50 % higher in rats receiving
cholesterol, the total amount of n-6 fatty acids was significantly decreased (Table 6.5).
A 40 % reduction in 20:4 was mainly responsible for this finding. Of interest, levels of
18:2, 18:3, 20:3, 22:4 and 22:5 did not alter as a result of the cholesterol
supplementation. Total levels of SFA were highly increased as a result of the
cholesterol feeding. (16:0 was increased two-fold and 18:0 increased five-fold).
Similarly, total amounts ofMUFA were markedly increased (16:1 was increased four¬
fold while both 18:1 and 20:1 were increased six-fold).
Only minor cholesterol induced differences in total plasma 14C and 3H were
detected (Appendix E). The majority of plasma 14C was incorporated into
phospholipids with slightly smaller amounts present in cholesterol esters. The identity
of the radioactive fatty acids in plasma lipid fractions was not determined and these
plasma radioactivity results will not be discussed further.
6.3.2 Microsomal radioactive fatty acids
6.3.2.1 Microsomal phospholipid [14C]labelIed fatty acids
There was a time related decrease in the total amount of 14C present in microsomal
phospholipids. Samples obtained 8 h post intubation contained approximately five
times as much 14C as those collected at 48 h (Table 6.6). Total 14C in microsomal
phospholipids did not differ significantly between cholesterol and control fed rats at
each of the three time points assessed.
At both 8 and 24 h after the oral administration of radioactive fatty acids, [14C]-
diene and [14C]triene fatty acid counts were not different between cholesterol and
control fed rats. At the same time points, however, [14C]tetraene counts were
significantly reduced by dietary cholesterol enrichment (Table 6.6). By the final time
point (48 h) more differences between the two groups were evident: levels of
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[14C]diene fatty acids were significantly increased while [14C]tetraenes were
significantly reduced by the cholesterol supplementation.
Table 6.6 Distribution of 14C in microsomal phospholipid fatty acids of rats fed a
control or cholesterol enriched dietfor 56 days at 8, 24 and 48 h after administration
ofradioactive fatty acids
Label Time (h) Control Choi. Significance
[14C]phospholipid # 8 3945±304a 3258±1068a n.s.
24 1282±225b 1438±398b n.s.
48 651±137c 711±113c n.s.
[I4C]dienes 8 3330±288a 2826±862a n.s.
24 796±159b 1080±279b n.s.
48 216±62c 349±65c **
[14C]trienes 8 236±29a 206±67a n.s.
24 189±38b 188±53a n.s.
48 87±18c 103±33b n.s.
[14C]tetraenes 8 268±53 103±43a ***
24 264±31 130±60a **
48 335±69 235±33b *
[14C]SFA & [14C]MUFA 8 11l±48a 123±124 n.s.
24 33±13b 41±21 n.s.
48 14±5C 25±12 n.s.
Values expressed as DPM/mg microsomal protein (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 v.v.
control. # Total 14C in the phospholipid fraction was calculated by the adding together 14C present in
diene, triene, tetraene, monoene and saturated fatty acids. Single a. b, c unlike symbols indicate
statistical significance (p<0.05) between two groups in the vertical plane for a particular measurement
by unpaired t-test after significant (p<0.05) one-way ANOVA.
The TLC band that comprised SFA and MUFA also contained small amounts of
14C (Table 6.6). Slightly higher counts of these fatty acids were observed in
microsomal phospholipids of rats supplemented with cholesterol. The difference,
however, did not reach statistical significance.
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6.3.2.2 Specific activity of [14C]labelled microsomal phospholipid fatty acids
Specific activities of n-6 fatty acids extracted from microsomal phospholipids are
shown in Table 6.7.
Table 6.7 Specific activity ofmicrosomal phospholipid [14C]labelled n-6 fatty acids
of rats fed a control or cholesterol enriched diet for 56 days at 8, 24 and 48 h after
administration of [1-I4C]18:2 n-6
Measurement Time (h) Control Choi. Significance
N-6 diene specific activity 8 38.9±4.4a 24.0±7.3a **
24 8.0±1.7b 8.3±1.9b n.s.
48 2.3±0.7C 2.9±0.5C n.s.
N-6 triene specific activity 8 25.4±5.2a 12.7±4.6a **
24 10.1±2.1b 8.2±2.2a n.s.
48 4.3±0.9C 4.4±1.2b n.s.
N-6 tetraene specific activity 8 1.2±0.2a 0.5±0.2a ***
24 1.3±0.2a 0.7±0.3a **
48 1.6±0.3b 1.2±0.2b *
Values expressed as DPM/nmol (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 vs. control. For
dienes the denominator is 18:2 n-6 plus 20:2 n-6 (<1.0 nmol 20:2 n-6 per mg microsomal protein),
for trienes the denominator is 18:3 n-6 plus 20:3 n-6 and for tetraenes the denominator is 20:4 n-6
plus 22:4 n-6. Single a, b. c unlike symbols indicate statistical significance (p<0.05) between two
groups in the vertical plane for a particular measurement by unpaired t-test after significant (p<0.05)
one-way ANOVA.
N-6 diene specific activity decreased with time after oral dosing with values at 48 h
approximately 1/17th and l/8tb of those existing at 8 h in control and cholesterol fed
rats, respectively. A significantly lower n-6 diene specific activity was observed in
cholesterol supplemented rats at 8 h post intubation. A similar finding was observed
for n-6 triene specific activity. Specific activities of n-6 tetraene fatty acids on the other
hand were lower in cholesterol supplemented rats at the 8, 24 and 48 h time points
(Table 6.7).
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6.3.2.3 Microsomal phospholipid [3H]labelled fatty acids
Count rates for 3H decreased with time from the oral administration of
radioactivity (Table 6.8). Samples obtained 8 h post intubation contained
approximately six times as much 3H as those collected at 48 h.
Table 6.8 Distribution of 3H in microsomal phospholipid fatty acids of rats fed a
control or cholesterol enriched dietfor 56 days at 8, 24 and 48 h after administration
of [11,12-3H118:0
Measurement Time (h) Control Choi. Significance
[3H]phospholipid 8 2799±476a 2088±592a *
24 870±322b 911±273b n.s.
48 345±191c 364±110c n.s.
[3H]SFA 8 2799±476a 2063±592a *
24 826±309b 829±248b n.s.
48 329±180c 327±99c n.s.
[3H]MUFA 8 n.d. 24±lla _
24 44±15a 82±28b *
48 17±12b 38±14a *
Values expressed as DPM/mg microsomal protein (Mean±SD). * p<0.05 vs. control, n.d. Not
detectable. - Not statistically tested. Single a, b, c unlike symbols indicate statistical significance
(p<0.05) between two groups in the vertical plane for a particular measurement by unpaired t-test
after significant (p<0.05) one-way ANOVA.
Eight h after the administration of [11,12-3H] 18:0, cholesterol fed animals had
significantly higher levels of 3H in microsomal phospholipids compared with controls.
No significant difference was observed between the two groups at the two later time
points. Levels of 3H in SFA showed the same pattern as that described for 3H
incorporation into total phospholipid fatty acids (Table 6.8).
Incorporation of 3H in MUFA was highly elevated by cholesterol supplementation.
At each of the three time points after the administration of [11,12-3H]18:0 cholesterol
fed animals had increased counts in the monoene fraction. This reached statistical
significance 48 h post intubation and supports the view that cholesterol feeding has
induced A9-desaturase. Direct measurement of A9-desaturase activity in one half of the
animals was increased (50±30 pmol/min/mg) in cholesterol fed rats compared with
controls (23±13 pmol/min/mg, p=0.03). However, the activity of quality control stock
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material had decreased during storage and the same was probably true for all samples.
Thus, A9-desaturase activity in this study may only be an indication and absolute levels
may be quite different. Other microsomal A9-desaturase activities were not measured
because of this very low activity.
6.3.2.4 Specific activity of [3H]labelled microsomal phospholipid fatty acids
The specific activities of SFA and MUFA are shown in Table 6.9. Eight h after the
administration of radioactivity, cholesterol fed rats had lower a SFA specific activity
than controls. This difference was not apparent at the two subsequent time points.
Table 6.9 Specific activity of microsomal phospholipid [3H]labelled fatty acids of
rats fed a control or cholesterol enriched diet for 56 days at 8, 24 and 48 h after
administration of [11,12-3H]18:0
Measurement Time (h) Control Choi. Significance























Values expressed as DPM/nmol (Mean±SD). * p<0.05 v.v. control. For SFA specific activity the
denominator is total microsomal SFA, for MUFA specific activity the denominator is total
microsomal MUFA. Single a, b, c unlike symbols indicate statistical significance (p<0.05) between
two groups in the vertical plane for a particular measurement by unpaired t-test after significant
(p<0.05) one-way ANOVA. - Not statistically tested.
Monoene specific activity was slightly higher in cholesterol fed rats at all time
points after the oral administration of radioactivity. This, however, did not reach
statistical significance.
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6.3.2.5 Microsomal phospholipid specific activity ratios
Specific activity ratios derived from n-6 PUFA, MUFA and SFA data are presented
in Table 6.10. Cholesterol supplementation significantly reduced the triene/diene and
18:2 D&E specific activity ratios at each time point following the administration of
radioactive fatty acids. The depressive effect of cholesterol feeding on the
tetraene/triene ratio was only significantly evident at the 24 h time point.
Table 6.10 Indices of [1-14C]18:2 n-6 and [11,12-3H]18:0 metabolism derivedfrom
microsomal phospholipid fatty acid specific activities of rats fed a control or
cholesterol enriched diet for 56 days at 8, 24 and 48 h after administration of
radioactive fatty acids
Measurement Time (h) Control Choi. Significance
14C


















































Values expressed as Mean±SD. * p<0.05, ** p<0.01, *** p<0.001. 18:2 D&E SA index relates to
(triene SA + tetraene SA)/diene SA. # SA specific activity. - Not statistically tested.
Cholesterol supplementation only tended to increased the MUFA/SFA specific
activity ratio (p=0.080 and p=0.067 at the 24 and 48 h time points, respectively; Table
6.10).
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6.3.3 Adipose tissue fatty acid composition and radioactivity
6.3.3.1 Adipose tissue triacylglycerol fatty acid composition
The effects of cholesterol supplementation on adipose tissue fatty acid composition
were minor. There was a small but significant decrease in the percentage of 16:0 while
18:1 and 18:2 n-6 were both increased (Table 6.11).
Table 6.11 Adipose tissue triacylglycerol fatty acid composition of rats fed a control
or cholesterol enriched dietfor 56 days §
Fatty acid species Control Choi. Significance
SFA
14:0 2.2±0.1 2.1±0.1 n.s.
16:0 22.6±0.5 21.6±0.5 **
18:0 11.2±1.5 11.2±1.4 n.s.
20:0# O.liO.O O.liO.O n.s.
MUFA
16:1 4.4±0.7 3.9±0.6 n.s.
18:1 47.3±0.7 48.3±0.6 *
20:1 1.1±0.0 1.2±0.1 n.s.
PUFA (n-6)
18:2 9.4±0.4 9.9±0.3 *
20:4 O.liO.O O.liO.O n.s.
PUFA (n-3)
18:3 0.3±0.0 0.3±0.0 n.s.
Values expressed as % (w/w) total fatty acids (Mean±SD). * p<0.05, ** p<0.01 vs. control. #
Unresolved peak contained unspecified amounts of 18:3 n-6. § All measurements made 48 h after
administration of radioactive fatty acids.
6.3.3.2 Adipose tissue [l-14C]linoleic acid and metabolites
No 14C was detected in fatty acids other than dienes in adipose tissue (Table 6.12).
Cholesterol supplemented rats had slightly higher levels of [l-14C]dienes than controls
but owing to large variability the difference was not significant. No difference in the
amount of n-6 dienes present in adipose tissue was manifest and no difference in the
specific activity of this fatty acid was observed.
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Table 6.12 Adipose tissue triacylglycerol diene content, radioactivity and specific
activity of rats fed a control or cholesterol enriched diet for 56 days §
Measurement Control Choi. Significance
[14C]diene \\i 4000±2100 5400±2000 n.s.
Diene content % 2160±280 2160±300 n.s.
Diene specific activity 1.9±1.0 2.4±0.6 n_s.
Values expressed as Mean±SD. vp DPM/10 mg adipose tissue, 2, nmol/10 mg adipose tissue. § All
measurements made 48 h after administration of radioactive fatty acids.
6.3.3.3 Adipose tissue [11,12-3H] stearic acid and metabolites
Adipose tissue SFA and MUFA 3F1 results are presented in Table 6.13. There was
large variability in the level of 3H in both fractions and no significant difference in the
amount of 3H in SFA and MUFA was apparent. The specific activities of these
respective fractions were slightly higher in cholesterol fed rats but this did not achieve
statistical significance.
Table 6.13 Adipose tissue triacylglycerol [11,12-3H]18:0 metabolism of rats fed a
control or cholesterol enriched dietfor 56 days §
Measurement Control Choi. Significance
[3H]SFA \\i 1190±630 1570±610 n.s.
SFA content ^ 8828±1151 8159±1301 n.s.
SFA specific activity # 13.4±7.3 18.7±5.2 n.s.
[3H]MUFA v)/ 310±160 440±170 n.s.
MUFA content 2, 12102±1335 11638±1691 n.s.
MUFA specific activity # 2.6±1.4 3.7±1.0 n.s.
Values expressed as Mean±SD. vg DPM/10 mg adipose tissue, 2, nmol/10 mg adipose tissue. # Specific




The central objective of this study was to use an alternative method to elucidate the
effect of cholesterol supplementation on the metabolism of 18:2 n-6. This in vivo
approach, carried out along similar lines to a study conducted by Zevenbergen and
Houtsmuller (1989), concentrated upon [1-14C] 18:2 n-6 metabolism in the liver
microsomal fraction as this forms the main site of 18:2 n-6 A6-desaturation in rats. The
metabolism of [11,12-3H] 18:0 by liver microsomal A9-desaturase was used as a
comparison.
As anticipated cholesterol supplementation modified key parameters, such as
microsomal cholesterol, fatty acid composition and A6-desaturase activity, in a manner
generally consistent with the findings of the previous cholesterol feeding studies.
Results of the radioactive fatty acids, on the other hand, depend on how the data is
expressed. Using pure count rate data, there was no significant difference in the total
amount of 14C in microsomal phospholipids between cholesterol and control fed rats.
However, the distribution of 14C in dienes, trienes and tetraenes was distinctly altered.
Despite some high count variability, it was clear that cholesterol feeding caused a
marked decline in [14C]tetraenes particularly 8 h after dosing with radioactive
substrate. The expected accumulation of precursor ([14C]dienes), however, was only
manifest at the 48 h time point.
The specific activity results, a more usual method of expressing data from
radioactive tracer studies, differed slightly from pure count rate data. No increase in
n-6 diene specific activity was observed at the 48 h time point but then the initial n-6
diene specific activity was significantly lower in cholesterol fed rats at 8 h.
Nevertheless, n-6 tetraene specific activity was markedly reduced at 8, 24 and 48 h.
The specific activity ratio pertinent to A6-desaturation was lower in cholesterol
supplemented rats and the index of overall metabolism of 18:2 n-6 revealed a similar
pattern. Therefore, combining all the data from this in vivo study it is evident that
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cholesterol supplementation reduces the metabolism of 18:2 n-6 in rats in a manner
consistent with a reduced liver microsomal A6-desaturase activity.
It is of interest that the conclusion of a comparable (but less comprehensive)
experiment in vivo, studying the effects of trans-fatty acids on 18:2 n-6 metabolism,
was different despite similar specific activity data (Zevenbergen and Houtsmuller,
1989). They found that tetraene specific activity was much higher in rats fed a diet
containing olive oil, whereas that of dienes and trienes was hardly influenced by the
dietary fats studied. They suggested that the diets examined did not affect 20:4 n-6
synthesis during the first steps of 18:2 n-6 conversion (i.e. A6-desaturation and
elongation) but during the events that take place after the formation of 20:3 n-6 (i.e
A5-desaturation). Yet, the specific activity of tetraene fatty acids must depend to some
extent on the metabolism of 18:2 n-6 at the level of A6-desaturase and although the
results of the present study are similar to those of Zevenbergen and Houtsmuller
(1989) a different conclusion can be drawn.
The results of A6-desaturase activities measured in vitro form a distinct contrast to
the data obtained in vivo. This difference may relate to the way in which the in vivo
data is obtained and questions whether the conclusions of the study in vivo can be
quite as definite. For example, the argentation TLC method used only separated fatty
acids according to the degree of unsaturation. Thus each of the n-6 PUFA specific
activities had to be calculated using a denominator that was the combined total of two
n-6 fatty acids. The triene/diene specific activity ratio, for example, included 20:3 n-6
as well as 18:3 n-6 and as a result may not relate strictly to the activity of A6-
desaturase per se but to A6-desaturation plus elongation. This methodological
limitation may also have had important implications for the MUFA/SFA specific
activity ratio. This ratio only showed a trend toward an increase in cholesterol fed rats
but the microsomal A9-desaturase activity obtained in vitro was significantly increased
by cholesterol feeding (despite a smaller group size).
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Other limitations exist with the in vivo study data. At the 8 h time point, for
example, microsomal phospholipid diene specific activity was significantly lower in
cholesterol fed rats. This could indicate that some of the administered substrate had
already been metabolised by A6-desaturase by this time point. Yet, other routes for
substrate utilisation are available in vivo. Increased substrate oxidation in cholesterol
fed rats may well have influenced diene specific activity. Indeed, this is supported by
increased levels of [14C]SFA and [14C]MUFA in microsomal phospholipids of
cholesterol fed rats, consistent with increased mitochondrial and peroxisomal (3-
oxidation of [1-14C] 18:2 n-6 with subsequent esterification of the de novo synthesised
[14C]fatty acids (Zevenbergen and Houtsmuller, 1989; Gronn et al., 1992). Lower
[ 1 -14C] 18:2 n-6 absorption may also have affected microsomal diene specific activity
but it is more likely that greater dilution of the substrate within the phospholipid 18:2
n-6 pool as well as other associated lipid compartments contributed to the lower
specific activity of this diene fraction.
A6-desaturase activities were in some cases highly variable. They were adjusted for
endogenous 14C present in the microsomal lipid but even then the variability was
greater than that presented in the previous cholesterol feeding studies (Chapters 4 and
5). The 21 h fast before the oral administration of radioactivity was used to facilitate
radio-label uptake. Unfortunately, this resulted in rats being analysed at different
degrees of refeeding which may have altered desaturase activities to different extents.
Furthermore, fasting depresses A6-desaturase activity while refeeding reactivates the
system (Brenner et al., 1968; De Gomez Dumm et al., 1970). The greatest variability
in A6-desaturase activities was generally observed 8 h after the administration of
radioactive fatty acids and may relate to individual responses to the 8 h period in which
refeeding occurred. In addition, diurnal variations also alter desaturase activities (De
Gomez Dumm et al., 1984). The activity of A6-desaturase is higher at 2000 hours than
at 1200 hours (De Gomez Dumm et al., 1984), a pattern that was generally mirrored
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by the results of this study. These influences on the activity of A6-desaturase should be
considered carefully in the design of similar experiments in vivo.
Despite differences between in vivo and in vitro systems, the results for [ 11,12-
3H]18:0 metabolism by A9-desaturase in vivo were more clear cut. Although
cholesterol feeding did not reduce [3H]SFA (except at the 8 h time point), [3H]MUFA
levels were increased in cholesterol fed rats at all three time points following the
administration of radioactive fatty acids. Using specific activities, the cholesterol
feeding effect was reduced but still evident in the monoene fraction. These results were
in agreement with microsomal A9-desaturase activity obtained in vitro (although these
were only tentative results) as well as the microsomal A9-desaturase fatty acid index.
Previous studies examining the effect of cholesterol feeding on A9-desaturase activity
measured in microsomal preparations in vitro are also compatible with these results
(Leikin and Brenner, 1987; Garg et al., 1988a).
Incorporation of 14C and 3H was also demonstrated in adipose tissue
triacylglycerols. Levels of 14C were only measurable in the dienes with undetectable
levels of 14C in the more unsaturated n-6 fatty acids. No effect of cholesterol
supplementation was observed. These results are thus inconclusive with respect to the
metabolism of 18:2 n-6 to longer chain n-6 fatty acids and possibly relate to the short
duration of the study but also to the original low level of long chain n-6 PUFA.
Detectable levels of 3H in the monoene fraction were present in adipose tissue
triacylglycerols. The origin of [3H]MUFA may have arisen from the A9-desaturation of
[11,12-3H] 18:0 in situ (Wahle, 1974) or from the circulating plasma triacylglycerol
compartment. This study, however, did not differentiate between these two sources.
A number of study components were considered at the outset of this in vivo
experiment. Not least was the form of the orally dosed radioactive fatty acids. The
ingestion of triacylglycerols formed the basis of the dietary fat intake. However, it was
not considered necessary to esterify radioactive fatty acids to glycerol as good label
uptake was demonstrated in a pilot study with [ 1 -14C] 18:2 n-6 and a similar fasting
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protocol. The amount and type of carrier oil were also considered carefully. Oral
dosing supplementation studies have been carried out with daily doses as high as 0.7
ml of dietary oil (Du, 1991). This present investigation used the oil purely as a carrier
for the radioactive fatty acids. A dose of 0.2 ml was chosen as it permitted accurate
volume administration. The type of dosing oil was also believed to be important. I used
a highly purified olive oil which was low in 18:2 n-6 (approximately 13 % w/w) so that
the [1-14C]18:2 n-6 was not diluted excessively. The use of molten dietary fat, which
was used as the oral dosing agent in some studies (Zevenbergen and Houtsmuller,
1989) was not deemed practical in the present study as it was largely saturated (m.p.
~34°C) and was not sufficiently liquid at temperatures easily employable for oral
dosing.
Therefore in conclusion, this study demonstrated once more that A6-desaturase
activity measured in vitro is increased by cholesterol supplementation. Much of the
data in vivo, however, indicates that the metabolism of 18:2 n-6 is impaired by dietary
cholesterol. Yet, since the two approaches measure similar but different facets of 18:2
n-6 metabolism these results can be rationalised.
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Chapter 7
Linoleic acid metabolism in the diabetic BB/E rat
7.1 Introduction
Elevated amounts of 18:2 n-6 with depressed levels of 20:4 n-6 in plasma, serum,
platelet and red blood cell lipids from Type 1 (insulin-dependent, ketosis prone) human
diabetics have been generally regarded to reflect an impaired 18:2 n-6 metabolism
(Jones et at., 1983; van Doormaal et at., 1988; Horrobin, 1992). However, not all
diabetic studies have documented such fatty acid patterns (Kalofoutis and Lekakis,
1981; Tilvis and Miettinen, 1985; Freyberger et at., 1989). Diet can also be a
determinant of tissue fatty acid composition and it is noteworthy that this often differs
between diabetics and the general population. Unfortunately, only a few human
diabetic studies examine both diet and tissue fatty acid compositions. Indeed, Tilvis
and Miettinen (1985) have documented that diabetic patients consume 40 % more 18:2
n-6 despite a total fat intake comparable with controls. In accord with this are World
Health Organisation (WHO) recommendations that propose a reduction in saturated
fat with a concomitant increase in unsaturates for diabetics (WHO, 1990). The
American Diabetic Association also puts forward such dietary advice (WHO, 1990).
This kind of dietary difference may skew diabetic tissue fatty acid compositions in a
manner that could be interpreted incorrectly as a depressed A6-desaturase activity.
Diabetes leads to a number of serious secondary complications such as
atherosclerotic cardiovascular disease due to macroangiopathy and microangiopathic
complications such as retinopathy, nephropathy and neuropathy. One proposed factor
implicated in the manifestation of these diabetic complications is an impaired 18:2 n-6
metabolism by A6-desaturase (Horrobin, 1993; Jamal, 1994). The resultant reduction
in long chain n-6 fatty acids has been postulated to lead to abnormal erythrocyte,
platelet, endothelial and neurone function. The question is whether diabetic patients
influence tissue fatty acid composition by a higher dietary intake of 18:2 n-6 or
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whether there is an impaired conversion of 18:2 n-6 to longer chain n-6 fatty acids.
Measurements of liver microsomal A6-desaturase activity in diabetic humans are not
generally feasible because of the ethical constraints associated with collection of liver
biopsies. Fortunately, the spontaneously diabetic Bio Breeding (BB) rat provides a
useful alternative with a destructive insulitis comparable with humans (Baird, 1989;
Chanussot et al., 1989; Elias et al., 1990; Okamoto, 1990). The aim of the present
study was to examine the effect of diabetes with and without normal insulin treatment
on the level of the regulatory enzyme A6-desaturase. This was compared with the fatty
acid compositions of liver, plasma and adipose tissue in rats fed a highly controlled
diet.
7.2 Methods
Twenty-four, male, Wistar BB/Edinburgh (E) rats, consisting of twelve insulin-
dependent diabetics and twelve normal controls, from the Edinburgh Western General
Elospital colony, were used. All rats were fed a commercially available chow
(Appendix F) that contained 2.5 % (w/w) fat with a fatty acid composition of 0.2 %
14:0, 17.2 % 16:0, 0.3 % 16:1, 1.7 % 18:0, 15.8 % 18:1, 57.4 % 18:2 n-6, 6.5 %
18:3 n-3 and 0.4 % 20:1. In the diabetic prone BB/E rat strain, spontaneous diabetes is
expressed in 50-60 % of animals at approximately 90 d of age (detected by urinary
glucose appearance and abnormal weight gain; Baird, 1989). In the control (sub-line)
strain of BB/E rats less than 1 % of animals develop diabetes by the age of one year.
When symptoms were detected, diabetic rats were maintained on daily subcutaneous
insulin injections essential for survival. Insulin dose was evaluated for each individual
rat, by highly experienced staff, to maintain body weight (monitored daily) and for
normal metabolic requirements (absence of urinary glucose and ketone bodies).
Diabetic rats were divided into two equal groups, matched for age, duration of
diabetes and insulin treatment (Table 7.1); one group continued the usual once daily
insulin injection with tissues (blood, liver and adipose tissue) assessed 6 h after the last
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insulin dose. The other group were given their routine insulin treatment and then
deprived of insulin for 54 h (at which time tissues were assessed). For simplifying the
description of the results, diabetic rats assessed 6 h post insulin injection will be
referred to as 'insulin treated' and diabetic rats withheld from insulin for 54 h will be
known as 'insulin withdrawn'.
Tissues from two BB/E, age-matched, non-diabetic, control groups were also
analysed (Table 7.1). The original control group rats (assessed alongside the diabetic
animals) were bred from a normal BB/E, non-diabetic pair whose family history at the
time of study was negative with respect to diabetes. However, the male of the breeding
pair later developed diabetes at seven months of age. The results of A6-desaturase
activity measurements from this group were heterogeneous and therefore another
BB/E, non-diabetic, age-matched control group was selected as a replacement. This
substitute group will be referred to as the control but results from the 'abnormal' group
will also be presented as a comparison (generally without results of statistical analysis).
Table 7.1 Group description
Measurement Control Control t Diabetic Diabetic
(n=6) (n=6) Assessed 6 h post
insulin treatment (n=6)
Assessed 54 h post
insulin treatment (n=6)
Age # 152±5 153±1 152±10 150±11
Duration of diabetes # n.a. n.a. 61±4 60±6
Insulin treatment q n.a. n.a. 3.0±0.3 2.7±0.1
Values expressed as Mean±SD. f 'Abnormal'
statistically significant differences were observed.
control. # d, | IU/d. n.a. Not applicable. No
Fed rats were anaesthetised between 1545 and 1615 hours with Sagatal®
(60 mg/kg body weight, Rhone Merieux, Dublin, Eire). Blood was withdrawn from the
heart and plasma and red blood cells prepared as described in Sections 2.3.2 and 2.4.4,
respectively. Rats were sacrificed by excising the heart (under anaesthesia) and then
both liver and adipose tissue were removed and processed. The study was designed so
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that liver microsomes were prepared from two animals from each group on three
separate days. This was to facilitate rapid processing and to limit the influence of
systematic variations in liver microsomal and other tissue preparation. Liver was rinsed
in homogenisation buffer, wrapped in aluminium foil and surrounded with ice for
immediate carriage to the laboratory (approximately 45 min). Liver microsomes were
prepared as described (Section 2.3.1) and A6-desaturase activity measured under
optimal conditions (Section 2.4.8). Microsomal and plasma lipid fatty acid
compositions were determined as described in Sections 2.5.2 and 2.5.4, respectively.
Plasma lipids, insulin and glucose were analysed as outlined in Sections 2.4.1, 2.4.2,
and 2.4.3, respectively. Red blood cell glycosylated haemoglobin was determined as
described in Section 2.4.4. Adipose tissue triacylglycerol fatty acid composition was
analysed as described in Section 2.5.6.
7.3 Results
7.3.1 General animal characteristics
Body weight remained stable for the seven days preceding sacrifice in control and
insulin treated diabetic rats. However, a profound body weight reduction was observed
in diabetic rats which had insulin administration withdrawn (Fig. 7.1 and Table 7.2). At
the time of insulin withdrawal (two days prior to sacrifice) weights were not
significantly different from those at seven days before sacrifice. Yet, one day later and
on the day of sacrifice, these diabetic rats had lost 15±12 g (p=0.033) and 30±14 g
(p=0.0035), respectively. Unfortunately, under these conditions one animal died
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Figure 7.1 Body weights of control and diabetic rats on the day of sacrifice and at 1,
2 and 7 days prior to sacrifice. Insidin withdrawn at -2 days. Results expressed as
Mean±SD. Body weights were reduced after insulin withdrawal at -1 and 0 days
(p<0.05, paired t-test). f Abnormal control.
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No significant differences were observed for the absolute weights of liver and
heart. However, insulin treated diabetic animals had a significantly higher relative liver
weight compared with controls and the insulin withdrawn group had a significantly
raised relative heart weight (Table 7.2). The latter was the result of the acute body
weight loss in this group.
Table 7.2 Body, liver and heart weights ofcontrol and diabetic rats
Measurement Control Control t Diabetic Diabetic
(n=6) n=6 Insulin treated (n=6) Insulin withdrawn (n=5)
Weight (g)
Body 420±24x 401±21 403±52x'y 354±39y
Liver 14.2±1.8 13.2±1.7 16.1±3.5 12.1±1.4
Heart 1.00±0.08 0.91±0.05 0.96±0.11 0.94±0.08
Relative weight (%)
Liver/body 3.38±0.32x 3.29±0.27 3.97±0.54y 3.47±0.08x
Heart/body 0.24±0.01x 0.23±0.00 0.24±0.02x o.27±o.oiy
Values expressed as Mean±SD. All weights measured at sacrifice. Single x, y unlike symbols indicate
statistical significance (p<0.05) between two groups in the horizontal plane for a particular
measurement by unpaired t-test after significant (p<0.05) one-way ANOVA. f 'Abnormal' control.
7.3.2 Glycaemic control
Rats were in the fed state before sacrifice. Control animals demonstrated this with
a moderate hyperglycaemia and hyperinsulinaemia (Table 7.3). Low plasma glucose
levels were detected in insulin treated diabetic rats which were associated with insulin
concentrations not dissimilar from control animals. Insulin withdrawn diabetic rats
demonstrated a considerable hyperglycaemia, three-fold that of controls. Plasma
insulin levels were consistent with this finding with three of the five samples below the
level of detection (i.e. <2.5 mU/1, Table 7.3). The control group that had a family
history of diabetes had plasma glucose and insulin levels not significantly different from
the true controls.
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Table 7.3 General blood biochemistry ofcontrol and diabetic rats
Measurement Control Control t Diabetic Diabetic
(n=6) (n=6) Insulin treated (n=6) Insulin withdrawn (n=5)
Glucose % 9.0±1.0X 9.2±1.1 3.5±1.4y 28.6±4.7Z
Insulin \\i 134±42x 125±79 173±70x (5,5)#
GHb C 3.4±0.1x 3.0±0.3 6.1±1.4y 9.2±1.9Z
Triacylglycerol % n.d. 0.9±0.3 0.9±0.4X 14.7±5.0y
Cholesterol ester ^ 1.9±0.2X 1.9±0.2 2.0±0.1x 1.3±0.2y
Phospholipid £ 1.6±0.2X 1.6±0.1 1.9±0.2y 3.5±0.3Z
Values expressed as Mean±SD. n.d. Not determined. Single x, y, z unlike symbols indicate statistical
significance (p<0.05) between two groups in the horizontal plane for a particular measurement by
unpaired t-test after significant (p<0.05) one-way ANOVA. # n=2, three samples below level of
detection. % mM, \\i mU/1, C, %. t 'Abnormal' control.
The percentage of glycosylated haemoglobin (GHb), used as an indicator of
glycaemic regulation, was doubled in treated diabetic rats compared with control
animals (p=0.006). The metabolically compromised, insulin withdrawn diabetic animals
showed a further 50 % increase in GHb levels (p=0.002 and p=0.02 vs. control and
insulin treated diabetic rats, respectively). The percentage of GHb in the 'abnormal'
control group was just significantly lower than controls (p=0.045).
7.3.3 Plasma lipids
Metabolic state also influenced plasma lipid concentrations. Compared with
controls, treated diabetic rats had significantly higher plasma phospholipid levels
(p=0.014) but cholesterol ester levels were not significantly different. Insulin
withdrawal caused a large increase in both triacylglycerol and phospholipid levels,
however cholesterol esters were decreased (p=0.024 vs. control).
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7.3.4 Microsomal A6-desaturase activity
Despite slightly higher circulating levels of insulin, A6-desaturase activity was
decreased 25 % in treated diabetic rats compared with controls (p=0.013, Table 7.4).
In diabetic rats in whom insulin was withdrawn for 54 h, A6-desaturase activity was
39 % lower than controls (p=0.002). The difference between the two diabetic groups
did not reach statistical significance (p=0.12, unpaired t-test).
Table 7.4 Microsomal A6-desaturase activity, non-esterified 18:2 n-6 and
phospholipid concentrations ofcontrol and diabetic rats
Measurement Control Control f Diabetic Diabetic
(n=6) (n=6) Insulin treated (n=6) Insulin withdrawn (n=5)
A6-desaturase activity C 367±53x 308±180 277±48y 223±54y
Non-esterified 18:2 n-6 # 1.9±0.2X 2.5±0.4 2.3±1.2X 7.7±3.7y
Phospholipid # 543±17x 473±35 482±29y 544±57x>y
Values expressed as Mean±SD. Single x, y unlike symbols indicate statistical significance (p<0.05)
between two groups in the horizontal plane for a particular measurement by unpaired t-test after
significant (p<0.05) one-way ANOVA. # nmol/mg protein, C pmol/min/mg protein, t 'Abnormal'
control.
The concentration of non-esterified 18:2 n-6 was not significantly different
between control and insulin treated diabetic rats (Table 7.4). Insulin withdrawal caused
a four-fold increase in microsomal non-esterified 18:2 n-6 in diabetic rats compared
with control animals (p=0.024).
The activity of A6-desaturase in the 'abnormal' control group is worthy of
comment. Within this group there appeared to be two distinct sub-groups of three rats.
In the first, a very low activity was demonstrated (150±5 pmol/min/mg). In the other, a
high activity was manifest (471±69 pmol/min/mg). Levels of non-esterified 18:2 n-6
were 2.8±0.6 and 2.2±0.2 nmol/mg microsomal protein, for these low and high activity
sub-groups, respectively (p=0.22, unpaired t-test). This could therefore not explain this
difference in A6-desaturase activity. In addition, microsomal phospholipid levels were
not differently distributed among high and low activity groups. It had been assumed
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that these 'abnormal' control rats were from normal parents. Measurements such as
urinary glucose were not carried out as this measurement is only used for diabetic
animals monitored to determine the onset of diabetes. This information is not routinely
carried out for sub-line animals because they only rarely become diabetic.
7.3.5 Microsomal phospholipid content
Insulin treated diabetic rats had significantly lower levels of microsomal
phospholipids (expressed as nmol/mg protein) compared with control animals
(p=0.0031; Table 7.4). Diabetic rats in whom insulin was withdrawn had phospholipid
levels comparable with controls.
Although generally statistical results are not shown for 'abnormal' controls, the
phospholipid results are worthy of note. The content of microsomal phospholipids of
the 'abnormal' control group was significantly lower than controls (p=0.0033) but not
statistically significant from both diabetic groups.
7.3.6 Microsomal phospholipid fatty acid composition
Microsomal phospholipid fatty acid composition of diabetic rats differed in many
respects in comparison to control animals (Table 7.5). Although total levels of SFA in
insulin treated diabetic rats did not differ from control rats, the composition did. There
was a significant increase in 18:0 and a reduction in 16:0. Insulin withdrawal for 54 h
raised the total amount of SFA in microsomal phospholipids of diabetic rats. This was
due mainly to 18:0 (p=0.0013 vs. control). MUFA content and composition remained
virtually unchanged.
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Table 7.5 Liver microsomal total phospholipid fatty acid composition of control and
diabetic rats
Fatty acid species Control Control f Diabetic Diabetic
(n=6) (n=6) Insulin treated (n=6) Insulin withdrawn (n=5)
SFA
14:0 4.3±0.5 6.6±2.1 4.6±2.6 2.8±1.0
16:0 257±8X 235±15 224±16y 232±35x>y
18:0 182±10x 224±16 223±34y 335±42z
MUFA
16:1 20±3X 18±2 26±6X 13±3y
18:1 118±10 114±11 122±14 109±23
20:1 3.7±0.3X 15±3 9.2±4.3y 13±4y
PUFA (n-6)
18:2 133±9x>y 112±11 125±8X 156±19y
20:2 5.0±0.6X 5.7±1.6 5.0±2.2x'y 2.7±1.5y
18:3 # 2.0±0.1x 3.2±1.0 5.4±1.8y 3.3±2.1x'y
20:3 12±lx 8.6±1.3 14±3X 6.8±1.9y
20:4 265±12x 163±15 160±20y 167±19y
22:4 2.6±0.4X 1.9±0.3 1.5±0.3y i.2±o.iy
22:5 3.0±0.2X 2.2±0.6 1.3±0.7y 0.9±0.2y
PUFA (n-3)
18:3 1.0±0.1x n.d. 0.9±0.3X n.d.
20:5 2.4±0.2X 1.2±0.5 3.6±1.8X 1.6±0.4y
22:5 8.2±1.0X 4.2±0.6 4.5±0.9y 3.7±0.7y
22:6 66±4X 30±3 33±6y 39±8y
PUFA (n-9)
20:3 n.d. n.d. 1.7±1.3 § t 0.5, 1.7 t
E SFA 444±17x 466±28 451±44x 570±75y
EMUFA 142±12 147±15 157±12 135±24
E n-6 423±19x 297±29 313±24y 338±38y
E n-3 78±4X 36±4 42±5y 44±8y
DBI 197±3X 147±5 152±5y 140±8Z
Values expressed as nmol/mg protein (Mean±SD). Single x, y, z unlike symbols indicate statistical
significance (p<0.05) between two groups in the horizontal plane for a particular measurement by
unpaired t-test after significant (p<0.05) one-way ANOVA. # Unresolved peak contained unspecified
amounts of 20:0. n.d. not detected, f 'Abnormal' control. § n=3. $ Three samples below level of
detection.
Insulin treated diabetic rats had levels of 18:2 n-6, 20:2 n-6 and 20:3 n-6 not
dissimilar from control rats. However, 18:3 n-6 was significantly increased and 20:4
n-6, 22:4 n-6 and 22:5 n-6 were significantly lower than in control rats.
Insulin withdrawal had no significant effect upon the concentrations of either 18:2
n-6 or 18:3 n-6 but the remaining n-6 fatty acids were all significantly lower (Table
7.5). Small differences between the two diabetic groups existed: 18:2 n-6 was higher in
the insulin withdrawn diabetic group (p=0.019), and the opposite was true for 20:3 n-6
(p=0.0007).
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Total amounts of n-3 PUFA were significantly reduced in diabetic rats, irrespective
of their insulin status, when compared with control. Insulin treated diabetic rats had
lower levels of both 22:5 and 22:6 while in the insulin withdrawn group all n-3 fatty
acids quantified were reduced (Table 7.5).
The DBI was also markedly affected. The index (calculated from the percentage
(w/w) fatty acids) was significantly reduced in both diabetic groups compared with
control animals (both p<0.001). Treated diabetic rats had a higher DBI compared to
insulin withdrawn diabetic animals (p=0.023).
The animals from the 'abnormal' control group presented a fatty acid profile more
compatible with the diabetic rats than with the true control group. This was
demonstrated with total levels of both n-6 and n-3 PUFA (Table 7.5). In addition,
20:4 n-6, either presented as an absolute amount (163±15 nmol/mg) or as a percentage
of total phospholipid fatty acids (17.2±0.6 %) was significantly lower than that
demonstrated for controls (265±12 nmol/mg (p<0.001) and 24.4±0.5 % (p<0.001),
respectively).
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7.3.7 Microsomal phospholipid fatty acid ratios
Indices derived from the fatty acid composition of phospholipids are shown in
Table 7.6. The 18:3 n-6/18:2 n-6 A6-desaturase index was elevated in the insulin
treated diabetic group (p=0.0076 vs. control). However, insulin withdrawal reduced
this index to a value no longer significantly different from control. The effect of
diabetes on the A5-desaturase index differed from that on the index for A6-desaturase.
A decrease in the A5-desaturase index was observed in insulin treated diabetic rats
(p<0.0001 vs. control) but it was no longer significantly different in diabetic rats in
whom insulin was withdrawn.
Table 7.6 Fatty acid indices derivedfrom microsomal phospholipidfatty acid ratios
ofcontrol and diabetic rats
Index Control Control t Diabetic Diabetic
(n=6) (n=6) Insulin treated (n=6) Insulin withdrawn (n=5)
n-6
18:3/18:2 (A6) 0.015±0.002x 0.028±0.007 0.044±0.016y 0.021±0.014x
20:4/20:3 (A5) 21.3±0.7X 19.1±1.7 n.5±i.6y 25.5±4.9X
22:5/22:4 (A6) 1.2±0.1x 1.1±0.2 0.9±0.3X'y o.8±o.iy
18:2 D&E 2.18±0.14x 1.64±0.07 1.51±0.25y 1.17±0.14z
n-9
18:1/18:0 (A9) 0.65±0.08x 0.51±0.03 0.56±0.13x 0.33±0.07y
Values expressed as Mean±SD. Single x, y, z unlike symbols indicate statistical significance (p<0.05)
between two groups in the horizontal plane for a particular measurement by unpaired t-test after
significant (p<0.05) one-way ANOVA. 18:2 D (Desaturation) & E (Elongation) refers to (18:3 n-6 +
20:2 n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6)/18:2 n-6. f 'Abnormal' control. No
triene/tetraene ratio presented as on control rats had no detectable 20:3 n-9.
The 18:2 D&E index was highest in controls, significantly lower in treated diabetic
animals and lower still in insulin withdrawal group. Both the 22:5 n-6/22:4 n-6 A6- and
A9-desaturase indices demonstrated a similar pattern.
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7.3.8 Plasma phospholipid fatty acid composition
Total amounts of SFA and MUFA in plasma phospholipids were significantly
raised in both diabetic groups compared with control animals (Table 7.7). This was
due mainly to increases in 18:0 and 18:1 in the respective fractions.
Table 7.7 Plasma phospholipid fatty acid composition ofcontrol and diabetic rats
Fatty acid species Control Control f Diabetic Diabetic
(n=6) (n=6) Insulin treated (n=6) Insulin withdrawn (n=5)
SFA
14:0 11±2 10±1 9.4±1.9 8.5±2.9
16:0 819±81x 795±63 887±75x 1615±113y
18:0 494±53x 515±39 678±90y 1565±149z
MUFA
16:1 51±10 39±5 61±9 71±27
18:1 300±47x 279±28 393±50y 582±154z
20:1 12±lx 12±1 14±3x-y i5±iy
PUFA (n-6)
18:2 587±41x 541±49 795±107y 1528±128z
20:2 11±2X 13±2 13±4X 6.2±0.9y
18:3 # 5.8±1.3 6.4±0.3 7.4±1.5 8.9±3.2
20:3 35±5X 28±3 53±9y 27±2Z
20:4 661±94x 721±69 695±95x 1268±117y
22:4 12±lx 12±2 8.6±1.5y 8.0±2.2y
22:5 9.3±1.4X 13±2 5.9±2.iy 4.2±2.0y
PUFA (n-3)
18:3 3.3±0.3X 3.1±0.7 4.2±1.0X 7.0±1.6y
20:5 7.0±1.2 4.0±1.4 10.9±4.4 7.0±2.4
22:5 19±2XA 19±1 17±2X 2o±iy
22:6 141±26x 131±12 125±23x 269±35y
£ SFA 1324±135x 1319±102 1575±149y 3188±244z
£MUFA 363±58x 330±34 468±55y 668±18iy
£ n-6 1320±136x 1334±122 1578±15iy 2851±149z
£ n-3 170±28x 156±15 157±24x 303±35y
18:2 D&E index 1.25±0.13x 1.47±0.06 i.oo±o.2iy 0.87±0.12y
Values expressed as p.mol/1 (Mean±SD). Single x, y, z unlike symbols indicate statistical significance
(p<0.05) between two groups in the horizontal plane for a particular measurement by unpaired t-test
after significant (p<0.05) one-way ANOVA. 18:2 D (Desaturation) & E (Elongation) refers to (18:3
n-6 + 20:2 n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6)/18:2 n-6. # Unresolved peak contained
unspecified amounts of 20:0. f 'Abnormal' control. 20:3 n-9 not detectable.
Significant alterations were also observed for n-6 PUFA (Table 7.7). Levels of
18:2 and 20:3 were increased in insulin treated diabetic rats while 22:4 and 22:5 were
reduced when compared with controls. Insulin withdrawn diabetic animals showed
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additional modifications: 18:2 and 20:4 were increased while 20:2, 20:3, 22:4 and 22:5
were decreased.
In the insulin withdrawal group, the presentation of plasma phospholipid fatty acids
as absolute amounts conceals some important changes. This is because the total plasma
phospholipid content in these animals was double that of controls. When the data is
presented as relative amounts, 18:2 n-6 was increased in insulin withdrawn diabetic
rats, 21.8±1.8 % vs. 18.6±1.3 % (p=0.01); and 20:4 n-6 was decreased compared with
controls (18.1±1.6 % vs. 20.7±0.8 %, p=0.02).
7.3.9 Plasma cholesterol ester fatty acid composition
Widespread significant changes were also observed for plasma cholesterol ester
fatty acids (Table 7.8).
The total amount of n-6 fatty acids remained the same for insulin treated diabetic
rats as controls. However, the distribution therein was modified with 18:2, 18:3 and
20:3 all significantly elevated and 22:5 reduced. The total amount of n-3 fatty acids
also remained similar to controls but 20:5 was doubled and 22:6 almost halved.
Insulin withdrawal reduced the levels of both n-6 and n-3 fatty acids in plasma
cholesterol esters when compared with insulin treated diabetic rats. In particular,
20:4 n-6 was roughly halved. For the n-3 series, both 20:5 and 22:6 were significantly
reduced by insulin withdrawal.
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Table 7.8 Plasma cholesterol ester fatty acid composition ofcontrol and diabetic rats
Fatty acid species Control Control f Diabetic Diabetic
(n=6) (n=6) Insulin treated (n=6) Insulin withdrawn (n=5)
SFA
14:0 6.5±0.9 7.5±1.5 5.9±1.1 4.3±2.6
16:0 176±18x 183±16 167±10x 145±4y
18:0 9.5±1.8X 25±3 13±3X 43±liy
MUFA
16:1 85±17x 66±11 112±12y 43±14z
18:1 105±13x 102±14 145±18y 137±25y
20:1 6.1±4.1x 15±6 5.7±1.4X 2i±7y
PUFA (n-6)
18:2 387±25x 363±30 457±19y 317±65x
20:2 n.d. n.d. n.d. n.d.
18:3 # 14±lx 16±2 20±4y ll±lz
20:3 8.9±1.0X 7.1±0.4 i2±2y 2.8±0.9Z
20:4 1062±126x 1094±96 1007±133x 591±13iy
22:4 0.6±0.1x 0.7±0.4 0.5±0.2X 2,i±i.oy
22:5 0.4±0.1x 0.9±0.3 o.2±o.2y n.d.
PUFA (n-3)
18:3 n.d. n.d. n.d. n.d.
20:5 15±2X 6.2±1.3 28±8y 4.8±2.8Z
22:5 0.6±0.2 0.6±0.1 0.5±0.2 0.4±0.5
22:6 33±4X 22±3 22±4y 12±3Z
E SFA 192±21 215±20 185±13 193±15
EMUFA 196±28x 183±25 263±18y 201±40x
E n-6 1472±146x 1482±127 1497±132x 923±182y
E n-3 49±6X 29±4 50±10x 17±6y
18:2 D&E index 2.80±0.26x 3.08±0.08 2.28±0.30y 1.94±0.34y
Values expressed as pmol/1 (Mean±SD). Single x, y, z unlike symbols indicate statistical significance
(p<0.05) between two groups in the horizontal plane for a particular measurement by unpaired t-test
after significant (p<0.05) one-way ANOVA. 18:2 D (Desaturation) & E (Elongation) refers to (18:3
n-6 + 20:2 n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6)/18:2 n-6. # Unresolved peak contained
unspecified amounts of 20:0. f 'Abnormal' control. 20:3 n-9 not detectable.
The cholesterol ester fatty acid derived 18:2 D&E index reflected the A6-
desaturase activities measured in liver microsomes. This index was highest in controls
and lowest in insulin withdrawn diabetic animals. However, no significant difference
was found between the two diabetic groups (p=0.12).
7.3.10 Adipose tissue triacylglycerol fatty acid composition
Diabetic rats showed significantly lower levels of n-6 and n-3 PUFA in adipose
tissue compared with control animals. The reduction in these PUFA was associated
with approximately a 30 % increase in MUFA and a small rise in SFA (Table 7.9).
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The large fall in n-6 PUFA in diabetic rats was due mainly to significant reductions
in 18:2, 20:4, 22:4 and 22:5. Percentages of 20:2 and 20:3 (both n-6) were not
significantly different from controls. Analysis of individual n-3 fatty acids revealed that
the depletion in the total percentage of this class was due to significant decreases in all
n-3 fatty acids. Despite the rise in MUFA in both groups of diabetic animals, the large
reductions in PUFA resulted in a significantly reduced DBI compared with control.
Table 7.9 Adipose tissue triacylglycerol fatty acid composition of control and
diabetic rats
Fatty acid species Control Control f Diabetic Diabetic
(n=6) (n=6) Insulin treated (n=6) Insulin withdrawn (n=5)
SFA
14:0 1.240. lx 1.4±0.1 1.640.2y 1.540.2y
16:0 24.140.7 22.6±0.7 26.041.6 24.541.8
17:0 0.3±0.0X 0.4±0.1 0.340.0y 0.540.02
18:0 2.5±0.1x 2.6±0.1 2.940.2y 3.440.4y
20:0 # 0.2±0.0X 0.4±0.2 0.340. iy 0.540. iy
MUFA
16:1 5.0±0.4X 5.1±0.6 9.741.4y 7.842.1XA
18:1 25.340.5X 25.740.5 29.64l.2y 29.242.4y
20:1 0.7±0.1x 1.040.3 0.840. iy i.i40.4y
PUFA (n-6)
18:2 35.841.lx 35.941.7 25.442.9y 28.l44.6y
20:2 0.340.0 0.440.2 0.340.1 0.340.2
20:3 0.140.0 0.240.1 0.240.1 0.240.1
20:4 0.740. lx 0.740.1 0.440. iy 0.340. iy
22:4 0.2±0.0X 0.240.0 o.uo.oy o.040.oy
22:5 0.1±0.0X 0.140.0 o.o4o.oy o.o4o.oy
PUFA (n-3)
18:3 2.5±0.1x 2.540.2 1.740.2y 1.840. iy
20:5 0.1±0.0X 0.040.0 o.o4o.oy o.o4o.oy
22:5 0.2±0.0X 0.340.4 o.uo.oy o.o4o.oy
22:6 0.4±0.1x 0.240.1 o.i4o.iy o.uo.iy
PUFA (n-9)
20:3 n.d. n.d. n.d. n.d.
Unknown 0.5±0.0X 0.440.0 0.540. lx 0.540. lx
I SFA 28.2±0.8X 27.440.6 3i.i4i.ey 30.341.5x>y
X MUFA 31.0±0.4X 31.841.1 40.242.4y 38.243.9y
X n-6 37.241.lx 37.541.4 26.243. iy 29.044.7y
X n-3 3.1±0.3X 2.840.3 2.040.3y 2.040.2y
DBI 82±lx 8342 7543y 7542y
Values expressed as % (w/w) of total fatty acids (Mean±SD). Single x, y, z unlike symbols indicate
statistical significance (p<0.05) between two groups in the horizontal plane for a particular
measurement by unpaired t-test after significant (p<0.05) one-way ANOVA. t 'Abnormal' control,
n.d. Not detectable. # Unresolved peak contained unspecified amounts of 18:3 n-6.
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7.3.11 Correlations of A6-desaturase activity and fatty acid indices
A highly significant correlation was observed between A6-desaturase activity and
microsomal 18:2 D&E index (Fig. 7.2 and Table 7.10). The relationship was weaker
but still significant for 18:2 D&E indices derived from two species of plasma lipids
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Figure 7.2 Correlation of A6-desatnrase activity and microsomal phospholipid 18:2
D&E index in control and diabetic rats
139






Mic. PL A6 Mic. PL Plasma PL
(22:5/22:4) 18:2 D&E 18:2 D&E
A6-desat. activity
Mic. PL A6 (18:3/18:2) index -0.179
Mic. PL A6 (22:5/22:4) index 0.652** -0.230
Mic. PL 18:2 D&E index 0.729*** -0.102 0.736***
Plasma PL 18:2 D&E index 0.545* 0.000 0.783*** 0.888***
Plasma CE 18:2 D&E index 0.526* -0.128 0.598* 0.872*** 0.869***
Values of r are derived from data from 17 animals (insulin treated and insulin withdrawn diabetic rats
(n=ll) and control rats (n=6)). * p<0.05, ** p<0.01, *** p<0.001. Mic. microsomal, PL
phospholipid, CE cholesterol ester, 18:2 D (Desaturation) & E (Elongation) refers to (18:3 n-6 + 20:2
n-6 + 20:3 n-6 + 20:4 n-6 + 22:4 n-6 + 22:5 n-6)/18:2 n-6.
All correlations with the 18:3 n -6/18:2 n-6 A6-desaturase index were not
significant (Table 7.10). However, the 22:5 n-6/22:4 n-6 A6-desaturase index




The BB diabetic rat is one of only two animal models available that are genetically
susceptible to insulin-dependent diabetes. BB diabetic prone rats spontaneously
develop autoimmune diabetes, characterised by destructive insulitis, that closely
corresponds to the situation manifest in Type 1 human diabetics (Baird, 1989;
Chanussot et al., 1989; Elias et al., 1990; Okamoto, 1990). The incidence of the
disease in the BB/E diabetic prone population is 50-60 % by the age of 90-100 d. The
model is relatively new and has not been studied extensively with respect to EFA
metabolism. Other diabetic models have been concerned with the use of toxic
diabetogenic agents such as streptozotocin (Rakieten et al., 1963) and alloxan (Dunn
et al., 1943) which produce a form of diabetes that does not fully mirror the disease
presented in humans. These toxic agents also have important side-effects on liver
(Marliss et al., 1982; Okamoto, 1990) which is particularly relevant when assessing a
hepatic based enzyme system such as A6-desaturase. Previous diabetic studies from
one laboratory group, examining A6-desaturase activity in BB rat colonies, have been
contradictory (Chanussot et al., 1989; Mimouni and Poisson, 1990; Mimouni and
Poisson, 1992). Unsuitable control groups (e.g. the use of normal Wistar rats instead
of BB Wistar) combined with inadequate assay conditions for A6-desaturase
estimation employed in these studies, may have led to some of these anomalies and
inconsistencies.
The results described also differed depending on which control group was
employed. It is essential that a control group closely parallels the experimental model.
For the BB/E diabetic rat, a non-diabetic, diabetes resistant, control is used
preferentially over the normal Wistar strain rats as they are closer linked genetically.
The origin of the diabetic and control animals in the study is shown in Figure 7.3.
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Figure 7.3 Control and diabetic group origins (Control animals selected from the
normal non-diabetic sub-line as normal non-diabetic main-line rats respond in a
variable manner to oral glucose tolerance tests (Baird, 1989))
The original control group, derived from a breeding pair of non-diabetic animals,
revealed A6-desaturase activities that were distinctly heterogeneous. Subsequent
family history examination showed that diabetes had been present in the father of the
litter. Unfortunately, this finding was not known at the time of study and therefore
liver, plasma and urine analyses were not available to give a more detailed description.
The family history of the replacement control group, also non-diabetic sub-line, was
checked thoroughly before being studied. This second group were fed the same diet
and demonstrated adipose tissue 18:2 n-6 levels, a good marker for 18:2 n-6 intake
(Wood et al., 1987; Katan et al., 1991), compatible with the original 'abnormal'
control group. The use of this new control group therefore seems justified. In
retrospect, however, some way of prior testing the control group such as a glucose
tolerance test may have highlighted the 'abnormal' control group earlier. Unfortunately,
this was not part of the project licence and therefore could not be carried out at that
time.
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As explained above, A6-desaturase activity has been examined in BB diabetic rats
but the published results have been contradictory. This present study re-examined the
effect of diabetes and employed a thoroughly characterised A6-desaturase method with
a control group that was as close as possible to the diabetic line used. A6-desaturase
activity was reduced by 25 % in the treated diabetic rats, while those that had
undergone insulin withdrawal had a A6-desaturase activity 39 % lower than controls.
The findings of this study and other studies on the diabetic BB rat are shown in Table
7.11.
Table 7.11 Comparison of studies on A6-desaturase activity and liver microsomal
fatty acid composition in the BB diabetic rat
Study Chanussot et at. Mimouni and Poisson Mimouni and Poisson Brown et at.
(1989) (1990) (1992) (1993)
BB rat Orleans strain, Orleans strain, Orleans strain, Edinburgh strain,
characteristics female, 21 weeks female, 16 weeks old, female, 16 weeks old, male, 22 weeks old,
old, 4 weeks, 3 weeks diabetic 7 weeks diabetic 9 weeks diabetic
diabetic duration duration duration duration
n/group 5 3 4 6
Time of Diab. rats analysed Diab. rats analysed Diab. rats given insulin Diab. rats analysed
analysis 20 h after last 3, 17 and 48 h after dose to achieve hypo-, 6 and 54 h after
insulin injection last insulin injection normo- and hyper-
glycaemic states
last insulin injection
Control rat Normal Wistar, Normal Wistar, Non-diabetic, Wistar Non-diabetic, Wistar
characteristics female rats, female rats, BB, female rats, BB, male rats,
21 weeks old 16 weeks old 16 weeks old 22 weeks old
Assay 5 mg mic. protein, 5 mg mic. protein, 5 mg mic. protein, 0.5 mg mic. protein,
conditions 40 nmol 18:2 n-6, 40 nmol 18:2 n-6, 40 nmol 18:2 n-6, 200 nmol 18:2 n-6,
5 min incubation. 5 min incubation 5 min incubation 20 min incubation
A6-desaturase No significant Control: 50.0±3.6 Control: 80.0±8.0 Control: 367±53
activity C, difference. Diab. (3 h): 49.4±7.5 Hypo- diab.: 84.8±2.2 Diab. (6 h): 277±48
Control: 43.2±16.0 Diab. (17 h): 29.5±0.8 Normo- diab.: 49.6±6.4 Diab. (54 h): 223±54
Diab.: 52.8±24.0 Diab. (48 h): 17.8±1.1 Hyper- diab.: 33.6±9.6
Microsomal Total lipid: Total lipid: Total lipid: Total phospholipid:
lipid Increased 18:2 n-6 No significant Increased 18:2 n-6 in Decreased 20:4 n-6
composition and decreased difference between hyper-glycaemic state, in insulin treated
20:4 n-6 in diab. control and diab. rats decreased 20:4 n-6 in diab. Increased 18:2
rats in 18:2 n-6 and both normo- and hyper- n-6 and decreased
20:4 n-6 glycaemic states 20:4 n-6 in insulin
withdrawn diab. rats.
Results expressed as Mean±SD. C pmol/min/mg microsomal protein. Mic. microsomal, diab. diabetic.
Further details in text below.
The first paper comparing BB/Orleans (0) diabetic rats with controls (age and sex
matched, normal Wistar rats) examined liver microsomal A6-desaturase activity, 20 h
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after the last insulin injection (Chanussot et al, 1989). Results demonstrated that A6-
desaturase activity was not significantly different from controls at this time point and
this was in contrast to the results of the microsomal total lipid n-6 fatty acid profile
that suggested a reduced A6-desaturase activity (Table 7.11). A subsequent study by
the same group (Mimouni and Poisson, 1990), examined liver microsomal A6-
desaturase activity in BB/O diabetic rats at three different time points after insulin
injection (Table 7.11). This study, using very small numbers (n=3/group), showed
decreased A6-desaturase activity in diabetic rats 17 and 48 h post insulin injection (41
and 64 % less than in controls, respectively) but not at 3 h. Wistar controls were again
used and the microsomal total lipid n-6 fatty acid composition was not significantly
altered. Of particular interest are the diabetic rats analysed 48 h after the last insulin
injection. These rats were in a severe hyperglycaemia (29.1±10.4 mM) which was
similar to that demonstrated in the present study 54 h after insulin injection (28.6±4.7
mM). High levels of microsomal non-esterified 18:2 n-6 were demonstrated in our
diabetic rats 54 h after insulin and so it would not be unreasonable to expect similarly
high values of the same fatty acid in their diabetic rat microsomes 48 h after insulin
injection. The authors, Mimouni and Poisson (1990), used 5 mg microsomal protein
with 40 nmoles [ 1 - 14C] 18:2 n-6 for their A6-desaturase estimation. Their control
microsomes were relatively low in activity (50.0±3.6 pmol/min/mg) and this may be
due to some extent to protein substrate binding. More importantly, with such high
amounts ofmicrosomal protein combined with low substrate concentrations it becomes
critical to correct for the dilution in substrate specific activity by endogenous non-
esterified 18:2 n-6. If we assume that the non-esterified 18:2 n-6 content was e8
nmol/mg microsomal protein from diabetic rats, the specific activity of [ 1 -14C] 18:2 n-6
in the assay would have been halved in comparison to non-diabetic controls. Therefore
instead of a 64 % reduction in A6-desaturase activity, it would be 32 %. Mimouni and
Poisson (1990) made no attempt to adjust for this endogenous non-esterified 18:2 n-6.
Consequently, it is difficult to perceive their results are accurate and they may be
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underestimating the effect of insulin withdrawal at this 48 h time point. Indeed, using
the combination of low substrate and high microsomal protein concentrations provides
the opportunity for control values of microsomal A6-desaturase to be likewise under¬
estimated by approximately 25 %. This by assuming the non-esterified 18:2 n-6
content as 2.0 nmol/mg microsomal protein, as documented in the present BB/E
control group, but also in rats fed either cholesterol or control diet from Chapter 5.
Nevertheless, these adjustments make no difference to the conclusion that insulin
withdrawal for 48 h leads to a significant reduction in A6-desaturase activity.
The most recent work from Mimouni and Poisson (1992) used a different approach
to determine the effect of insulin upon A6-desaturase activity in the BB diabetic rat.
Their study aimed at establishing hyper-, normo- and hypo-glycaemic states in three
groups of BB/O diabetic rats (Table 7.11). The hypoglycaemic phase (0.4±0.2 mM)
induced by giving 10 IU insulin (per kg body weight) for two consecutive days prior to
sacrifice, normalised A6-desaturase activity. Furthermore, much of the microsomal
total lipid n-6 fatty acid profile showed a similar normalisation. Our study was
designed so that A6-desaturase activity was analysed 6 h after the last insulin injection.
This time point was chosen to coincide with peak protein synthesis rates. The activity
of A6-desaturase, however, was 25 % lower than that present in control rats and it is
apparent from other data of Mimouni and Poisson (1990) that normalisation of A6-
desaturase occurs much sooner (i.e. 3 h post insulin injection; assuming low amounts
ofmicrosomal non-esterified 18:2 n-6).
Besides the methodological aspects of A6-desaturase measurement, the type of
microsomal lipid analysed for fatty acid composition is also of importance (Table
7.11). Under normal conditions, microsomes contain mainly phospholipids but
triacylglycerols and cholesterol esters are also present in minor amounts (Garg et al.,
1988b). The contribution of the latter lipids depends on nutritional and hormonal state
and this is particularly relevant in diabetes. For example, in uncontrolled diabetes liver
triacylglycerol content is dramatically increased (Murthy and Shipp, 1979; Howard,
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1987). Microsomal triacylglycerol fatty acid composition differs markedly from that of
phospholipids and so any increase in the proportion of this lipid will affect the total
lipid fatty acid profile, in particular 20:4 n-6. The fatty acid profile of total microsomal
phospholipids may therefore not be particularly useful for estimation of desaturase
activities under different levels of circulating insulin. The use of a defined lipid pool,
such as phospholipids, may therefore be superior in monitoring the differences that
occur.
As with the previous chapters, rats were provided diets with a fatty acid
composition which was devoid of all n-6 fatty acids other than 18:2 n-6. This means
that fatty acids derived from 18:2 n-6 in lipid pools, such as microsomal phospholipids,
may be used as an indicator of 18:2 n-6 metabolism. The microsomal phospholipid
18:3 n-6/18:2 n-6 A6-desaturase ratio was increased in the insulin treated diabetic rats
but not significantly different in the insulin withdrawn group. The other A6-desaturase
ratio (22:5 n-6/22:4 n-6) was decreased in the insulin treated diabetics and lower still
in the diabetics withdrawn from insulin. It is therefore apparent that the indices for A6-
desaturase differ depending on which fatty acids are used. Values obtained for the
activity of the enzyme relate well with the 22:5 n-6/22:4 n-6 ratio for A6-desaturase
and the index for total 18:2 n-6 desaturation and elongation. Yet, the more specific
ratio (18:3 n-6/18:2 n-6) bears no relationship with A6-desaturase activity and
suggests that other factors are involved in the regulation of phospholipid fatty acyl
composition as suggested by Poisson and Cunnane (1991).
Adipose tissue triacylglycerol fatty acid composition was markedly altered by
diabetes almost regardless of insulin treatment for the two days prior to sacrifice. Both
diabetic groups presented lower relative amounts of n-6 and n-3 fatty acids with
compensatory increases in the saturated and monounsaturated acids. Thus, even
though once daily insulin injections maintained body weight, the treatment failed to
normalise adipose tissue fatty acid composition. Only a small number of studies
specifically document adipose triacylglycerol fatty acid composition in diabetes under
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controlled dietary conditions. Reports of human diabetic adipose tissue composition
are limited and generally show that there are no differences between diabetic and
normal subjects (Heffernan, 1964; Antonini, et a/., 1970) but of course these studies
lack dietary control.
Data on animals have been only concerned with experimentally induced diabetes to
date. Streptozotocin induced diabetic rats show some similarities with the BB/E
diabetic rat (Huang et al., 1984). These include elevated amounts of 18:1 and
depressed levels of 20:4 n-6, 22:5 n-6, 20:5 n-6 and 22:6 n-3. However, adipose
18:2 n-6 was raised in contrast to the BB/E diabetic rat. Alloxan induced diabetes
shows an even greater contrast (Brenner et al., 1968). Here the relative amounts of
18:2 n-6 and 20:4 n-6 were raised and the monounsaturated and saturated components
decreased in epididymal fat compared with controls. This may relate to site specific
differences in adipose tissue composition (Calder et al., 1992), but also the extra-
pancreatic toxicity of the diabetogenic agent.
In summary, it is clear that the activity of A6-desaturase is depressed in the insulin
treated BB diabetic rat and reduced fractionally further by insulin withdrawal.
Microsomal phospholipid fatty acid composition is altered in a manner that overall
reflects this reduction of 18:2 n-6 metabolism but the more specific index for A6-
desaturase (18:3 n-6/18:2 n-6) shows no relationship with activity. Despite a
normalisation of plasma lipid levels, the n-6 fatty acid profile is also indicative of an
impaired 18:2 n-6 metabolism. This is evident in both phospholipids and cholesterol
esters. Further still, adipose tissue triacylglycerol fatty acid composition is not
normalised by long term insulin therapy despite maintenance of body weight. It is
therefore apparent from combining the above results with observations from the
current literature that insulin therapy given subcutaneously does not provide adequate
control to normalise A6-desaturase and other parameters measured. Ideally, the
situation to be attained is for insulin therapy to be relevant for metabolic need. A large
dose of insulin (double that required to maintain body weight and plasma lipid content)
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can possibly correct the deficiency in A6-desaturase experimentally but is associated
with extreme hypoglycaemia (Mimouni and Poisson, 1992). It is also not clear how
relevant this is to diabetic patients. Tighter control of blood glucose concentrations,
with consequent lower HbAj levels, have been associated with lower progression rates
of neuropathy in patients but a greater frequency of hypoglycaemic phases (Diabetes
Control and Complications Trial Research Group, 1993). Whether such treatment
results in an improved A6-desaturation of 18:2 n-6 remains to be seen. However,
improved nerve function has been shown experimentally by bypassing A6-desaturase
with y-linolenic acid (Lockett and Tomlinson, 1992) and it may be more rational to
supplement with this fatty acid in addition to achieving a reasonable control of
glycaemia in diabetic patients. Beneficial effects of y-linolenic acid supplementation on
nerve conduction have been demonstrated in diabetic patients (Jamal et al., 1986;
Keen et al., 1993). Therefore until the effects of insulin therapy on A6-desaturation in
man are understood, direct supplementation with y-linolenic acid may be the way




The explanation for the high CHD mortality rates in Scotland and other analogous
regions in northern latitudes is still not fully understood. Dietary factors, such as a low
intake of 18:2 n-6 have been associated with the disease process (Logan et al., 1978)
but an impaired metabolism of 18:2 n-6 to 20:3 n-6 and 20:4 n-6 has also been
suggested in case-control and cross-sectional studies of CHD (Wood et al., 1984;
Riemersma et al., 1986; Abraham et al., 1990). The A6-desaturation of 18:2 n-6,
believed to be rate limiting step in the conversion of 18:2 n-6 to 20:4 n-6, is slow in
humans (De Gomez Dumm et al., 1975) and may be influenced by known CHD risk
factors, such as raised serum cholesterol, stress and diabetes. In this thesis, the effects
of a number of risk factors for CHD on the activity of liver microsomal A6-desaturase
activity and tissue fatty acid composition were examined.
At the outset of the work a range of methodological aspects pertinent to the study
of A6-desaturase were considered. Argentation TLC was employed to separate the
substrate from the products of A6-desaturation. This approach, in combination with
scintillation counting, provides greatest sensitivity but lacks the specificity of
techniques such as GLC and HPLC which can separate 18:3 n-6 from 20:3 n-6.
Nevertheless, these two products would have to be summated if analysed by GLC or
HPLC to obtain total A6-desaturase activity. Of course using GLC or HPLC can
provide information about the specific activity of 18:3 n-6 which would be necessary
to interpret any 20:3 n-6 data. Since, malonyl-CoA is not routinely added to the A6-
desaturase incubation mixture there is little formation of 20:3 n-6 anyway. Therefore
with these provisos in mind the results using argentation TLC are valid.
Another concern using argentation TLC was the potential for the formation of
oxidised substrate that could interfere with A6-desaturation measurement. Products
originating from 18:2 n-6 oxidation have a reduced mobility during argentation TLC
and may coincide with the 18:3 n-6 band. The assay routinely used in the work
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described in this thesis contained antioxidants and there was no evidence that under the
conditions employed (using BHT and argon during work up) that 18:2 n-6 was
oxidised in blanks or by boiled microsomes.
Contamination of the microsomal fraction with mitochondria and/or peroxisomes
was also considered as a potential source of error in the estimation of A6-desaturase.
The activity of succinate dehydrogenase, a marker of mitochondrial contamination,
was low and did not differ significantly between control and cholesterol fed rats. In
addition, the products generated by peroxisomal P-oxidation (mainly acetate and water
soluble compounds), would not interfere with the estimation of A6-desaturase as they
are not extracted into the solvent phase.
Packed column GLC was used to separate tissue fatty acid methyl esters for
subsequent calculation of A6-desaturase indices. This technique does not separate 18:3
n-6 from 20:0 and so strictly speaking the 18:3 n-6/18:2 n-6 A6-desaturase ratio is
incorrect. Nevertheless most of this peak contains 18:3 n-6 (approximately 80 %
estimated by capillary GLC) and in the first cholesterol feeding study (Chapter 4) there
was no systematic effect on the amount of 20:0 in microsomal phospholipids
suggesting that this is not a major source of error.
Therefore by establishing a very sensitive technique to measure microsomal A6-
desaturase activity and by limiting the extent to which substrate oxidation affects its
measurement, it was possible to assess accurately the effects of specific factors on
linoleic acid A6-desaturation in the rat. Comparisons between A6-desaturase activity
and tissue fatty acid compositions (product-precursor ratios) are discussed below.
Sprague Dawley rats subjected to isolation stress had a lower liver microsomal A6-
desaturase activity than controls and this finding was recently confirmed in
normotensive (Wistar Kyoto) and spontaneously hypertensive rats by Mills et al.
(1994). Diabetes, generally assumed to be associated with a reduced A6-desaturase
activity, was also investigated. Diabetic models using chemical diabetogenic agents
were avoided as it is questionable whether these models adequately reflect the situation
presented in humans (Marliss et al., 1982; Baird, 1989). Animals that spontaneously
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develop autoimmune diabetes, such as the BB/E diabetic rat, have distinct advantages
over these earlier models in that the disease exhibited closely resembles that found in
Type I human diabetics (Baird, 1989). Moreover, insulin can be administered at
varying levels to achieve different degrees of diabetic control. Under conditions of
regular insulin treatment BB/E diabetic rats had a 25 % lower liver microsomal A6-
desaturase activity compared to non-diabetic controls. The activity of A6-desaturase
was reduced slightly further in BB/E diabetic rats in whom insulin treatment was
withdrawn for 54 h. An important finding in the insulin withdrawn group was the
marked elevation of microsomal non-esterified 18:2 n-6 levels which possibly explains
previous inconsistent published results. By not using the correct specific activity one
would in fact underestimate the activity of A6-desaturase in diabetic animals. This
could therefore cast doubt on the correctness of some of the published results. The
concentration of microsomal non-esterified 18:2 n-6 in the present optimised assay
system, although theoretically important, did not seriously affect the activity of A6-
desaturase. Clearly, assay conditions are important for an accurate assessment of the
activity of this enzyme.
Other work on risk factors, examining the role of dietary cholesterol
supplementation on A6-desaturase activity, consistently demonstrated, though contrary
to expectations, a significant increase in activity compared with controls. This result
was observed when the optimised assay for A6-desaturase (developed for this project)
was used as well as when the sub-optimal assay conditions as detailed by Garg et al.
(1988a) were deliberately employed. Sub-optimal measurements exhibited 30-fold
lower A6-desaturase activities and were characterised by a larger standard deviation of
replicate analyses. Differences in the level of microsomal non-esterified 18:2 n-6
between optimal and sub-optimal assay conditions could not explain these divergent
results. Furthermore, isolation of rats believed to alter the effect of cholesterol feeding
on A6-desaturase did not modify the cholesterol-induced increase in activity.
Measurements of A6-desaturase in vitro and in vivo gave constrasting results. Data
from the in vitro assay demonstrated a cholesterol-induced increase in activity. The
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results obtained in vivo indicated the opposite. A number of reasons may explain this
difference. For example the in vitro assay was designed to obtain maximum A6-
desaturase activity by providing saturating substrate and cofactors; a situation not
present in vivo. In addition, certain inhibitors of the A6-desaturative process in vivo
may be too dilute to interfere with the process in vitro or may have been lost during
microsomal preparation. Until this has been fully resolved, in vitro data on its own
should be considered with some caution.
Product-precursor ratios of fatty acids esterified to microsomal phospholipids,
frequently used to assess the activity of a particular fatty acid metabolic conversion,
were also examined in the above studies. For example, the 18:3 n-6/18:2 n-6 ratio (A6-
desaturase index) in BB/E diabetic rats, treated regularly with insulin, was increased
compared with controls (direct A6-desaturase measurements showed a 25 % decrease
in activity). However, the same ratio did not differ from controls in diabetic animals in
whom insulin was withdrawn, although A6-desaturase activity was 39 % lower in these
rats compared with controls. In contrast, the 22:5 n-6/22:4 n-6 ratio, which also
reflects A6-desaturase activity, was decreased in insulin treated diabetic rats and
reduced slightly further by insulin withdrawal. Indeed, this fatty acid ratio correlated
well with microsomal A6-desaturase activity as well as with an overall index of 18:2
n-6 metabolism (calculated from adding all microsomal phospholipid n-6 fatty acids
derived from 18:2 n-6 and dividing by 18:2 n-6). It is therefore evident that n-6 fatty
acid compositions and the derived fatty acid ratios, do not adequately relate to the
activity ofA6-desaturase in liver microsomes.
Adipose triacylglycerol and plasma phospholipid fatty acid compositions, used in
human studies as indicators of intake and metabolism of 18:2 n-6 (Riemersma et al.,
1986; Wood et al., 1987), showed small, inconsistent changes in our rats. Isolation did
not affect these compositions at all. Such variable results with two CHD risk factors
occurred despite the fact that these studies were tightly controlled using inbred strains
and semi-synthetic diets. It is therefore unlikely that in human studies, where variations
in both dietary intake and genetic origin occur, the difference observed with A6-
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desaturase indices based on plasma and adipose tissue fatty acid composition can be
interpreted to indicate the activity of this pathway. Of course, adipose 18:2 n-6 is
generally accepted as a good indicator of long term dietary intake of this EFA in an
individual but the situation is further complicated by specific dietary advice given to
sections of the community (diabetics, hyperlipidaemics, and other subjects with a high
risk ofCHD). In the absence of a valid marker (i.e. A6-desaturase index on the basis of
fatty acid compositions of plasma or adipose tissue) that can be used in population
studies, extrapolation to the human situation is virtually impossible for A6-desaturase.
Extrapolation of rat data to humans, cannot be necessarily justified also in view of
major differences between species in A6-desaturase activity, in resistance to cholesterol
feeding and in other aspects of lipoprotein metabolism. Future studies should therefore
be carried out to assess the effect of CHD risk factors on A6-desaturase activity in
humans. Obviously, the use of liver biopsies from human volunteers for A6-desaturase
estimation is not ethical and alternative methods are required. Appraisal of 18:2 n-6
metabolism in vivo using [I3C] 18:2 n-6 (Emken et al., 1987; Emken et al1990) is not
widely used because of the high cost of the stable isotope and associated separation
and detection equipment (gas liquid chromatography-mass spectrometry). In addition
the method does not give a quantitative measure of whole body A6-desaturase activity.
Another method that is potentially applicable to human and epidemiological studies is
the measurement of A6-desaturase in circulating blood cells. Cunnane has claimed that
isolated white blood cells have measurable activity (Cunnane et al., 1984). However,
this methodology has not been validated in humans using stable isotopes or in animals
by measuring both liver microsomal and white blood cell A6-desaturase activity.
However, if suitable cells exist in which A6-desaturase activity reflected that of the
liver then raising antibodies to the terminal A6-desaturase protein of such cells may
provide another potential way for the assessment of an individual's ability to
metabolise 18:2 n-6. This latter method, which necessitates isolation and purification
of the human A6-desaturase enzyme complex, could be very useful and permit
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differentiation between active and inactive forms of the enzyme and so allow the
identification of factors that induce enzyme synthesis and activation.
Extrapolation of data derived from the rat cholesterol feeding experiments to
humans may be difficult to justify. The typical cholesterol content in the human diet is
in the order of 300 mg per day, equivalent to approximately 4 mg/kg body weight/day.
The cholesterol enriched diet given to rats in the present study was equivalent to
approximately 200 mg/kg body weight/day. It is therefore evident that these animals
consumed much greater amounts of cholesterol than that ever naturally consumed by
humans. However, plasma cholesterol levels increased only modestly, suggesting that
the use of this type of method can be justified (A similar dietary regimen causes plasma
cholesterol levels in excess of 45 mM in rabbits; Weidinger et a/., 1991). The use of
dietary cholesterol in the present study, however, has mainly been as a tool to assess
the effect of a specific dietary factor on A6-desaturation of 18:2 n-6.
The project described in this thesis did not examine the relation between impaired
18:2 n-6 A6-desaturation and CHD, directly. In view of the fact that it is still uncertain
whether the activity in the liver microsomes in vitro reflects that in vivo, as discussed
above, it would be hasty to draw wide ranging conclusions. Nevertheless it is
worthwhile to reconsider this hypothesis in some detail.
First of all, the results suggest that dietary cholesterol possibly decreases the
activity of A5-desaturase more than that of A6-desaturase. This was observed in the in
vivo experiments in particular. Furthermore, the overall index of 18:2 n-6 desaturation
and elongation was consistently decreased despite increased or decreased A6-
desaturase activity in the cholesterol fed or diabetic animals. This suggests that other
factors that control the metabolism of 18:3 n-6, whether elongation followed by
desaturation by A5-desaturase or incorporation into phospholipids are affected to a
larger degree than the so called rate limiting step of A6-desaturase. This raises the
question whether A6-desaturase should be linked with the development of CHD in the
first place.
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There are several mechanisms whereby a low activity of this enzyme could increase
the risk of CHD. y-Linolenic acid has been claimed to lower serum cholesterol levels
(Horrobin and Manku, 1983; Horrobin, 1992). However, human studies using a range
of 18:3 n-6 intakes (by supplementing with evening primrose oil) do not support this
finding (Abraham et al., 1990). It is also unlikely that the activity of A6-desaturase
could influence tissue levels of 20:4 n-6 and hence the production of prostanoids in a
major way. First of all careful dietary feeding studies using 18:2 n-6 rich diets have
shown that it is virtually impossible to change the amount of 20:4 n-6 in cardiac
phospholipids (with the exception of fish oil; Sargent, 1990). The effect of prostacyclin
and thromboxane A2, both formed from phospholipid 20:4 n-6, differ in their effects on
the cardiovascular system. Prostacyclin inhibits platelet aggregation, induces
vasodilation and prevents ischaemic arrhythmias, whilst thromboxane A2 does
essentially the opposite. Therefore it is the balance between prostacyclin and
thromboxane A2 that determines whether there is a pro-thrombotic of pro-arrhythmic
effect. Secondly, the amount of 20:4 n-6 released is under the control of phospholipase
A2 and the levels of prostacyclin and thromboxane A2 produced are controlled by
prostanoid synthase. Thus it is questionable that the relative amount of 20:4 n-6 could
be the main determinant of prostanoid production. Recent studies suggest there are
differences in constitutive and inducible forms of prostanoid synthase (PGHS-1 and
PGHS-2) and if the analogy with nitric oxide is valid (Xie and Nathan, 1994) it may be
that the factors that cause an induction of PGHS-2 are more closely related to the
pathological changes and inflammation than the activity of PGHS-1 itself (Hla, 1992;
Vane, 1994).
Perhaps there are other explanations for the apparent association between low A6-
desaturase and CHD. Low A6-desaturase activity is proposed to be associated with
diets low in EFA and rich in SFA. Under these conditions, the inverse association
between adipose 16:1 and 18:2 n-6 has been observed for a long time (Kingsbury et
al., 1974; Wood et al., 1984). Furthermore, if an increased A9-desaturation of 18:0
occurs the resulting elevated content of 18:1 could overwhelm the A6-desaturation of
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18:2 n-6. Similarly, lack of access of 18:2 n-6 to the enzyme, perhaps because it is
conserved within the microsomal phospholipid pool, may decrease 20:4 n-6 levels. As
a result 20:3 n-9 levels are increased. This end product cannot be converted to 20:4
n-9 as humans and other mammals cannot insert a double bond between C2 and C3 as
they do not possess microsomal A2-desaturase. Elevated levels of 20:3 n-9 are present
in platelets of individuals that have sustained an acute myocardial infarction (Wood et
al., 1987) and this fatty acid is linked with platelet hyperactivity (Nordoy et al., 1985).
Indeed, increased levels of the pro-thrombotic 12-lipoxygenated derivative of 20:3 n-9
are formed under thrombin stimulated platelet aggregation (Lagarde et al., 1985).
Human diets rich in SFA also tend to be rich in animal fats and cholesterol. Dietary
cholesterol has little influence, however, on plasma total cholesterol levels
(Bronsgeest-Schoute et al., 1979a; Bronsgeest-Schoute et al., 1979b; McGill, 1979),
although it is now recognised that the individual response to dietary cholesterol differs
considerably and is under genetic control (apo-lipoprotein E polymorphisms). In
susceptible individuals if raised cholesterol does inhibit A6-desaturase, then this could
reinforce the effect of SFA on A9-desaturation and stimulate the formation of 20:3 n-9
further. It is noteworthy, where both dietary cholesterol and SFA are combined with
fish oil, the inhibitory effect of fish oil on A9- and A6-desaturase activities prevents a
rise in tissue 20:3 n-9 levels (Garg et al., 1988a).
Much of this is very speculative. Direct measurements of A6-desaturase activity in
CHD case control studies, in which classical risk factors will also be measured, are
needed. This to examine if low A6-desaturase is indeed a new, independent risk factor
for CHD. As the nature of such epidemiological evidence is still circumstantial,
additional proof would be required. The role of A6-desaturase in predicting
development of CHD in prospective and intervention studies, aimed at reducing
factors that inhibit A6-desaturase in humans, need to be examined. Until then, no firm
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Ingredients for the dietary salt mix (2.677 kg)
Compound Supplier Amount (g)
Calcium carbonate (CaCC^) BDH 1007
Copper chloride (CuC12.2H20) Sigma 2.35
Ferric citrate (FeC6H507) Sigma 21.95
Magnesium phosphate (MgHP04.3H20) Sigma 478
Manganese sulphate (MnS04) Sigma 33.9
Trisodium citrate (C6H507Na3.3H20) Sigma 355.5
Potassium hydrogen carbonate (KHCO3) BDH 359.5
Potassium chloride (KC1) BDH 175
Potassium dihydrogen phosphate (KH2P04) Sigma 237.5
Potassium iodate (KIO3) BDH 0.035
Zinc chloride (ZnCl2) Sigma 6.25
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Appendix B
Ingredients for the dietary vitamin mix (1.5 kg)
Compound Supplier Amount (g)
Calcium pantothenic acid Sigma 7.5
Choline chloride Sigma 750
Folic acid BDH 0.375
Menadione BDH 0.375
Myo-inositol Sigma 37.5
Nicotinic acid Sigma 7.5
Vitamin A (Retinol acetate) Sigma 0.588
Vitamin Bj (Thiamine hydrochloride) Sigma 2.250
Vitamin B2 (Riboflavin) Sigma 2.250
Vitamin B6 (Pyridoxine monohydrochloride) Sigma 0.75
Vitamin B12 (Cyanocobalamin) BDH 0.008
Vitamin D2 (Calciferol) BDH 0.140
Vitamin H (d-Biotin) Sigma 0.075
Made up to 1.5 kg with fumed silica (75 g) and sucrose (615.7 g).
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Appendix C
Ingredients for the diets (2.0 kg)
Compound Supplier Amount (g)
Cornflour A.Clark Food Service, Glasgow, U.K. 478




Beef tallow A.Clark Food Service, Glasgow, U.K. 360
Safflower oil Lipid Teknik, Stockholm, Sweden. 40
Mineral mix see Appendix A 46.6





Cobas Bio Centrifugal analyser details
No. Command Protein assay ATP assay CP assay
1 Units Pg/ml pmol/1 pmol/1
2 Calculation factor 1494 0 0
3 Standards 100, 200, 300, 400, 500 684, 684, 684 1125, 1125, 1125
6 Limit 0 2000 2000
7 Temperature. (°C) 37 37 37
8 Analysis type 7.6 6 6
9 Wavelength (nm) 750 340 340
10 Sample volume (pi) 10 15 0
11 Diluent volume (pi) 30 15 0
12 Reagent volume (pi) 240 340 0
13 Incubation time (s) 600 80 10
14 Start reagent volume (pi) 45 8 8
15 Time of first reading (s) 0.5 60 60
16 Time interval (s) 60 10 10
17 Number of readings 7 10 10
18 Blanking mode 1 1 5
19 Printout mode 5 1 1
No. Command Cholesterol assay Triacylglycerol assay
1 Units mmol/1 mmol/1
2 Calculation factor 0 0
3 Standards 8.82, 8.82, 8.82 3.58, 3.58, 3.58
6 Limit 10 7
7 Temperature. (°C) 37 37
8 Analysis type 1 6
9 Wavelength (nm) 500 340
10 Sample volume (pi) 5 8
11 Diluent volume (pi) 40 40
12 Reagent volume (pi) 340 320
13 Incubation time (s) 0 120
14 Start reagent volume, (pi) 0 8
15 Time of first reading (s) 0.5 0.5
16 Time interval (s) 20 600
17 Number of readings 19 02
18 Blanking mode 1 1
19 Printout mode 1 1
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Appendix E
Table E.l Body and liver weights of ratsfed a control or cholesterol enriched dietfor
30 days at 8, 24 and 48 h after administration ofradioactivefatty acids
Measurement Time (h) Control Choi. Significance
Weight (g)
Body 8 268±14 259±27 n.s.
24 275±23 266±55 n.s.
48 291±44 282±43 n.s.
Liver 8 8.7±0.8 10.4±1.3 *
24 11.6±1.2 12.6±2.7 n.s.
48 11.4±1.8 12.3±2.3 n.s.
Relative weight (%) 8 3.2±0.1 4.0±0.1 ***
24 4.2±0.2 4.7±0.4 *
48 3.9±0.1 4.4±0.3 *
Values expressed as Mean±SD. * p<0.05, *** p<0.001 vs. control.
Table E.2 Microsomal cholesterol and phospholipid contents and A6-desaturase
activity of ratsfed a control or cholesterol enriched diet for 30 days at 8, 24 and 48 h
after administration ofradioactive fatty acids
Measurement Time (h) Control Choi. Significance
Cholesterol £, 8 88±7a 108±19a n.s.
24 75±8b 114±28a *
48 69±8b 92±15a *
Phospholipid £ 8 463±23a 462±30a n.s.
24 456±26a 487±36a'b n.s.
48 497±20b 502±20b n.s.
Cholesterol/phospholipid \g 8 0.19±0.02a 0.23±0.05a n.s.
24 0.17±0.02a-b 0.23±0.05a *
48 0.14±0.02b 0.18±0.04a *
A6-desaturase activity C 8 490±82a 611±128a n.s.
24 466±43a 455±105b n.s.
48 455±45a 470±69b n.s.
Values expressed as Mean±SD. * p<0.05 vs. control. % nmol/mg protein, vg mol/mol, C A6-desaturase
activity estimated with 0.5 nig microsomal protein (activity expressed as pmol/min/mg). Single a, b, c
unlike symbols indicate statistical significance (p<0.05) between two groups in the vertical plane for a
particular measurement by unpaired t-test after significant (p<0.05) one-way ANOVA.
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Table E.3 Microsomal totalphospholipidfatty acid composition of rats fed a control
or cholesterol enriched diet for 30 days at 8, 24 and 48 h after administration of
radioactive fatty acids
Fatty acid species Time (h) Control Choi. Significance
18:0 8 265±15 265±15 n.s.
24 215±17 220±40 n.s.
48 263±15 237±31 n.s.
18:1 8 89±8 107±8 **
24 109±12 144±19 **
48 103±10 142±6 ***
20:1 8 1.2±0.1 1.4±0.2 *
24 1.6±0.5 3.0±1.0 *
48 2.0±0.7 3.1±0.7 *
n-6
18:2 8 79±11 106±11 **
24 109±9 146±19 **
48 106±6 138±9 ***
18:3 # 8 0.6±0.3 0.9±0.3 n.s.
24 2.3±0.7 2.0±0.4 n.s.
48 1.3±0.2 1.5±0.3 n.s.
20:3 8 8.0±2.0 14±3 **
24 16±1 22±3 **
48 19±2 26±1 ***
20:4 8 240±9 206±19 **
24 192±13 170±13 *
48 226±11 193±7 ***
22:4 8 2.7±0.2 1.9±0.3 ***
24 2.4±0.5 1.8±0.8 **
48 2.6±0.5 1.8±0.2 **
22:5 8 6.4±1.8 3.5±1.7 *
24 5.9±1.6 4.3±1.5 n.s.
48 11±3 5.4±1.2 *
Values expressed as nmol/mg microsomal protein (Mcan±SD). * p<0.05, ** p<0.01, *** p<0.001 vs.
control. # Unresolved peak contained unspecified amounts of 20:0.
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Table E.4 Microsomal total phospholipidfatty acid composition of rats fed a control
or cholesterol enriched diet for 56 days at 8, 24 and 48 h after administration of
radioactive fatty acids
Fatty acid species Time (h) Control Choi. Significance
18:0 8 259±24a 277±18a n.s.
24 218±18b 196±14b *
48 232±19b 205±15b *
18:1 8 83±6a 115±9a ***
24 102±7b 138±8b ***
48 100±7b 150±llb ***
20:1 8 1. l±0.2a 1.6±0.3a *
24 1.4±0.2b 3.0±0.5b ***
48 1.9±0.2C 3.0±0.6b **
n-6
18:2 8 86±lla 117±7a ***
24 99±5b 129±9b ***
48 94±7a'b 120±7a'b ***
18:3 # 8 0.9±0.1a l.l±0.1a **
24 3.2±0.6b 2.7±0.3b n.s.
48 1.9±0.2C 1.6±0.4C n.s.
20:3 8 8.6±1.2a 15±la ***
24 16±lb 20±lb ***
48 18±2C 22±3b *
20:4 8 231±29a 223±28a n.s.
24 199±14b 175±10b **
48 205±16a'b 188±15b n.s.
22:4 8 2.5±0.3 1.9±0.3 *
24 2.8±0.3 1.8±0.2 ***
48 2.4±0.3 1.7±0.2 **
22:5 8 4.4±0.8a 3.4±2.3 n.s.
24 7.0±2.1b 3.6±1.1 ***
48 8.4±2.0b 4.7±1.3 **
Values expressed as nmol/mg microsomal protein (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 vs.
control. # Unresolved peak contained unspecified amounts of 20:0. Single a, b, c unlike symbols
indicate statistical significance (p<0.05) between two groups in the vertical plane for a particular
measurement by unpaired t-test after significant (p<0.05) one-way ANOVA.
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Table E.5 Microsomal phospholipid fatty acid ratios of rats fed a control or
cholesterol enriched diet for 30 days at 8, 24 and 48 h after administration of
radioactivefatty acids































































Values expressed as Mean±SD. * p<0.05, ** p<0.01, *** p<0.001 vs. control. Single a, b, c unlike
symbols indicate statistical significance (p<0.05) between two groups in the vertical plane for a
particular measurement by unpaired t-test after significant (p<0.05) one-way ANOVA. 18:2 D




Table E.6 Distribution of 14C in microsomal phospholipid fatty acids of rats fed a
control or cholesterol enriched dietfor 30 days at 8, 24 and 48 h after administration
ofradioactive fatty acids
Label Time (h) Control Choi. Significance
[14C]phospholipid 8 3027±843 3330±1320 n.s.
24 1341±518 1579±447 n.s.
48 714±138 741±132 n.s.
f14C]dienes 8 2616±771 2901±1151 n.s.
24 877±384 1183±343 n.s.
48 242±46 337±48 **
[14C] trienes 8 181±66 222±103 n.s.
24 180±75 207±70 n.s.
48 91±15 129±24 **
[14C] tetraenes 8 171±34 103±38 *
24 254±88 123±34 *
48 363±78 243±73 *
[14C]SFA& [14C]MUFA 8 59±28 105±37 *
24 31±6 66±35 n.s.
48 18±5 32±11 *
Values expressed as DPM/mg microsomal protein (Mean±SD). * p<0.05, ** p<0.01 vs. control.
Table E.7 Specific activities of microsomal phospholipid [14C]labelled n-6 fatty
acids of rats fed a control or cholesterol enriched diet for 30 days at 8, 24 and 48 h
after administration of [1-14C]18:2 n-6
Measurement Time (h) Control Choi. Significance
N-6 diene specific activity 8 32.5±6.5 26.9±9.1 n.s.
24 7.9±3.0 8.1±2.0 n.s.
48 2.3±0.4 2.4±0.3 n.s.
N-6 triene specific activity 8 20.7±2.9 14.5±4.7 *
24 9.9±3.7 8.4±1.8 n.s.
48 4.4±0.9 4.7±0.7 n.s.
N-6 tetraene specific activity 8 0.7±0.1 0.5±0.2 n.s.
24 1.3±0.4 0.7±0.2 *
48 1.6±0.3 1.2±0.3 n.s.
Values expressed as DPM/nmol (Mean±SD). For dienes the denominator is 18:2 n-6 plus 20:2 n-6
(<1.0 nmol 20:2 n-6 per mg microsomal protein), for trienes the denominator is 18:3 n-6 plus 20:3
n-6 and for tetraenes the denominator is 20:4 n-6 plus 22:4 n-6. * p<0.05 vs. control.
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Table E.8 Distribution of 3H in microsomal phospholipid fatty acids of rats fed a
control or cholesterol enriched dietfor 30 days at 8, 24 and 48 h after administration
of [11,12-3H]18:0
Measurement Time (h) Control Choi. Significance
[3H]phospholipid 8 3280±417 2653±521 *
24 1310±388 1382±393 n.s.
48 481±169 496±151 n.s.
[3H]SFA 8 3280±417 2638±519 *
24 1256±372 1282±391 n.s.
48 459±149 449±141 n.s.
[3H]MUFA 8 n.d. 15±14 -
24 55±36 100±48 n.s.
48 21±11 47±22 *
Values expressed as DPM/mg microsomal protein (Mean±SD). * p<0.05 vs. control, n.d. not
detectable. - Not statistically feasible.
Table E.9 Specific activity of microsomal phospholipid [3H]labelled fatty acids of
rats fed a control or cholesterol enriched diet for 30 days at 8, 24 and 48 h after
administration of [11,12-3H]18:0
Measurement Time (h) Control Choi. Significance
SFA specific activity 8 7.6±0.7 6.2±1.2 *
24 3.1±0.8 3.1±0.6 n.s.
48 1.0±0.3 l.liO.3 n.s.
MUFA specific activity 8 n.d. O.liO.l .
24 0.4±0.2 0.6±0.2 n.s.
48 0.2±0.1 0.3±0.1 n.s.
Values expressed as DPM/nmol (Mean±SD). * p<0.05. For SFA specific activity the denominator is




Table E.10 Plasma total cholesterol, cholesterol ester, triacylglycerol and
phospholipid concentrations of rats fed a control or cholesterol enriched diet for 30
days at 8, 24 and 48 h after administration of radioactive fatty acids

















































Values expressed as mmol/1 (Mean±SD). * p<0.05, *** p<0.001 vs. control, a, b, c unlike symbols
indicate statistical significance (p<0.05) between two groups in the vertical plane for a particular
measurement by unpaired t-test after significant (p<0.05) one-way ANOVA.
Table E.ll Plasma total cholesterol, cholesterol ester, triacylglycerol and
phospholipid concentrations of rats fed a control or cholesterol enriched diet for 56
days at 8, 24 and 48 h after administration ofradioactive fatty acids

















































Values expressed as mmol/1 (Mean±SD). ** p<0.01 vs. control. Single a, b, c unlike symbols indicate
statistical significance (p<0.05) between two groups in the vertical plane for a particular measurement
by unpaired t-test after significant (p<0.05) one-way ANOVA.
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Table E.12 Plasma phospholipid fatty acid composition of rats fed a control or
cholesterol enriched dietfor 30 days §
Fatty acid species Control Choi. Significance
SFA
14:0 6.7±1.4 9.6±2.3 *
16:0 659±76 644±47 n.s.
18:0 737±122 670±62 n.s.
MUFA
16:1 31±6 52±13 *
18:1 400±58 524±47 **
20:1 6.8±1.6 11±3 *
PUFA (n-6)
18:2 679±90 753±74 n.s.
20:2 3.6±1.2 4.4±0.6 n.s.
18:3 4.2±1.1 5.0±0.9 n.s.
20:3 64±12 83±5 *
20:4 452±105 388±42 n.s.
22:4 6.0±3.1 4.9±0.9 n.s.
22:5 23±9 13±4 *
PUFA (n-3)
18:3 1.0±0.5 0.8±0.4 n.s.
20:5 5.2±2.3 6.4±2.4 n.s.
22:5 7.9±2.8 7.3±1.9 n.s.
22:6 84±28 68±5 n.s.
PUFA (n-9)
20:3 35±11 29±4 n.s.
I SFA 1403±194 1324±75 n.s.
EMUFA 438±64 587±61 **
E n-6 1231±192 1252±83 n.s.
E n-3 98±33 82±8 n.s.
Values expressed as pmol/1 (Mean±SD). * p<0.05, ** p<0.01 vs. control. § All measurements made
48 h after administration of radioactive fatty acids.
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Table E.13 Plasma phospholipid fatty acid composition of rats fed a control or
cholesterol enriched dietfor 56 days §
Fatty acid species Control Choi. Significance
SFA
14:0 7.9±1.6 8.8±1.5 n.s.
16:0 648±113 595±99 n.s.
18:0 690±98 569±67 *
MUFA
16:1 35±5 55±11 **
18:1 412±81 521±91 n.s.
20:1 6.5±1.6 9.1±1.5 *
PUFA (n-6)
18:2 594±93 625±104 n.s.
20:2 2.9±0.9 3.5±1.1 n.s.
18:3 # 5.1±1.3 5.0±1.0 n.s.
20:3 65±10 69±10 n.s.
20:4 451±65 377±28 *
22:4 7.3±0.9 5.0±0.6 ***
22:5 21±6 11±3 *
PUFA (n-3)
18:3 0.8±0.5 0.6±0.3 n.s.
20:5 6.4±1.4 7.8±2.3 n.s.
22:5 9.3±1.1 6.8±1.2 **
22:6 76±13 55±10 *
PUFA (n-9)
20:3 42±14 34±6 n.s.
I SFA 1346±204 1172±161 n.s.
£MUFA 453±87 585±102 *
£ n-6 1146±166 1096±133 n.s.
£ n-3 93±14 70±11 *
Values expressed as p.mol/1 (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 v.v. control. # Unresolved




Table E.14 Plasma cholesterol ester fatty acid composition of rats fed a control or
cholesterol enriched dietfor 30 days §
Fatty acid species Control Choi. Significance
SFA
16:0 149±19 283±46 ***
18:0 16±3 63±8 ***
MUFA
16:1 52±12 195±69 **
18:1 214±36 987±198 ***
20:1 2.6±0.9 21±8 **
PUFA (n-6)
18:2 427±66 422±88 n.s.
18:3 15±4 15±4 n.s.
20:3 17±5 19±10 n.s.
20:4 700±108 438±122 **
22:5 1.5±1.0 0.8±0.5 n.s.
PUFA (n-3)
18:3 0.8±0.3 2.0±0.5 **
20:5 17±7 19±10 n.s.
22:6 16±3 10±3 **
PUFA (n-9)
20:3 19±6 11±2 *
X SFA 165±21 347±51 ***
X MUFA 268±46 1203±272 ***
X n-6 1160±159 894±208 *
X n-3 34±9 31±12 n.s.
Values expressed as pmol/1 (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 vs. control. § All
measurements made 48 h after administration of radioactive fatty acids.
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Table E.15 Plasma cholesterol ester fatty acid composition of rats fed a control or
cholesterol enriched dietfor 56 days §
Fatty acid species Control Choi. Significance
SFA
16:0 131±18 301±73 **
18:0 12±2 68±22 **
MUFA
16:1 59±7 229±65 **
18:1 198±30 1171±385 **
20:1 4.6±2.5 28±6 ***
PUFA (n-6)
18:2 399±53 381±54 n.s.
18:3 # 19±2 15±4 n.s.
20:3 22±6 20±3 n.s.
20:4 753±144 448±60 **
22:4 0.9±1.0 0.8±1.0 n.s.
22:5 2.6±1.4 1.2±0.8 n.s.
PUFA (n-3)
18:3 0.4±0.4 2.5±0.9 **
20:5 26±3 25±5 n.s.
22:6 19±5 11±3 *
PUFA (n-9)
20:3 25±9 15±3 n.s
E SFA 143±20 368±95 **
EMUFA 262±37 1428±452 **
E n-6 1196±199 865±106 **
E n-3 45±6 38±6 n.s.
Values expressed as pmol/1 (Mean±SD). * p<0.05, ** p<0.01, *** p<0.001 vs. control. # Unresolved




Table E.16 Adipose tissue triacylglycerol fatty acid composition of rats fed a control
or cholesterol enriched dietfor 30 days §
Fatty acid species Control Choi. Significance
SFA
14:0 2.3±0.2 2.3±0.2 n.s.
16:0 23.1±0.6 22.5±0.6 n.s.
18:0 11.2±0.9 ll.Oil.O n.s.
20:0 O.liO.O 0.1±0.0 n.s.
MUFA
16:1 4.2±0.5 4.2±0.6 n.s.
18:1 46.3±1.3 46.9±0.9 n.s.
20:1 1.2±0.1 1.3±0.1 n.s.
PUFA (n-6)
18:2 9.9±0.4 10.0±0.3 n.s.
20:4 O.liO.O O.liO.O n.s.
PUFA (n-3)
18:3 0.4±0.0 0.4±0.0 n.s.
Values expressed as % (w/w) total fatty acids (Mean±SD). § All measurements made 48 h after
administration of radioactive fatty acids.
Table E.17 Adipose tissue triacylglycerol n-6 diene content, radioactivity and
specific activity of ratsfed a control or cholesterol enriched diet for 30 days §
Measurement Control Choi. Significance
N-6 diene radioactivity vp 5700±2200 5800±2100 n.s.
N-6 diene content \ 2280±650 2450±210 n.s.
N-6 diene specific activity 2.5±0.6 2.3±0.7 n.s.
Values expressed as Mean±SD. vj/ DPM/10 mg adipose tissue, § nmol/10 mg adipose tissue. § All
measurements made 48 h after administration of radioactive fatty acids.
Table E.18 Adipose tissue triacylglycerol [3H]18:0 metabolism of rats fed a control
or cholesterol enriched dietfor 30 days §
Measurement Control Choi. Significance
[3H]SFA 2060±540 1890±1040 n.s.
[3H]MUFA 560±210 540±120 n.s.
Values expressed as DPM/10 mg adipose tissue (Mean±SD). § All measurements made 48 h after





Figure E.l Plasma total I4C of rats fed a control or cholesterol enriched diet for 56
days at 8, 24 and 48 h after administration of [1-I4C]18:2 n-6. * p<0.05 compared




Figure E.2 Plasma total 3H of rats fed a control or cholesterol enriched diet for 56







Figure E.3 [14C]labelled plasma phospholipids in rats fed a control or cholesterol
enriched diet for 56 days at 8, 24 and 48 h after administration of [1-14C]18:2 n-6.
No significant differences observed.
DPM/ml
Time (h)
Figure E.4 [3H]labelled plasma phospholipids in rats fed a control or cholesterol
enriched diet for 56 days at 8, 24 and 48 h after administration of [11,12-3H]18:0.









Figure E.5 [14C]labelled plasma cholesterol esters in rats fed a control or
cholesterol enriched diet for 56 days at 8, 24 and 48 h after the administration of






Figure E.6 [3H]labelled cholesterol esters in rats fed a control or cholesterol
enriched diet for 56 days at 8, 24 and 48 h after administration of [11,12-3H]18:0.









Ingredients for the Rat and Mouse No. 1 (Modified) diet, S.D.S. Witham, Essex, U.K.
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